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Abstract 
 
LIM-homeodomain (LIM-HD) proteins are a class of transcription factors involved in 
tissue specification and cell determination during development and are important in adult gene 
regulation. Six families of LIM-HD proteins, with two close paralogues in each family, are 
commonly found in tetrapods. They bind DNA via HDs, whereas their interactions with other 
proteins are mediated mainly by a pair of closely spaced LIM-domains (LIMs) in each protein. 
These proteins take part in various transcriptional complexes with Ldb1 and other cofactors that 
contain LIM-interaction domains (LIDs).  
In this thesis, protein-protein interactions of LIM-HD proteins were analysed in order to 
better understand the molecular mechanisms of transcriptional complex formation.  
Based on previous research that showed LIM-LID mediated interactions between Lhx3 
and Isl1, yeast two-hybrid mating arrays were used to investigate how widespread protein-
protein interactions are amongst the 12 mammalian LIM-HD proteins. Due to high levels of 
background growth in experiments with full-length proteins in pGBT9 vectors, the mating arrays 
focused on LIM-domain mediated interactions with full-length LIM-HDs or known LIDs. The 
arrays revealed a relatively strong interaction between Lhx3 (or Lhx4) and Isl1 (or Isl2), and 
detected weaker interactions between Lmx1a or Lmx1b and the LIM-binding domain of Isl1.  
The contribution of separate LIM-domains to the overall interaction with Ldb1 for each 
of the proteins was analysed by the same method. In most cases one of the LIM domains in each 
protein was able to independently interact with the LID domain of Ldb1 by yeast two-hybrid 
analysis indicating a dominant binder: LIM1 in Isl1 and Isl2, or LIM2 in other proteins. The 
exceptions were paralogues Lhx1 and Lhx5, for which no separate domain showed interaction 
with Ldb1LID by this approach. All tandem LIM-domain constructs showed a much stronger 
interaction with Ldb1LID than any isolated LIM domain supporting the idea that both domains are 
required for high affinity binding to Ldb1. 
Bimolecular Fluorescence Complementation experiments in yeast were designed and 
conducted as an alternative approach to test interactions between full-length LIM-HD proteins in 
the hope that a non-transcription based assay would lead to no or less background signal 
compared to yeast two-hybrid analysis. A plasmid system was developed based on existing yeast 
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two-hybrid vectors using split green fluorescent proteins in place of domains from the GAL4 
transcription factor. The assay was able to detect interactions between different LIMs and their 
partners but unfortunately interactions between full-length proteins were still difficult to detect 
due to low fluorescence, self-complementation in the controls and localization effects. 
LIM domains from LIM-HD proteins cannot be used in standard bimolecular binding 
assays because they tend to be insoluble and/or aggregate in the absence of a binding partner. 
Stable, soluble intramolecular ‘tethered complexes’ can be generated in which LIMs are tethered 
to Ldb1LID via a flexible linker. Introduction of a specific protease site into the tether allows the 
formation of intermolecular cut complexes, which have previously been used in homologous 
competition ELISA experiments.  
In this thesis attempts were made to develop more robust biophysical binding assays that 
could be used to assess the binding affinities of different LIMs for Ldb1LID. Several different 
labelling approaches were used to generate proteins with fluorescent tags for use in fluorescence 
anisotropy assays. In one of these approaches expressed protein ligation was applied to generate 
proteins with an N-terminal fluorescein. Although this labelling strategy was of low efficiency 
for LIMs-Ldb1LID tethered constructs, some preliminary fluorescence anisotropy experiments 
were carried out, which indicated that this could be a useful strategy providing a more efficient 
labelling strategy can be found. GFP-tagged tethered complexes were easier to generate, but 
could not be used in anisotropy experiments because of the intrinsically high anisotropy of GFP 
proteins. However, preliminary experiments indicated that these proteins can be used in clear 
native gel shift competition assays to compare binding affinities of different tandem LIM 
domains to Ldb1LID.  
Data presented in this thesis provide valuable insight into protein-protein interactions of 
LIM-HD transcription factors and the advantages, as well as disadvantages, of applied 
experimental approaches. The results and their implications are discussed, raising questions that 
can be resolved in future studies. 
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Chapter 1    Introduction 
1.1 Complex interactions of transcription factors 
Regulation of gene expression is a process that has likely been in place for more than 3 
billion years, and is still ongoing in every living cell today. It follows inherited genetic programs 
and epigenetic effects, which are modulated by extracellular signals that are, in turn, brought 
about through actions of macromolecular complexes.  
Transcription factors (TFs) are proteins that are involved in the regulation of gene 
expression at the level of transcription and take part in the chromatin-bound macromolecular 
complexes. TF complexes interact with gene-regulatory elements (REs), RNA polymerases, 
histones, and with each other, to activate or repress transcription [1-4]. These complexes are 
dynamic and overlapping entities that include the pre-initiation complex (PIC), Mediator 
complex (or other co-activators), chromatin remodelling complexes (CRCs such as NuRD and 
BAF), insulators and others. The complexity of TF-interactions is evident in a following model 
of gene activation.   
In order to activate transcription, 'pioneer' transcription factors infiltrate more densely 
packed chromatin and bind regulatory elements (REs) in the regions that have been primed (or 
'bookmarked') by CRCs (Figure 1.1) [5]. 
Master TFs (e.g., Oct4, Sox2, Nanog, Klf4, etc.) bind primed so-called super-enhancers 
and are pulled out into more active regions of chromatin while larger complexes are 
progressively assembled and the local chromatin structure is modified due to CRC activity. The 
larger complexes potentially prevent the diffusion of regulatory elements back into inactive 
chromatin. The enhancer-bound complexes recruit components of Mediator (a multiprotein 
assembly that acts as a co-activator of transcription) or other co-activator complexes, whereas the 
promoter-bound complexes (which contain a pre-initiation complex at various degrees of 
assembly) are brought from less active chromatin regions to join them. In some cases, insulator 
factors such as CTCF rearrange to release a loop that contains the gene that is about to be 
activated. Chromatin looping caused by interactions between these two types of complexes is  
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Figure 1.1 A stylized model of transcriptional activation in eukaryotes. (A) So-called transcription factories in 
the active chromatin are represented by coloured circles and the associated chromatin loops are shown as grey and 
black lines. A chromosomal territory (area in the nucleus where an interphase chromosome is located) is shown as a 
green oval. (B) Activation of gene expression. The activity of chromatin remodelling complexes (CRCs; not shown) 
transforms densely packed inactive chromatin (dark grey) to relaxed active chromatin (white). A typical enhancer in 
active chromatin is bound by master transcription factors (TFs) and subsequent multiprotein transcriptional 
complexes. Transcription of non-coding RNA at enhancers attracts RNA-binding components of Mediator to move 
the assembly towards a local transcription factory. A gene that is about to be activated is 'bookmarked' by CRCs, 
resulting in a specific 'histone code' that makes the promoter accessible to pioneer TFs (position 1). As additional 
TFs bind, the promoter is pulled towards the more active chromatin (positions 2 and 3). CTCF insulators release 
unfavourable loops and create favourable loops that allow activation of a particular gene. Appropriate complexes are 
progressively assembled at proximal promoter RE (ppRE) and basal promoter (e.g., TATA block) regions. (C) 
Enhancer-ppRE connecting complexes likely initiate and (D) support the interactions of Mediator (or a similar 
coactivator) as it covers the basal pre-initiation complex (PIC) with support from cohesin rings. At this point, the 
promoter is brought into the transcription factory, the RNAPII in PIC is activated and gene transcription starts, 
generating pre-mRNA. min PIC = minimal pre-initiation complex (complete PolII and all GTFs); ppRE = promoter-
proximal response elements; GTF = general transcription factors. 
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often stabilized by cohesin rings and is characteristic of transcription factories, which are hot-
spots of transcription in the nucleus.  
During Metazoan development, induced transcriptional programs determine the ultimate 
fate of stem cells, so specific combinations of TFs are often used as markers of specific cell 
progenitors and of differentiated cells. Even in terminally differentiated cells, functions and 
response to stimuli are maintained by actions of different specific TF complexes.  
Mutations and agents that affect TF complexes can lead to developmental disorders, 
cancer and other disease, but conversely, gene regulation shows significant plasticity due to 
multiple pathways which can compensate for non-functional proteins [6]. 
1.2 Multidomain nature of TFs 
Protein-expressing genes are classified into gene families according to DNA sequence 
similarities that reflect the common origin and evolution of these sequences. Proteins are often 
classified according to common structural and/or functional elements (referred to as domains) or 
by their participation in particular protein complexes or biological processes. As most proteins 
contain several domains and are multifunctional, these classification systems partially overlap. 
TFs usually contain DNA-binding domains such as zinc fingers (ZnFs), helix-turn-helix (HTH), 
basic helix-loop-helix (bHLH), leucine zipper and others, but they generally contain additional 
domains that can mediate interactions with proteins, RNA and other cofactors. Metazoans tend to 
have TFs that contain conserved combinations of domains that give rise to complex protein 
networks that regulate inter-cell communication and create complexes that bind a large repertoire 
of REs in the non-coding genomic DNA. For example, a few thousand TFs regulate the 
expression of >20000 genes in the human genome through interactions with over a million 
known REs [7, 8]. The TF toolkit is enhanced by the existence of alternatively spliced 
polypeptide variants and modifications. 
1.3 Homeodomains (HDs) 
Homeodomains (HDs) are ~60 residue DNA-binding HTH domains that were first 
discovered in proteins coded by homeobox regions of fruitfly homeotic genes. HDs contain an 
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N-terminal basic 'arm', and two antiparallel shorter α-helices on top of a third, longer, 
perpendicular helix (Figure 1.2). HDs typically bind the TAAT core DNA sequence as 
monomers, with lower intrinsic specificity in vitro. Helix 3 is essential for DNA binding and the 
N-terminal arm that wraps around DNA provides a degree of specificity in some cases (Figure 
1.2A). However, HD proteins commonly cooperatively bind as homo- or heterodimers on hybrid 
or neighbouring DNA sites, which is thought to provide RE-specific binding of complexes in 
vivo (Figure 1.2B and C) [9-14]. Many HD-proteins contain multiple HD and/or other domains. 
For example, Zfhx3 contains four HDs and 22 C2H2 ZnFs. 
 
Figure 1.2 Homeodomain (HD) structure and classification. (A) The Clawless HD:DNA complex with DNA in 
grey surface representation and the HD shown as a red ribbon (pdb code 3A01). (B) HDs from the Drosophila 
proteins Aristaless and Clawless form a heterodimer on DNA (pdb code 3A01). (C) The Mammalian Oct4 and Sox2 
proteins form heterodimeric complexes on DNA (pdb code 1GT0). (D) Classes of HD-containing proteins in 
humans. DNA-binding specificity is increased by dimerisation on hybrid DNA sites. 
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Proteins that contain HDs are transcription factors involved in cell specification and the 
maintenance of cell-specific gene expression in terminally differentiated cells. 
Human homeobox genes can be classified into 11 classes (Figure 1.2D), which 
collectively contain over 100 gene families with a total of 235 genes [15]. One of these classes 
contains the LIM-HD proteins. 
1.4 LIM-homeodomain (LIM-HD) proteins 
LIM-HD proteins are a class of related transcription factors that contain two N-terminal, 
tandemly arrayed, ZnFs known as LIM domains, a central DNA-binding HD and a C-terminal 
region (Figure 1.3A). Some LIM-HD proteins also have N-terminal regions (95 residues in 
Lhx6) and/or a LIM-HD connecting region (~80 residues in Lhx2). The C-terminal regions of 
some LIM-HD proteins were shown to cause transcriptional activation [16, 17] and/or contain 
additional protein interaction domains [18, 19]. In several cases, alternative splicing can result in 
variants (isoforms) with alternative N-terminal or C-terminal domains, as well as variants 
lacking other domains [20-22]. LIM-HD protein variants and etymology are described in 
Appendix A. 
The twelve mammalian LIM-HD genes are grouped into six families, each consisting of a 
pair of paralogue genes (Figure 1.3B) thought to have formed by genome duplication some time 
before the last common ancestor of jawed vertebrates. In jawless fish and most other animal 
groups, one gene per family is present in the genome, whereas additional genome duplication 
events in teleost fish resulted in more paralogues in each family (Figure 1.3C)[23]. LIM-HD 
proteins are closely related to LIM-only proteins (LMO1–4), which contain related tandemly 
arrayed LIM domains but generally little other sequence, and it has been proposed that LMO 
genes descended from an ancestral LIM-HD gene [24]. Both protein groups were shown to 
function primarily as transcription factors as detailed below. 
LIM-HD proteins can bind DNA as monomers and show a preference for A/T-rich 
binding sites (Figure 1.3D) [10, 11, 25, 26]. Several promoters and enhancers were shown to 
contain monomeric, homo- and heterodimeric LIM-HD binding sites [25, 27-38]. 
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Figure 1.3 LIM-HD proteins. (A) LIM-HD protein structure schematic. Examples of tandemly arrayed LIM 
domains and HDs that are highly conserved in all LIM-HD proteins are shown; the remaining sequences are 
generally predicted to be intrinsically disordered. Positions of transactivation and/or protein interaction domains are 
indicated. The length and sequence of the intrinsically disordered regions varies between LIM-HD proteins. (B) 
LIM-HD phylogenetic tree [23, 24] with paralogue pairs shown in ovals of similar colours. (C) Evolutionary history 
of LIM-HD genes. WGD = whole genome duplication.LCA = last common ancestor. (D) Sequence logos of DNA-
binding sites for LIM-HD monomers. Taken from Lee et al., 2008 [25](Isl1 logo only) and Berger et al., 2008 [10]. 
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During animal embryonic development, LIM-HD proteins are expressed in cell 
progenitors and are involved in cell specification. LIM-HD proteins also help to maintain cell 
identity in specific differentiated cells throughout life. They are especially important for 
development of neurons in the central nervous system and sensory organs (retina, inner ear and 
olfactory neurons; Table 1.1). Patterns of expression for vertebrate LIM-HD proteins from the 
same family are mostly overlapping, but can differ in a few tissues. Combinations of two to three 
LIM-HD proteins from different families have been detected in the developing and adult 
pituitary, pancreas, intestine, limbs and reproductive system, whereas a specific LIM-HD protein 
or paralogue pair can be characteristic for the development of other cells and tissues, including 
heart, teeth, palate, kidneys, and red blood cells.   
   
Table 1.1 Proposed functions of LIM-HD genes 
Gene Function Gene Function 
Lhx3 
Interneuron and motoneuron specification in 
the ventral spinal cord; dorso-ventral 
patterning in the pituitary and for anterior 
pituitary development [39, 40]; development 
of inner ear, retina and heart [41, 42]. 
Lhx4 
Necessary for pituitary and lung development, 
axon projections of ventral MNs in spinal cord 
[41]. 
Lhx1 
Roles in blastoporal organizer activity [17]; 
important role during gastrulation for axis 
formation, regulates gastrulation movements 
[43]; required in both primitive streak-
derived tissues and extraembryonic tissues 
for head formation [44]; controls terminal 
differentiation and circadian function of the 
suprachiasmatic nucleus [45]; required for 
specification of the renal progenitor cell field 
[46]; directs the trajectories of motor axons 
in the limb [47]. 
Lhx5 
Required for normal development and 
distribution of Cajal-Retzius cells in 
mammalian cerebral cortex [48-50]. Both 
Lhx1/5 are involved in development of the 
mammalian urogenital system [51], 
consolidate the inhibitory-neurotransmitter 
(GABAergic) program of dorsal interneurons 
in the spinal cord, control Purkinje cell 
differentiation in cerebellum, activate 
transcription of Wnt antagonists in the 
forebrain and specify horizontal cell laminar 
position in retina [49, 52-55]; 
Lmx1a 
Specification of dopaminergic neurons with 
a correct midbrain identity; required for the 
proper formation of the roof plate, 
cerebellum, and the inner ear [56-58]. 
Lmx1b 
Dorso-ventral patterning of limbs and 
patterning the otic vesicle [59]; important for 
specification of serotonergic neurons [60, 61] 
and dopaminergic neurons [58, 62]; regulates 
anterior eye development [63]. 
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Gene Function Gene Function 
Lhx2 
Lhx2 controls talamocortical axonal 
guidance [64]; co-ordinates multiple 
patterning events for the formation of the 
optic cup [65]; necessary for differentiation 
of the neuroretina [66]; involved in trophic 
hormone gene regulation in the pituitary, 
development of cerebral cortex (especially 
hippocampus), limb, and erythropoiesis. 
Lhx9 
Lhx2/9 have roles in patterning the nervous 
system, wing development, muscle 
development, axon guidance, neurotransmitter 
choice [67, 68]; required for development of 
olfactory sensory neurons. Lhx9 has a role in 
early gonadal development [69]; important in 
development of retina and the reproductive 
system. Lhx2/9 are required for midline 
axonal crossing in the spinal cord [70]. 
Lhx6 
Roles in mandibular and maxilar paterning; 
in precursors of cortical interneurons 
expressing calbindin, parvalbumin, and 
somatostatin [71]; regulate migration of 
GABAergic neurons [72]. 
Lhx8 
Important in development of basal forebrain 
cholinergic neurons [73]; important for 
survival of mesenchymal cells of the tooth 
germ in development [74]; critical in early 
folliculogenesis [75]. Lhx6/8 are important for 
development of striatal interneuron subtype 
[35, 76, 77]. 
Isl1 
Specification of motoneurons and dorsal 
interneurons in spinal cord [78]; 
specification of cholinergic neurons [79, 80]; 
development of pancreatic mesenchyme and 
islet cells, development of cardiac progenitor 
cells, limbs and essential for early pituitary 
development [32, 40, 81-83]. Isl1 specifies 
the identity of hypothalamic melanocortin 
neurons [84]. 
Isl2 
Motoneuron specification in the spinal cord 
and axonal pathfinding; development of retina, 
inner ear, pancreas; promotes midline crossing 
in the visual system by gene repression [85]. 
 
Homozygous knockout mutants of LIM-HD genes (Table A2)  are embryonic or perinatal 
lethal in mice, except in the following cases. For Lhx9 pups survive but show defects in gonadal 
development) [86]. Incomplete penetrance allows survival to weaning for Lmx1a knockouts and 
to adulthood for Lhx8 (Table A.2, Appendix A). Mutations in LIM-HD genes are associated with 
a number of syndromes and diseases such as combined pituitary hormone deficiency (Lhx3 or 
Lhx4), nail-patella syndrome (Lmx1b), cleft palate (Lhx8), Mayer-Rokitansky-Kuster-Hauser 
syndrome (Lhx1) and others. Aberrant methylation or expression of some LIM-HD genes is 
associated with some types of cancer (e.g. Lhx1 in nephroblastoma, Lhx2 in leukaemia, Lhx6 in 
cervical cancer, Lhx8 in odontoma, Lhx9 in glioma) [86].   
1.5 LIM-HD proteins and the TF-codes for neuron specification 
In embryonic development, rostral-caudal (front-back) patterning of the spinal cord is 
initiated by opposing gradients of caudally-expressed fibroblast growth factor (Fgf) and rostrally 
produced retinoic acid (RA). These gradients translate into expression patterns of Hox genes that 
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correspond to their order in the Hox gene cluster. The dorsal-ventral (top-bottom) axis is 
governed by gradient of Sonic hedgehog protein (Shh; ventral), bone morphogenetic proteins 
(BMPs; dorsal) and Wnt proteins (dorsal). These gradients trigger transcriptional programs that 
specify the identities of cells in each progenitor zone, while acting to oppose adjacent 
transcriptional programs and sharpen boundaries between the neighbouring zones [87].  
The combinatorial nature of LIM-HD protein expression in the spinal cord was shown to 
be important for differentiation of neuron subclasses that segregate into different spinal columns 
and select specific axonal pathways (Figure 1.4A). This combinatorial expression was 
particularly evident for motoneurons, and lead to proposition of a motoneuron 'LIM code' [90, 
91]. Later, a similar hypothesis was proposed for the definition of boundaries in the developing 
brain [92, 93]. 
In the spinal cord, Lhx3 is the first LIM-HD protein that is expressed in mitotic cells from 
the pMN (progenitor of motoneuron) zone. The expression of the LIM-HD Isl1 and a HD-protein 
Mnx1(Hb9), is detected early in postmitotic motoneurons, overlapping with the expression of 
Lhx3 and bHLH factors (Figure 1.4A) [89, 94]. Expression of the LIM-only protein LMO4, and 
the LIM-HD proteins Isl2, Lhx1, and/or other TFs, is detected in cell groups that define spinal 
motor columns and later direct axons towards correct targets. Studies performed by Pfaff and 
colleagues suggest that potential feedback loops, mediated by Isl1, Lhx3, Mnx1, Vsx2 (Chx10 or 
Hox10), LMO4 and associated TFs, help to maintain motoneuron and V2 interneuron identities 
(Figure 1.4B) [25, 95].  
The term LIM code is an oversimplification because other HD proteins, bHLH, ETS and 
forkhead TFs are also necessary to define each stage and transition in neuron specification. In 
vitro experiments show that coexpression of key transfected TFs, Ngn2, Isl1 and Lhx3 
(collectively referred to as NIL programming), can rapidly and efficiently program cultivated 
and induced neural pluripotent stem cells (ipSCs) to acquire cervical motoneuron identity [96-
98]. By expressing Phox2a instead of Lhx3 (NIP programming), ipSCs can instead be 
programmed to acquire cranial motoneuron identity [99].   
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Figure 1.4 Transcription factor code in motoneuron specification and axon pathfinding. A) Proposed model of 
the TF expression program in spinal motoneuron cell fate determination and axon pathfinding. Ovals represent 
progenitors from the pMN, motoneuron columns or muscles. Expressed proteins are shown as squares. Sharp angles 
for Foxg1, Isl1 and Isl2 indicate lower concentrations of these proteins in specific lineages. HD proteins are in 
yellow and LIM-HD proteins have a red border. LMCl, LMCm, HMC, MMC and PGC refer to lateral portion of 
lateral motor column, medial portion of lateral motor column, hypaxial motor column, medial motor column and 
preganglionic column, respectively. This figure is adapted from figures in Alaynick et al., 2011 [88] and Lu et al., 
2015 [89]. B) Isl1 and Lhx3 proteins are essential for proposed feedback loops that sharpen the boundary between 
pMN and p2 progenitor zones in the spinal cord. All HD proteins are shown as squares. LMO4 is thought to inhibit 
the formation of complexes from low levels of misexpressed LIM-HD proteins. 
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1.6 LIM-domains  
In the early 1990's, a new type of zinc-coordinating domain was discovered in the N-
terminal regions of the C. elegans HD proteins Lin-11 [100] and Mec3 [101], and rat HD protein 
Isl1 [102]. The domain was named LIM after the first letters of these proteins and the new 
protein class was named LIM-HD proteins.  
A LIM domain is a ZnF consisting of two sequential zinc-coordinating modules, each of 
which forms a so-called treble clef fold [103], connected by a common small hydrophobic core 
(Figure 1.5A). LIM domains share the following consensus sequence:  
CX2CX16-23(H/C)X2/4(C/H/E)X2CX2CX14-21(C/H)X1-3(C/H/D/E), 
where the Zn-coordinating residues are shown in bold font. Each of the treble clef folds closely 
resembles a GATA-type ZnF [104-106], except that in a LIM domain the C-terminal helices of 
the treble clefs are of variable length, and in the first modules are very short, comprising one turn 
only (Figure 1.5A). LIM domains contain conserved hydrophobic residues that stabilize the 
separate treble clefs, form a central LIM domain core and the hydrophobic pockets for protein 
interactions.  
Unlike the GATA ZnFs they closely resemble, most LIM domains do not bind nucleic 
acids. Rather they bind proteins and often act as adaptors between multiple partner proteins [103, 
107-110]. There are, however, some reports that LIM domains from a small number of proteins 
can bind non-specifically to nucleic acids [111, 112], but at this stage there are no well-
characterised studies of DNA binding by LIM domains. 
Many LIM-domain proteins are involved in regulation of cytoskeletal dynamics including 
actin polymerisation, cross-linking and bundling all of which build scaffolding at focal 
adhesions, adherens junctions and other structures. These molecular processes are a basis for cell 
spreading, motility, growth, cytokinesis and cell specification. Many LIM-domain proteins seem 
to shuffle between cytoplasm and the nucleus implying that they are involved in both cell 
signalling and gene regulation (Figure 1.5B). Given these functions, it is not surprising that LIM 
domain proteins play important roles in the development of nervous and muscular systems [110]. 
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Figure 1.5. LIM domains and LIM domain proteins. A) LIM domain structures contain two fused treble clef 
motifs, each of which contains a small hydrophobic core (yellow) the first of which forms part of a larger central 
hydrophobic core (purple). B) Classes of LIM domain proteins, structure, proteins and localization. LIM domains 
are shown as green ovals, sequence similarity between domains is indicated by dashed red lines. The HD is shown 
as a red rectangle and other domains are indicated. Proteins in blue font are cytoplasmic, proteins in red font are 
nuclear and proteins in purple were found both in cytoplasm and nucleus.    
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1.7 Ldb1/2 cofactors stabilize LIM-HD/LMO proteins and can mediate 
interactions between relevant chromatin-bound complexes 
LIM-domain binding (Ldb) proteins Ldb1 (CHIP/NLI/CLIM2) and Ldb2 (CLIM1) are 
transcription factors that specifically bind to the LIM-domains of all LIM-HD/LMO proteins, but 
not other LIM domain proteins [113, 114]. Ldb1 is widely expressed throughout development 
and in adult tissues, while the expression of Ldb2 is much more restricted [86, 115]. Ldb proteins 
act as adapters that connect different tissue or stage-specific combinations of TFs (Figure 1.6A) 
[113, 116].  
Ldb proteins contain an N-terminal self-association domain (SA), followed by a 
Ldb/CHIP conserved domain (LCCD), nuclear localization signal (NLS) and an ~30 residue 
LIM-interaction domain (LID) (Figure 1.6B). 
The ubiquitin-proteasome system (UPS) regulates the turnover of cytoskeletal, signalling 
and other proteins, including transcription factors. In neural development, the selective removal 
of TFs by this system is important for migration, axon guidance, neurite outgrowth and synaptic 
plasticity [117-120]. Rnf12 (RLIM), a E3 ubiquitin-protein ligase, was shown to bind Ldb1, 
ubiquitinate the protein at K170, and target the protein for proteosomal degradation (Figure 
1.6C) [115, 121-123]. In contrast, single-strand DNA binding proteins Ssbp3 (Ssdp1) and Ssbp2 
were shown to bind Ldb1, inhibit the interaction with RLIM, prevent RLIM-mediated 
ubiquitination, and protect Ldb proteins and complexes from proteasomal degradation [124-127].  
The Ldb proteins were originally assumed to form dimers [128-139], but in vitro data for 
the isolated self-association domain, expressed from E coli. suggests that it may form higher 
order complexes [140]. Work is still ongoing to confirm the self-association state of the protein 
in vitro and in vivo.  
Several studies have demonstrated that Ldb1 plays an important role in mediating long 
range interactions (DNA-looping) between RE-bound haematopoietic complexes. For example, 
complexes with LMO, GATA, Tal1/E12 and Klf1 TFs in the regulation of β-globin gene 
transcription (Figure 1.6D) [114, 134, 141-144] or complexes with Isl1 during the activation of 
genes in cardiac progenitor cells [38] were found to participate in DNA-looping. Ldb-containing 
complexes that contain Tal1/E12 and LMO proteins are predominantly found to act as 
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transcriptional activators, but some participation in repression complexes that contain Cbfa2t3 
(Eto2) or Fog proteins has been reported [145-147].  
 
Figure 1.6. LIM-domain binding proteins. A) STRING database interaction map shows genetic and direct 
interactions, and the relative position of Ldb cofactors and LIM-HDs/LMOs, within the network of cellular 
interactions from the database. A colour code indicates protein types. B) Domain structure of Ldb proteins. The 
residue numbers shown correspond to Ldb1. LCCD = Ldb/CHIP conserved domain, NLS = nuclear localization 
signal and LID = LIM-interaction domain. C) Protein interactions protect LIM-HD proteins from aggregation and 
Ldb proteins and their partners from proteasomal degradation. Red shading indicates instability and green shading 
indicates stability. D) Different core Ldb-mediated complexes can loop and mediate contact between distant REs.  
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1.8 Interactions between Isl1/2 and Lhx3/4 proteins 
In the early years of research on LIM domain proteins, various binding studies performed 
using cell lysates suggested that some LIM domains have the ability to specifically homo- or 
heterodimerize [148, 149]. Following the discovery of Ldb1 interaction studies suggested that it 
appeared that Ldb cofactors were likely to mediate all of those interactions in vivo [132]. 
Expression and biophysical characterisation of recombinant LIM-HD/LMO proteins 
showed that in the absence of Ldb1, the LIM domains of these proteins tend make nonspecific 
interactions, including forming protein aggregates in vitro [150-152]. However, several 
subsequent studies have demonstrated that some LIM-HD proteins can physically interact with 
each other and form Ldb1-containing TF complexes that play key roles in the definition of cell 
identities in the developing spinal cord [78, 132, 153].  
Lhx3:Ldb1 complexes are formed through the interaction of the LIM domains from Lhx3 
(Lhx3LIMs) and the LID from Ldb1 (Ldb1LID). These complexes are formed in two neighbouring 
zones in the developing ventral spinal cord: the p2 zone that produces V2 interneurons, and pMN 
zone ultimately produces motoneurons. Motoneuron progenitors also express Isl1 allowing the 
formation of Lhx3:Isl1:Ldb1 complexes, where the LIM domains of Isl1 (Isl1LIMs) contact 
Ldb1LID, and Lhx3LIMs interacts with the C-terminal region of Isl1 (Figure 1.7). This complex 
was shown to be crucial for activation of the Mnx1 gene and motoneuron specification [25, 78], 
whereas the Lhx3:Ldb1 complex is required for V2 interneuron specification. The Lhx3:Isl1 
complex was later shown to regulate gonadotrope-specific expression of the gonadotrope-
releasing hormone receptor (Gnrhr) in the pituitary [32]. 
Our laboratory further investigated the Isl1:Lhx3 interaction and employed yeast two-
hybrid (Y2H) analysis and truncation mutagenesis to define the minimal Lhx3-binding domain in 
the C-terminal region of Isl1. This ~30-residue domain is termed the LIM-binding domain 
(LBD) [18]. The laboratory further showed that an LBD is also present in the Isl1 paralogue, 
Isl2, and that each of Lhx3 and Lhx4 interact with each of Isl1LBD and Isl2LBD [19]. The 
Lhx3:Isl1 interaction probably exists in all vertebrates and many other animal groups where Isl1 
and Lhx3 orthologues are coexpressed. For example, Lim3 and Islet are required for motoneuron 
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development in fruit flies [154], and the Ceh14LIMs and Lim7LBD domains from C. elegans 
protein orthologues are coexpressed in some neurons and can interact in Y2H assays [155].  
An interaction between Lmx1a and Isl1, which was dependent on Isl1LIMs, was detected 
in the same co-immunoprecipitation experiments that identified the Lhx3:Isl1 interaction [132, 
154].  
 
 
Figure 1.7 Two complexes that differentiate motoneurons from V2 interneurons in the developing ventral 
spinal cord. A) Lhx3:Ldb1 complex B) Lhx3:Isl1:Ldb1 complex. The stoichiometry of the Ldb mediated 
complexes is uncertain but for simplicity, is presented as dimeric.   
 
1.9 General characteristics of LIM domain interactions 
1.9.1 Tethered LIM-LID ‘complexes’  
Initial experiments on LIM-only proteins (see section 1.4), in which LMO2 and LMO4 
were expressed in bacteria gave rise to very low yields of soluble proteins that were prone to 
aggregation, making structural studies impossible, as such studies require milligram quantities of 
soluble protein [150, 151]. Mutagenesis of two non-ligating cysteines to serines in LMO4 only 
marginally increased solubility, but it was noted that the co-incubation of LIM-constructs with 
Chapter 1 17 
 
 
 
Ldb1LID peptide significantly reduced aggregation, albeit temporarily. Therefore, LIM domains 
were expressed as fusion constructs in which the LIM domains were tethered to Ldb1LID by a 
glycine/serine-linker (see Appendix C). The resulting intramolecular ‘complexes’ were soluble, 
folded and stable [150]. The incorporation of a specific protease site in the linker, and 
comparison of NMR spectra before and after proteolytic cleavage, showed that tethered LIM-
LID constructs form native-like complexes [152, 156]. This tethering approach has subsequently 
allowed structure determination of numerous LIM-partner complexes, and studies of higher order 
assemblies to be carried out [18, 19, 150, 151, 156-165]. Tethered complexes were used in most 
in vitro experiments described in this thesis. 
1.9.2 LIM domain interfaces and the β-zipper binding mode of linear 
partner motifs 
Currently there are numerous structures that exist of LIM-partner complexes, including 
LIM domains from the LIM-HD/LMO classes as well as other LIM proteins. These partners can 
be broken into two main groups: peptides binders (such as LID and LBDs) and globular proteins. 
Whereas globular proteins can bind various surfaces on LIM domains, including partially 
exposed hydrophobic treble clef cores (e.g., LMO2:Tal1:E47, pdb code 2YPA; PINCH:ILK, pdb 
code 2KBX; and TES:MENA, pdb code 2XQN), to date all of the peptide binders bind a 
common interface, referred to here as the 'front' interface. This front interface is characterised by 
exposed beta sheets and hydrophobic pockets and surfaces, and is found in LIM-HD/LMO 
complexes with Ldb1, Isl1/2, CtIP and DEAF1 (pdb codes: 1RUT, 2XJY, 2RGT, 3MMK, 2JTN, 
2L4Z, 2MBV), and in the TES:ARP7A complex (pdb code: 2SQN) (Figure 1.8A and B). This 
class of interaction is discussed in more detail below and an example of binding to other surfaces 
is shown for LMO2:Tal1:E47 (Figure 1.8C and D).  
LIM-binding peptides are generally unstructured prior to binding, and bind the front 
interface of the LIM domains in an extended conformation in which short β-hairpins in the LIM 
domains are augmented by short antiparallel β-strands in the peptide, forming a β-zipper [166]. 
Although peptide binding partners of LIM domains share low sequence identity, hydrophobic 
residues are conserved in a few positions. These conserved residues, some of which have been 
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identified as hot-spot residues from mutagenic studies, cover hydrophobic surfaces or fill 
hydrophobic pockets on the surface of the LIM domain (Figure 1.9A and B). The binding of 
peptides to tandem LIM domains is modular, where each LIM domain binds to a linear motif in 
the peptide. Cooperative binding of these modules leads to high affinity and apparently high 
specificity binding [18, 167]. Interestingly, in some other ZnFs and LIM-domains sequences N- 
or C-terminal to the ZnF form similar antiparallel β-sheets, but via intramolecular rather than 
intermolecular β-augmentation. 
 
Figure 1.8 Alternate binding modes of tandem LIM domains of LMO2. Hydrophobic atoms are shown as dark 
salmon with hydrophobic core residues shown in red. A) Ldb1LID binds the front interface of LMO2 in a β-zipper 
conformation (yellow arrows). Anchoring or ‘hot-spot’ hydrophobic residues of LID, as defined by mutagenic 
studies, are shown as blue spheres. B) LMO2 front surface (bound state) shows hydrophobic pockets in which core 
residues are exposed (yellow circles). C) Tal1:E47 dimer binds to LMO2 back interface and covers a pocket with 
exposed core of treble clef. Hydrophobic residues of the bHLH dimer are shown as blue spheres. D) Back surface of 
LMO2 (bound state) with the interacting hydrophobic pocket (yellow circle). 
 
The LIM domains from LIM-HD and LMO proteins share a number of conserved 
hydrophobic, charged and glycine residues that are not generally conserved in all LIM domain 
proteins, and preferences for specific residues or residue types exist at many positions (Figure 
1.10). These residues are generally not found in the LIM domains from LIM kinases (LIMK1/2), 
which contain closely related tandem LIM domains, but which do not bind Ldb1, suggesting that 
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those residues are responsible for the specific binding of Ldb1 to LIM-HD and LMO but not 
other LIM domain proteins [152]. Mutations of several of these LIM-HD/LMO specific residues 
in LMO4LIM1 to corresponding residues from LIMK1 was shown to inhibit binding to Ldb1LID 
[152].   
 
 
Figure 1.9 Linear motifs form β-zipper motifs at 'front' interfaces of LIM domains. A) Ribbon representation 
of the β-zipper structure of the LMO2 (black):Ldb1LID (red) complex (pdb code:2YPA). In each LIM domain, a 
hydrophobic pocket created by the loop of the first treble clef motif is indicated in green, the LIM core in purple, 
and core of the second treble clef in yellow. Coordinated zinc atoms are grey spheres. Positions of conserved 
charged residues are indicated. B) Alignment of structurally characterised LIM-HD/LMO-interacting peptide 
domains. β-sheets are shown as red arrows, and hotspot residues that interact with specific LIM surfaces or pockets 
are highlighted in the same colour as the corresponding hydrophobic region. Acidic residues are shown in light blue, 
basic residues are in red, and prolines are green. Parts of LIM-binding motifs for which the structure has not been 
determined are in rectangles with red dashed borders. Alanine or glycine mutations that significantly decrease 
binding are shown above the alignment (white font with black highlights). C) Examples of ZnF domains that exhibit 
intramolecular β-augmentation are shown in cartoon representation. Complementing β-strands segments are shown 
in cyan. 
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Figure 1.10 Comparison of LIM domain amino acid sequences from LIM-HD/LMO and LIMK1/2. LIM1 
alignment. Residue position 1 was set 3 residues before the first Zn-ligating cysteine. LIMK1/2 residues in bold font 
indicate potentially significant differences compared to LIM-HD/LMO residues at the same positions. 
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Tandemly arrayed LIM domains (up to five) exist in many LIM-domain proteins but the 
spacers between them vary from ~50 in CRP1/2 and 8–10 residues in some other LIM proteins to 
1–3 residues in LIMK1/2, LIM-HDs and LMO proteins (Figure 1.10) [108]. Other multi-LIM 
proteins also contain closely spaced LIM domains (e.g., TES LIM2 and LIM3). As there are 
generally few contacts between the LIM domains, it is thought that in the unbound state the LIM 
domains flex relative to one another, but close spacing creates an essentially continuous 
interaction interface, and the binding peptides provide interdomain constraints and influence the 
relative angle between the LIM domains [19, 165, 168].  
1.10 Potential interactions between other LIM-HD proteins 
The coexpression of Lhx3 and Isl1 proteins in the developing spinal cord is only one of 
many examples of overlapping expression patterns of LIM-HD proteins. Therefore, it seems 
feasible that other LIM-HD proteins could interact in a similar fashion. Indeed, as mentioned 
above, Lmx1a showed some evidence of binding to Isl1 in co-immunoprecipitation experiments 
[132], and Y2H experiments performed in our laboratory indicated that an Lmx1a:Isl1 
interaction is mediated by Lmx1aLIMs and Isl1LBD [169]. Other LIM-HD proteins contain 
sequences with unidentified functions, especially in the C-terminal regions, so it is possible that 
LIM-domain binding motifs exist in LIM-HD proteins other than Isl1/2. 
As noted at the beginning of this chapter many HD-proteins can cooperatively bind DNA 
through direct HD-HD interactions [12, 170, 171]. This could point to a mechanism for the 
interaction of LIM-HD proteins, independent of, or in addition to, interactions via the LIM 
domains.  
It is also possible that intramolecular contacts between the LIM domains and LBDs from 
the same protein can take place. Such interactions may reversibly affect localization and/or 
protein function of some LIM domain proteins [172, 173]. The autoinhibitory effects of some 
LIM domains on HD-mediated DNA-binding have been reported [174] and recent work from our 
laboratory showed that the LIM and LDB domains in Isl1/2 do interact in an intramolecular 
fashion, which may protect against non-specific binding and non-productive complex formation 
in the absence of other binding partners [162]. 
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1.11 In vitro competition experiments can investigate binding affinities of 
competing LIMs:LID/LBD complexes 
Given the poor solution properties of isolated LIM domains from LIM-HD and LMO 
proteins, it is not possible to measure binding affinities between their LIM domains and peptide 
binding partners using standard methods. However, it is feasible to use homologous competition 
experiments to estimate binding affinities for LIM domain interactions with peptide partners.  
In the past, homologous competition ELISAs were used to estimate binding affinities for 
this family of proteins. For those ELISAs, GST-LIMs-LID constructs (containing LIMs from 
LMO2, LMO4, Lhx3 and Isl1) were generated that contained a protease site in the tether 
between the LIMs and LID. The purified proteins were treated with the protease, and the cut 
complexes bound to ELISA plates that had been pre-coated with anti-GST antibodies. Increasing 
concentrations of Ldb1LID peptide containing a C-terminal FLAG-tag were added. After 
washing, bound FLAG-tagged peptides were detected using an anti-FLAG antibody conjugated 
to a peroxidase. The initial study resulted in binding curves suggesting that this format of 
ELISAs can be used to compare in vitro binding of LMO4LIMs to wild type and mutant Ldb1LID 
peptides, and gave an estimate of IC50 = 1 nM for the wild type LMO4:Ldb1LID interaction [156]. 
After more experiments using lower starting concentrations of Ldb1LID-FLAG, this estimate was 
revised to ~10 nM and the IC50 for the interactions of Ldb1LID with three other LIM domain 
proteins were reported: 20 nM for LMO2, 35 nM for Lhx3 and 90 nM for Isl1 [18, 167].  
In these experiments, it was assumed that non-specific binding is not significant, binding 
affinities are not affected by protein tags and that surface-adsorbed complexes can approximate 
low concentrations of complexes in solution. It was further assumed that incubation allows for 
the system to come to equilibrium and that subsequent washing steps do not significantly affect 
this equilibrium [175, 176]. Based on these assumptions, the IC50 is a reasonable approximation 
of Kd. However, it is likely that these assumptions do not hold, especially through numerous 
washing steps. Further, the method cannot measure weaker interactions, and data can be 
inconsistent. Thus, part of the project described in this thesis focussed on exploring approaches 
to generate a more robust assay for this system. 
Chapter 1 23 
 
 
 
1.12 Aims of the thesis 
LIM-HD proteins are involved in many developmental and disease processes but 
questions remain about their mechanisms of action, especially with respect to overlapping 
expression patterns and their potential to form multi-protein transcriptional complexes. Given 
that LIM-domains of Lhx3/4 interact with LBD-domain of Isl1/2, do other LIM-HD proteins 
interact with Isl1/2, or with each other? How do the different LIM domain modules contribute to 
binding Ldb1LID and similar polypeptide sequences? What are the binding affinities of the 
different tandem LIM-domains to Ldb1LID? If there is a competition between LIM-HD proteins 
for their common partner Ldb1, could differences in binding affinities explain the formation of 
specific complexes? Answering these questions should lead to a better understanding of cell 
specification associated with this family of LIM domain proteins. This information could be 
important for the development of treatments to inhibit neoplasms associated with the 
overexpression of various LIM-HD and LMO proteins, to regenerate damaged tissues with 
appropriately induced stem cells, or to induce proper axon pathfinding in recovering nerves. The 
key aims of this thesis were to develop a number of experimental procedures that could provide 
some of these answers. 
 
The specific aims, as broken down into results chapters were: 
 
1. To apply Y2H screening approaches based on yeast mating to detect interactions 
between LIM-HD proteins (Chapter 3). 
2. To establish the contributions from individual and tandem LIM-domains of LIM-HD 
proteins to interactions with Ldb1LID (Chapter 4). 
3. To develop fluorescence-based complementation assays in yeast to address some of the 
limitations of Y2H experiments (Chapter 5).  
4. To develop strategies for the specific N-terminal fluorescent labelling of tethered LIM-
LID complexes for use in solution-based homologous competition assays as an alternative to 
ELISAs (Chapters 6 and 7). 
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Chapter 2    Materials and methods 
2.1 Materials  
2.1.1 Chemicals, enzymes and kits 
Table 2.1 Chemicals. 
Chemical Manufacturer/Source 
2,2-Dimethyl-2-silapentane-5-sulfonic acid (DSS) Fluka 
2
H2O (Deuterium oxide) Aldrich 
2-Mercaptoethanol Sigma-Aldrich 
2-Log DNA standard New England Biolabs 
3-Amino-1,2,4-triazole (3-AT) 
Sigma 
3,5-Dimethoxy-4-hydroxycinnamic acid 
(sinapinic acid) 
4-Mercaptophenylacetic acid (MPAA) 
5-Bromo-4-chloro-3-indolyl-α-D-galactopyranoside 
(X-α- gal) 
GOLD Biotechnology 
α-Cyano-4-hydroxycinnamic acid (CHCA) Sigma 
Agarose 
Sigma-Aldrich 
Ampicilin (Amp), sodium salt 
Arabinose, 
Bis-Tris 
Bovine serum albumin (BSA, monomeric) 
Chloramphenicol GOLD Biotechnology 
Complete EDTA-free protease inhibitor cocktail 
tablets 
Roche 
Coomassie Brilliant Blue G-250 Bio-Rad 
Deoxyribonucleotide triphosphates 
(dNTP for PCRs) 
Bioline 
Dimethylformamide (DMF) Sigma-Aldrich 
Dithiothreitol (DTT) GOLD Biotechnology 
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Deoxyribonuclease I (DNaseI) Roche 
EDTA 
Sigma-Aldrich 
Ethidium bromide 
Ficoll GE Life Sciences 
Glutathione (GSH) Sigma-Aldrich 
HEPES Sigma-Aldrich 
Imidazole Sigma 
Immersion oil Cargille 
Isopropyl-β-D-thiogalactopyranoside (IPTG) GOLD Biotechnology 
Lithium Dodecyl Sulphate (LDS) 
Sigma-Aldrich 
Maltose 
Mark 12 protein standard Life Technologies 
MgCl2 
Sigma-Aldrich 
MOPS 
Paraformaldehyde (PFA) 
Polyethylene glycol (PEG) 4000 
Rainbow™ molecular weight marker GE Life Sciences 
Sorbitol Sigma-Aldrich 
Salmon sperm (10 mg/mL) Thermo Fisher Scientific 
Trifluoroacetic acid (TFA) 
Sigma-Aldrich 
Tricine 
Tris(2-carboxyethyl)phosphine hydrochloride 
(TCEP-HCl) 
Sigma 
 
All other standard chemicals and reagents were obtained from Boehringer Mannheim 
(Castle Hill, NSW), ICN Biochemicals (Seven Hills, NSW), Promega (Madison, WI), Sigma 
(Castle Hill, NSW) or Univar (Auburn, NSW).  
Stock solutions of simple sugars (D-glucose, maltose and arabinose), sorbitol, Ficoll and 
glycerol were made as syringe-filtered 40% or 50% stocks. MgCl2 was made as a 2 M stock and 
sterile filtered. 
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Table 2.2 Enzymes and antibodies. 
Enzyme Manufacturer 
Restriction endonucleases 
New England Biolabs 
Factor Xa 
HRV3C protease 
Produced in house by Angela Nikolic, SMB. Specific 
activity not specified. 
Lysozyme Sigma 
Pfu Turbo DNA polymerase Stratagene 
T4 DNA ligase New England Biolabs 
Taq DNA polymerase Boehringer Mannheim 
TEV protease Produced as a part of this thesis, section 2.5.3.2 
Thermosensitive Shrimp 
Alkaline Phosphatase 
(TSAP) Promega 
Sequencing Grade Trypsin 
Rabbit anti-GFP polyclonal IgG 
Amersham biosciences 
HRP-conjugated anti-rabbit IgG 
 
Table 2.3. Kits used in this study. 
Kit Manufacturer 
QIAprep Miniprep Kit 
QIAGEN GmbH QIAquick PCR Purification Kit 
QIAquick Gel Extraction Kit 
Expand Long Template PCR System Roche 
QuikChange II Site-Directed Mutagenesis Kit Agilent Technologies 
SNAP-Cell Starter Kit New England Biolabs 
Pierce™ ECL Western Blotting Substrate kit Life Technologies 
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2.1.2 Buffers and solutions 
All reactions performed with commercial DNA-modifying enzymes used the appropriate 
commercial buffers recommended by the manufacturer. Buffers used in cell lysis, protein 
purification, proteolysis and labelling are shown in Tables 2.4–2.7. All aqueous buffers and 
solutions were made with MilliQ water (Millipore). Protein purification buffers were filtered 
with the 0.45 µm filter, whereas NCL labelling reaction buffer, Factor Xa buffer, competition 
assay buffer and solutions used for bacterial or yeast cultures were sterile filtered using a 0.22 
µm syringe filter. All buffers were made fresh, and cooled to 4 °C before use where necessary. 
 
Table 2.4. Lysis and affinity purification buffers. 
Yeast breaking buffer 
20 mM Tris-HCl pH 8.0, 10 mM MgCl2, 1 mM EDTA, 5% 
glycerol, 1 mM DTT, 0.3 mM (NH4)2SO4,  
1 mM PMSF and 1 tablet/50 mL buffer of  
Complete EDTA-free protease inhibitor cocktail 
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GST-Lysis buffer 
50 mM Tris-HCl pH 8, 300 mM NaCl, 10 mM 2-mercaptoethanol, 
1 mM PMSF, 0.1 mg/mL lysozyme,  
10 µg/mL DNase I, 10 mM MgCl2   
GST-Wash buffer 
50 mM Tris-HCl pH 8.0, 300 mM NaCl, 1 mM DTT,  
1 mM PMSF 
GST-Proteolysis buffers 
(HRV3C or TEV) 
20 mM Tris-HCl pH 7.5–8.0, 150 mM NaCl, 1 mM DTT, 
GST-Elution buffer 
20 mM Tris-HCl pH 7.5–8.0, 150 mM NaCl,  
1 mM DTT and 10 mM freshly prepared reduced GSH 
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MBP-Lysis buffer 
20 mM Tris-HCl pH 7.4, 0.2 M NaCl, 1 mM DTT, 1 mM PMSF, 1 
mM EDTA, 0.1 mg/mL lysozyme,  
10 µg/mL DNase I, 10 mM MgCl2 
MBP-Wash buffer 
20 mM Tris-HCl pH 7.4, 0.2 M NaCl, 1 mM DTT,  
1 mM PMSF, 1 mM EDTA 
MBP-Elution buffer MBP-Column buffer with 10 mM maltose 
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Ni-NTA-Lysis buffer 
20 mM Tris-HCl pH 8.0, 0.4 M NaCl, 20 mM imidazole, 0.1% 
Triton X-100, 10 mM 2-mercaptoethanol,  
1 mM PMSF 
Ni-NTA-Wash buffer 
20 mM Tris-HCl pH 8.0, 1 M NaCl, 50 mM imidazole,  
10% glycerol, 10 mM 2-mercaptoethanol, 1 mM PMSF 
Ni-NTA-Elution buffer Ni-NTA-Wash buffer with 250 mM imidazole 
Ni-NTA-Proteolysis buffer 
20 mM Tris-HCl pH 8.0, 150 mM NaCl,  
10 mM 2-mercaptoethanol 
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Table 2.5. HPLC buffers. 
Size exclusion chromatography 
buffer 
20 mM Tris-HCl pH 8.0, 300 mM NaCl, 1 mM DTT 
Anion-exchange chromatography 
buffers 
10 mM Tris-HCl pH 7.4–8 or 10 mM sodium-phosphate pH 7.4, with 1 
mM DTT 
Buffer A: 
0 M NaCl 
Buffer B: 
with 1 M NaCl 
Reverse phase chromatography 
buffers 
Buffer A: 
0.1% TFA 
Buffer B: 
0.1% TFA in acetonitrile 
 
Table 2.6. Electrophoresis buffers. 
50×TAE buffer 40 mM Tris-base, 5.7% glacial acetic acid, 10 mM EDTA (diluted 1-in-50 for use) 
SDS-PAGE running 
buffer 
1-in-20 dilution of Life Technologies NuPAGE MES SDS Running Buffer (20×). At 
1× = 50 mM MES, 50 mM Tris Base, 0.1% SDS, 1 mM EDTA, pH 7.3 
10×Bis-Tris-Tricine 
buffer 
200 mM Bis-Tris, 200 mM Tricine, pH 6.8 (diluted 1-in-10 for use) 
 
Table 2.7. Specific buffers and solutions. 
NCL labelling reaction buffer 
0.1 sodium-phosphate pH 7.5, 0–150 mM NaCl,  
0.5–10 mM TCEP 
SNAP-tag labelling buffer 20 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM DTT 
Western blot transfer buffer SDS-PAGE Running Buffer, 20% methanol 
TBST buffer 
50 mM Tris-base (pH 7.4), 150 mM NaCl,  
0.05% (v/v) Tween-20 
4×LDS (SDS-PAGE loading buffer) 
0.3125 M Tris base pH 6.8, 10% LDS, 50% glycerol, 25% DTT, 0.5% 
bromophenol blue in aqueous solution 
Native gel loading buffer 
3% (w/v) Ficoll in Competition assay buffer (from 15% stock) 
or 5–10% glycerol in Competition assay buffer (from 50% stock) 
Coomassie blue stain solution 
0.125% (w/v) Coomassie Brilliant Blue G-250,  
40% (v/v) methanol, 7% (v/v) acetic acid 
Gel fixing and destaining solution 30% (v/v) methanol, 10% (v/v) acetic acid 
20×Na-borate buffer 
47 g/L boric acid, 200mM NaOH,  
pH 8.7 (diluted 1-in-20 for use) 
Factor Xa buffer Competition assay buffer with 2 mM CaCl2 
10×TE buffer 100 mM Tris-HCl, 10 mM EDTA, pH 8.0 
10×LiAc solution 1 M LiAc, pH 7.5 
1×TE/LiAc buffer 1×LiAc solution, 1×TE buffer 
Chapter 2 29 
 
 
 
PEG/LiAc buffer 40% PEG, 1×LiAc solution, 1×TE buffer 
K-phosphate/sorbitol buffer 
1.2 M sorbitol (diluted from a 2 M stock) 
0.1 M potassium phosphate pH 7.5 (diluted from a 1 M stock) 
Yeast fixation solution 
4% paraformaldechyde (made in warm water, NaOH 1M added 
dropwise with stirring until dissolved), 3.4% sucrose 
Competition assay buffer 20 mM sodium phosphate buffer pH 7.5, 150 mM NaCl, 1 mM DTT 
 
Table 2.8. Buffers for preparing competent E. coli cells. 
TFB1 
100 mM RbCl, 50 mM MnCl2, 10 mM potassium-acetate, 10 mM 
CaCl2, 15% glycerol, pH 5.8, sterile-filtered (0.22 μm) 
TFB2 
10 mM MOPS, 10mM RbCl, 75 mM CaCl2, 15% glycerol, 
adjusted to pH 6.8 with KOH, sterile-filtered (0.22 μm) 
Resuspension buffer (100 mL) 
10% PEG, 5% DMSO, 10 mM MgCl2, 10 mM MgSO4, 10% glycerol, 
LB broth, pH 6.1 
 
Table 2.9. Solutions for preparation of MALDI-TOF samples. 
Wetting Solution 0.1% TFA, 50% acetonitrile 
Wash Solution 0.1% TFA 
Matrix Solution 
0.1% TFA, 70% acetonitrile, 
10 mg/mL matrix (CHCA or sinapinic acid) 
 
2.1.3 General media components 
Table 2.10. General media components. 
Component Manufacturer 
Bacto Peptone Difco 
Bacto Tryptone Difco 
Yeast extract Difco, Affymetrix 
Yeast nitrogen base Difco 
Amino acids and nucleobases Sigma-Aldrich 
Agar Amyl Media 
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2.1.4 Resin and other material  
Table 2.11. Resin 
Resin Manufacturer 
Glutathione (GSH)-sepharose resin GE Life Sciences 
Ni-NTA resin Invitrogen, Life Technologies, Qiagen 
Amylose resin New England Biolabs 
Table 2.12. Other disposable and reusable materials. 
Material Manufacturer 
Glass beads, 425–600 µm Sigma-Aldrich 
SnakeSkin dialysis tubing 
(various molecular weight cut-offs) 
Life Technologies 
PD-10 desalting columns GE Life Sciences 
Millex-GP Syringe Filter (0.22 μm) Sigma-Aldrich 
Nanosep MF centrifugal filters (0.45 µm) Pall 
ZipTips C18 Merck Millipore 
Vivaspin sample concentrators 
(3 , 5 or 10 kDa cut-offs) 
Sartorius Stedim Biotech 
Concentrators Thermo Scientific Pierce 
Microscope slides and cover glass Sail Brand 
NativePAGE Novex Bis-Tris precast gels 
(3–12%) 
Life Technologies 
4–12% SDS-PAGE precast gels Invitrogen 
Biotrace
TM
 NT pure nitrocellulose transfer membrane Pall Gelman Laboratory 
Velveteen Purchased at Lincraft 
Petri dishes (90 and 140 mm) Thermo Scientific 
96-well plates Life Technologies 
Replica plating apparatus Made by the School of Molecular Biology Workshop 
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2.1.5 Bacterial and yeast strains  
Table 2.13. E. coli strains, genotypes and their purpose. The pLysS plasmid is in bold. 
 
Bacterial 
strain 
Genotype Purpose Source 
DH5α 
F
-
 endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR 
nupG Φ80dlacZΔM15 Δ(lacZYA-argF)U169, 
hsdR17(rK
-
 mK
+), λ– Plasmid cloning 
Bethesda 
Research 
Laboratories 
XL1-Blue 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac 
[F´ proAB lacIqZΔM15 Tn10 (Tetr)] 
Stratagene 
BL21(DE3) 
F
–
 ompT gal dcm lon hsdSB(rB
-
 mB
-) λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5]) 
Protein 
overexpression 
Novagen 
*BL21-AI
TM
 
F
–
 ompT gal dcm lon hsdSB(rB
-
 mB
-
) araB::T7RNAP-
tetA 
Invitrogen 
Rosetta
TM
 2 
(DE3)pLysS 
F
-
 ompT hsdSB(rB
-
 mB
-
) gal dcm (DE3) pLysSRARE2 
(Cam
R
) 
Novagen 
 
*Tight regulation of the T7 RNA polymerase by the arabinose-inducible araBAD promoter and high overexpresed 
protein yields make BL21-AI cells optimal for expression of toxic proteins (BL21-AI
TM
 One Shot
R
 Chemically 
Competent E. coli manual, Invitrogen) [177]. These cells can be used in combination with any T7 promoter-based 
vector.  
 
Table 2.14. S. cerevisiae yeast two-hybrid (Y2H) strains, genotypes and reporters. Reporters in bold were used 
in this thesis.  
Y2H strain Genotype Reporters 
AH109 
MATa, trp1-901, leu2-3, leu2-112, ura3-52, his3-200, 
gal4Δ, gal80Δ, LYS2::GAL1UAS-GAL1TATA-HIS3, 
GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZ, MEL1 
HIS3 
ADE2 
lacZ 
MEL1 
Y187 
MATα, ura3-52, his3-200, ade2-101, trp1-901, leu2-3, leu2-112, met15Δ, 
gal4Δ, gal80Δ, URA3::GAL1UAS-GAL1TATA-lacZ, MEL1 
lacZ 
MEL1 
2.1.6 Bacterial and yeast culture media  
Table 2.15. Media for bacterial cultures. LB broth and all solid media were autoclaved. 
LB media (1L) 
Bacto-Peptone/Tryptone 10 g, Yeast Extract 5 g, NaCl 5 g, 
agar (for plates only) 15 g, deionized water added to 1L, autoclaved 
SOC media 
Bacto-Tryptone 8 g, Yeast Extract 2 g, NaCl 0.2 g, KCl 4 mL of 250 mM stock, deionized 
water to 390 mL, adjusted to pH 7 and autoclaved. 
2 mL of 2 M MgCl2 and 8 mL of 1 M D-glucose was added from filtered stocks 
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Antibiotics as appropriate were added to LB broth after cooling to ~37 °C, and to agar-
containing media after cooling to 40–50 °C, after which the agar-containing media was poured 
into plastic petri dishes and further cooled to solidify. LBAmp broth and solid media contained 
100 µg/mL ampicillin, while LBAmp+Cam broth and solid media contained 50 µg/mL ampicillin 
and 100 µg/mL chloramphenicol. 
Table 2.16. Rich and minimal media for yeast growth. YPD broth and all solid media were autoclaved. 
YPD Media 20 g/L bacto peptone, 10 g/L yeast extract, 
2% (w/v) agar (for solid media) 
Yeast Synthetic  
Drop-out 
(SD) Media 
6.7 g/L yeast nitrogen base solution (autoclaved), 
1×DO solution (see below for 10×DO solution), 2% D-glucose, 1× 
appropriate supplemental nutrients (Table 2.18), 
1.5% (w/v) agar (for solid media) 
 
Table 2.17. Components of 10×Dropout (DO) Solution.  
Component Concentration (mg/mL) 
L-Isoleucine 300 
L-Valine 1500 
L-Adenine hemisulfate salt 200 
L-Arginine HCl 200 
L-Histidine HCl.monohydrate 200 
L-Leucine 1000 
L-Lysine HCl 300 
L-Methionine 200 
L-Phenylalanine 500 
L-Threonine 2000 
L-Tryptophan 200 
L-Tyrosine 300 
L-Uracil 200 
 
Table 2.18. Supplement nutrient solutions added to SD media. All solutions were filter-sterilized. 
Component Concentration (mg/mL) 
100× Uracil 2000 
100× L-Histidine 2000 
100× Adenine hemisulfate 2000 
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2.2 Constructs 
2.2.1 LIM-HD full-length constructs 
Unless otherwise indicated, all proteins are from M. musculus. Mouse proteins were 
chosen because of their high similarity to human proteins and because they allow testing in 
mouse models. The sequences used are those identified as isoforms current at the time of starting 
the project. In the interim several other isoforms have been added to the NCBI Consensus CDS 
(CCDS) protein set of LIM-HD proteins, of which all except Lhx3b, Lhx9.1 and Lhx9.2 were 
analysed in this thesis (see Appendix A). All four isoforms of Lhx6 were used in Y2H mating 
arrays. Lhx424–390 (hereafter referred to as Lhx4) was used to represent full-length protein in all 
assays. The Isl2 construct used in this thesis was based on the NCBI Reference Sequence 
NP_081673.1 and contains the mutations S157T, H185D, L267F and R282G. This version was 
succeeded by the NP_081673.2 NCBI Reference Sequence.  
Full-length Lhx1, Lhx2, Lhx9.3 and Lmx1a were cloned by Vanessa Craig (Matthews 
laboratory, SMB, University of Sydney) from mouse brain mRNA. Isl1α and Lhx3a full-length 
constructs were obtained from Prof Ingold Bach (University of Massachusetts Medical School) 
as cloned cDNA and Lhx4, Lhx5, Lmx1b, Isl2, Lhx6.1 and Lhx6.2 were obtained from Codon 
Devices (Cambridge, MA 02139, USA) and Lhx8 was obtained from GenScript (Piscataway, NJ 
08854,USA) as synthetic genes. Y2H vectors containing Lhx1, Lhx2, Lhx9.3 and Lmx1a 
constructs were obtained from Vanessa Craig and Lhx5 and Lhx6.2 were obtained from Dr Sally 
Eaton (Matthews laboratory, SMB, University of Sydney). Lhx6.3 and Lhx6.4 variants were 
generated by PCR from Lhx6.1 and Lhx6.2 templates, and were cloned along with Lhx4, Lhx6.1, 
Lhx8, Lmx1a and Isl2 into Y2H vectors as a part of this thesis. Note that in this thesis, the 
protein variants (Isl1α, Lhx3a, Lhx6.1, etc.) are specified only in case of full-length proteins.  
2.2.2 Tandem and separate LIM domain constructs 
Tandem and separate LIM constructs of Lhx3, Lhx4 and Isl1 in Y2H vectors and 
NpGBT9-Lmx1aLIMs plasmid were obtained from Amy Nancarrow, Dr Mugdha Bhati, Vanessa 
Craig, Dr Cy Jeffries, Dr Morgan Gadd and Dr Sally Eaton (all from within the Matthews 
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laboratory, SMB, University of Sydney). Tandem and separate constructs of Lhx1, Lhx2, Lhx5, 
Lhx6, Lhx8, Lhx9, Lmx1b, Isl2 and separate LIM constructs of Lmx1a were created and cloned 
into Y2H vectors as a part of this thesis. 
Both tandem LIMs and separate LIM-domains contained 6 residues before the first Zn-
ligating cysteine (N-terminal extension) and 6 residues after the last Zn-ligating residue (C-
terminal extension), except for the N-terminal extensions of the following LIMs and LIM1 
constructs: Lhx5, 4 residues; Lhx1, 3 residues (these represent the full extent of the native 
protein sequence); and Lmx1a, 2 residues. Two versions of Lhx1LIMS were used. An initial 
Lhx1LIMs* construct did not contain any C-terminal extension and was replaced by a 3-residue 
extended construct part way through experiments as detailed in section 3.6.1.  
2.2.3 LIDs and other constructs 
Ldb1LID and Isl1LBD constructs in Y2H vectors were obtained from M. Bhati in the 
laboratory, and an extended LID domain (residues 331–375) construct was generated by PCR 
and cloned it into the pIH1121 plasmid for expression with an N-terminal Maltose binding 
protein (MBP)-tag (see section 6.10.1). Plasmids containing constructs encoding other ZnF 
proteins (LIMs of proteins LMO1–4, ZnF 1 and 9 of U-shaped, N-terminal ZnF of Pannier) were 
sourced from the laboratory. Human SSB1 in Y2H vectors was obtained from Dr Liza Cubbedu 
(Matthews laboratory, SMB, University of Sydney) for use as a non-related protein negative 
control in mating arrays (section 3.4). Full-length coding sequence of rat Pit1 protein (98% 
identical to the mouse protein) was cloned into Y2H vectors. DEAF1404–438(T435D), cloned into the 
pRSET vector was obtained from Dr Soumya Joseph (Matthews laboratory, SMB, University of 
Sydney). 
2.2.4 Tethered LIMs-LID constructs with the Factor Xa site 
Tethered LMO4LIMs-Ldb1LID DNA construct [156] and Lhx3LIMs-Ldb1LID DNA construct 
[18] were designed to code for the Factor Xa protease cleavage site in the linker between the 
LIMs and LID domains. These LIMs-LID constructs were originally cloned into pGEX-2T 
vectors (GE Healthcare) for expression with an N-terminal glutathione-S-transferase (GST)-tag 
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that could be removed by treatment with thrombin. The LIMs-LID DNA constructs containing 
LIMs-coding sequences of the remaining 11 LIM-HD proteins were cloned in pGEX-2T by Dr 
Mitchell O'Connell (Mackay laboratory, SMB, University of Sydney).  
 
2.3 Cloning methods 
2.3.1 PCR-based cloning and mutagenesis 
PCR-based cloning was used to generate new constructs (wild type and mutant, 
fragments or fusion/tethered constructs), and introduce/remove restriction sites in plasmids. 
2.3.1.1 Primer design 
Primers were designed such that regions complementary to the template, or over 
overlapping regions of primers used for overlap extension PCR, had optimal melting 
temperatures (Tm, estimated as Tm = [2 × #(A+T) + 4 × #(G+C)]°C). Primers that formed the 
termini of PCR products intended for ligation were engineered with restriction sites (e.g., BamHI 
for the forward and EcoRI for the reverse primer). The reverse primer included 3 consecutive 
stop codons (transcribed as UGAUAAUAG) in front of the restriction site, except when the 
resulting PCR fragment was intended as an N-terminal part of a fusion or tethered construct. To 
increase the efficiency with which restriction enzymes digested PCR products, primers were 
designed with extra bases on the terminal sides of restriction sites as recommended by the 
manufacturer. See Appendix A for details of primers used in this thesis. 
2.3.1.2 Standard polymerase chain reaction (PCR)  
All PCR reactions were performed in an Eppendorf Mastercycler (Eppendorf AG, 
Hamburg, GER), Hybaid PCRsprint thermal cycler (Thermo Electron Corp., Waltham, MA, 
USA) or the T3000 Thermocycler (Biometra, GER). Reaction mixtures (50 or 100 μL) contained 
two primers (0.02 nM each), 2.5 mM each of dATP, dCTP, dGTP and dTTP, 8% (v/v) DMSO 
(Dimethyl sulfoxide), 1× volume of manufacturer-supplied or home-made Pfu Turbo PCR 
buffer, 10–500 ng template DNA and 1 U Pfu Turbo DNA polymerase. The reaction mixtures 
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were subjected to 25 cycles of the temperature sequence: 94 °C (1 min), [Tm – 2] °C (1 min), 72 
°C (1 min), followed by a final elongation step at 72 °C (10 min). A 'hot-start' version of the 
method was used for most reactions, where a reaction without the enzyme was initially subjected 
to a long denaturation step (5 min at 95 °C), after which the enzyme was added and the standard 
PCR programme initiated. Completed reactions were stored at 4 °C or -20 °C until required. 
2.3.1.3 Inverse PCR  
The Expand Long Template PCR System Kit was used to perform inverse PCR. For this 
method, two primers with matching restriction sites at their 5’ ends were designed to extend 
away from each other using a circular plasmid template. When the primers were designed to be 
complementary to sites on each side of the sequence that is intended to be removed, inverse PCR 
results in amplification of an entire plasmid except for the sequence between the primer-
complementary sites. The linear product was digested with the primer-specific restriction 
enzyme(s) and the plasmid re-circularized by ligation. Reaction mixtures (50 µL) contained 
~10 ng of plasmid DNA as template, primers at 300 nM, 5 µL of provided 10×Buffer 3 and 3.75 
U (0.75 µL) of the supplied enzyme mix (Taq and Tgo DNA polymerases) [178]. The PCR 
program included a hot start step, followed by addition of the enzyme mix and 10 cycles of: 94 
°C (30 s), 52 °C (30 s) and 68 °C (4 min). The programme continued with 20 cycles of: 94 °C 
(30 s), 52 °C (30 s) and an elongation step at 68 °C that increased in length from 4 min by 20 s 
with each successive cycle, with an additional final elongation step of 7 min.  
The QuikChange Site-Directed Mutagenesis kit was used to perform a version of the 
inverse PCR where the forward and reverse primers had complementary (overlapping) 5' ends 
that contained the designed mutation, whereas the 3' primer ends were complementary to the 
surrounding sequence in the template on each side. Reactions contained 125 ng (125 nM) of each 
primer, 1 µL of dNTP mix, 5 µL of the 10× Pfu buffer, 1 µL of Pfu polymerase (2.5 U/ µL) and 
10 ng of the plasmid template in 50 µL reaction volume. The product of PCR reaction had 
complementary sticky 5' ends introduced by primers and circularized but did not ligate until it 
was transformed into the XL1-Blue supercompetent E. coli strain and the nick in the plasmid has 
been repaired. DpnI digestion after PCR was used to degrade the original methylated template 
plasmid leaving the newly generated non-methylated template intact. 
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2.3.1.4 Overlap extension PCR  
Overlap extension PCR was used to introduce mutations or remove restriction sites from 
DNA sequences. Pairs of precisely overlapping oligonucleotides were designed that contained 
mutations flanked by 12 bp of wild type sequence on each side. Each oligonucleotide from a pair 
was used in a separate reaction with a primer corresponding to the 5’ or 3’ ends of the full-length 
construct (end primers). The overlapping fragments were gel purified and aliquots (5–10 μL) 
were combined and used as templates in a second round PCR reaction which contained end 
primers. In cases where multiple distant mutations were needed, the product of this reaction was 
gel-purified and used as a template in following rounds of PCR reactions with different pairs of 
overlapping primers.  
2.3.1.5 Purification of PCR products 
DNA from inverse PCR reactions was purified by ethanol precipitation. Sodium-acetate 
(5 µL of a 3 M stock solution) was added to a 50 µL PCR reaction, followed by 100 µL chilled 
ethanol. The tube was incubated on ice for ~30 min followed by centrifugation at 12000 × g for 
20–30 min at 4 °C. The supernatant was carefully removed and the pelleted DNA dried in a 
SpeedVac concentrator. DNA from other PCR reactions was either purified by the QIAquick 
PCR Purification Kit or by agarose gel electrophoresis followed by the use of the QIAquick Gel 
Extraction Kit. In all cases the purified DNA was resuspended or eluted in ~30 µL of MilliQ 
water. 
2.3.1.6 Restriction endonuclease digestion of PCR products 
PCR products were digested by restriction endonucleases to prepare them for directional 
cloning into plasmids. Purified PCR product (section 2.3.1.6), 4 µL of the recommended 10× 
restriction enzyme buffer, 4 µL of 10×BSA, and 1 µL of each enzyme were made up to a total 
volume of 40 μL with MilliQ water, and the reaction was incubated 37 °C for 2–4 h. 
2.3.1.7 Agarose gel electrophoresis of digested DNA  
DNA samples from restriction digestion or PCR reactions were mixed with 6× loading 
dye (Fermentas Life Sciences, Ontario, Canada) and loaded into 1–2% (w/v) agarose gels 
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containing ethidium bromide (1 μg/mL) that were prepared in 1×TAE buffer, and subjected to 
electrophoresis at 80–100 V for 45–60 min. Gels were visualised under long-wave UV light and 
target bands were excised from the gel, stored at -20 °C until required, and purified using the 
QIAquick gel extraction kit according to the manufacturer’s instructions (Qiagen, Valencia, CA, 
USA). 
2.3.2 Plasmid-based cloning 
2.3.2.1 Restriction endonuclease digestion of plasmid DNA 
Plasmid DNA was treated with the same restriction enzymes as used for the PCR 
products to prepare a target (empty) plasmid for ligation with a new DNA fragment, or to excise 
a previously cloned DNA fragment from a plasmid, as described in section 2.3.1.6 but the final 
volumes were 30 µL (with 3-μL aliquots of 10× solutions) with 5–10 µL of miniprep purified 
plasmid (see section 2.3.2.6). 
2.3.2.2 Ligation reactions  
All ligation reactions were performed in a total volume of 10 µL. Reactions contained 
1 µL of commercially supplied 10× T4 DNA ligase buffer (400 mM Tris, 100 mM MgCl2, 100 
mM DTT, 5 mM ATP) and 1 Weiss unit of T4 DNA ligase (1 µL). Restriction enzyme digested 
plasmid DNA was combined with an excess of similarly digested insert DNA and incubated at 
room temperature for 4 h or in icy water overnight. The reactions were usually heated at 65 ºC 
for 20 min to deactivate the ligase. The total reaction mixture was transformed into DH5α E. coli 
cells. 
2.3.2.3 Plasmid amplification 
Most plasmids were amplified by propagation in E. coli strain DH5α (Table 2.13). 
Plasmid products of QuickChange PCR reactions were transformed into the XL1-Blue 
supercompetent cells (QuikChange® II Site-Directed Mutagenesis Kit). Bacteria were plated on 
a solid LBAmp media and cultured in Luria-Bertani (LB) broth.  
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2.3.2.4 Preparation of competent E. coli 
MgCl2 method. Antibiotic-free SOC media (400 mL) was inoculated with a 10 mL 
overnight SOC culture of a strain, then grown at 37 °C until OD600 = 0.4. The culture was cooled 
for 20 min by placing the tube in an ice/water slurry and the cells were subsequently centrifuged 
at 1000 × g for 15 min in cold 50 mL tubes. The pellet was resuspended in 20 mL autoclaved 
Resuspension buffer. The resuspended cells were divided into small (50–100 µL) aliquots, snap 
frozen in liquid N2 and stored at -80 °C. DH5α, BL21(DE3) and Rosetta 2(DE3)pLysS strains 
were made competent for transformation by this method. 
RbCl method (BL21-AI cells) [179]. LB broth (50 mL) was inoculated with a single 
colony of BL21-AI cells and was grown, with shaking at 37 °C to an OD600 of 0.3–0.5. The 
culture was cooled on ice for 5 min, the cells centrifuged (4000 × g) at 4 °C, and the supernatant 
was discarded. Cells were gently resuspended in ice-cold TFB1 buffer (15 mL) and incubated on 
ice for 90 min. The cells were collected by centrifugation (5 min, 4000 × g, 4 °C) and the cell 
pellet carefully resuspended in 2 mL ice-cold TFB2 buffer, aliquoted (50 µL) into sterile 
microcentrifuge tubes, frozen on dry ice, and stored at -80 °C. 
2.3.2.5 Transformation of E. coli 
Plasmid DNA (1 μL of prepared plasmid DNA) or 10 μL ligation mixture was added to 
30 and 100 μL of competent E. coli cells, respectively, and incubated on ice for ~15 min. Cells 
were heat-shocked at 42 ºC for 5 min and 200 µL of sterile LB broth added. Cells were allowed 
to propagate for a further 1.5 h at 37 ºC before being spread onto LBAmp plates. Transformed 
Rosetta 2 cells were spread onto LBAmp+Cam platesand incubated overnight at 37 ºC. 
2.3.2.6 Amplification and preparation of plasmids  
A single colony of DH5α or XL1-Blue E. coli cells transformed with plasmid DNA 
(section 2.3.2.5) was used to inoculate 5 mL of LBAmp broth and incubated overnight at 37 ºC. 
The cells were then collected by centrifugation (5000 × g, 4 ºC, 10 min) and plasmid DNA 
prepared using a QIAprep Miniprep Kit according to the manufacturer’s instructions. Final 
solutions of plasmid DNA were eluted in 50 µL elution buffer and stored at –20 ºC. 
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2.3.3 Verification by DNA sequencing 
All plasmid inserts generated by PCR were sequenced to confirm their identities at 
SUPAMAC, University of Sydney, NSW or Australian Genome Research Facility (AGRF). 
Samples were prepared according to SUPAMAC or AGRF guidelines. 
 
2.4 Plasmids 
2.4.1 Plasmids for bacterial protein over-expression 
See Appendix B for details of design strategies for bacterial overexpression plasmids in 
this thesis. 
2.4.1.1 Plasmids for generating MBP-tagged constructs 
Plasmids that code for N-terminally-tagged MBP constructs were derived from the 
pIH1119 plasmid, which was in turn derived from the pMAL-c2x plasmid (New England 
Biolabs) such that the EcoRI and BamHI restriction sites were swapped (MBP-linker-BamHI-
EcoRI in pIH1119). The pMAL-stop plasmid contains a stop codon after the MBP sequence and 
it was used to produce MBP-only protein controls for competition assays (Chapters 6 and 7).  
The pIH1121 plasmid was created by replacing the Factor Xa protease site in pIH1119 
with an HRV3C protease site. This was achieved by digesting the pIH1119 plasmid with AvaI 
and BamHI restriction enzymes to excise the Factor Xa protease site, and ligating annealed and 
phosphorylated complementary oligonucleotides that encoded the HRV3C protease site into the 
AvaI and BamHI sites in. An extended variant of Ldb1LID spanning residues 331–375 was cloned 
into the pIH1121 plasmid and was used for expression of MBP-Ldb1LID.  
2.4.1.2 Plasmids for GFP-tagging 
The GFPsol full-length sequence was created by joining the NGFPsol and CGFP split-
GFP fragments by overlap extension PCR. Note that the C-terminal fragment is the same in 
GFPuv and GFPsol and is therefore referred to simply as CGFP. NGFPsol, the N-terminal 
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fragment of the GFPsol was created by introducing F64L and S65T mutations in the NGFPuv 
fragment from a BiFC plasmid template (see section 2.4.3) by QuickChange PCR. Plasmid 
pET15b, which allows proteins to be expressed with an N-terminal His tag, was modified to 
remove an EcoRI restriction site positioned between HindIII and AatII sites, and an out-of frame 
BamHI site that lay close to an NdeI site. Standard PCR was performed in which the new in-
frame BamHI and EcoRI sites were incorporated into the sequence of the forward primer, which 
was complementary to the template BamHI site with additional downstream sequence. The 
reverse primer was complementary to sequence just upstream of the template EcoRI site and 
contained an AatII site on the 5' end. The resulting plasmid was named pET15bBE. A BglII-
GFPsol-BamHI-TAATGA-EcoRI construct was created using PCR that contained two stop 
codons in frame before the EcoRI site to allow expression of GFPsol-only constructs. This 
construct was digested with BglII and EcoR1 and inserted between the BamHI and EcoRI sites 
of a pHisGB1 plasmid that contained an HRV3C site in place of the original thrombin site 
(created by Dr. Soumya Joseph, Matthews laboratory, SMB, University of Sydney). The 
construct was similarly inserted into pET15bBE and pGEX-6P. The resulting plasmids have a 
hybrid BamHI/BglII that is not cuttable by either enzyme before the GFPsol sequence and only 
the downstream BamHI-EcoRI site is available for further cloning. Tethered constructs of 
LMO4LIMs, Lhx3LIMs and Isl1LIMs with Ldb1LID (with Factor Xa protease sites in the linkers) were 
subcloned into these vectors. 
2.4.1.3 SNAP-tag plasmid with a cleavable His-tag 
The pSNAP-tag(T7) Vector (New England Biolabs) was modified by standard PCR to 
include an N-terminal His-tag for Ni-NTA purification and a TEV protease site in the linker for 
removal of the tag. The LMO4LIMs-Ldb1LID construct, which was initially cloned into the 
pSNAP-tag(T7) vector between the BamHI and EcoRI sites, was amplified by PCR for which 
the forward primer contained a coding sequence for the TEV site and the NdeI restriction 
enzyme site on its 5' end. The PCR product and the pSNAP-tag(T7) were digested with NdeI and 
EcoRI, and the two ligated. The resulting plasmid was named pT7-His-SNAP-LMO4LIMs-
Ldb1LID. 
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2.4.1.4 Plasmids that allow production of proteins with an N-terminal 
cysteine 
The pGEX 2TKE plasmid (a modified version of pGEX 2T from GE Healthcare in which 
a pseudo thrombin site in the GST moiety was removed by mutation) was edited by overlap 
extension PCR to generate pGEX-TEVC in which the thrombin protease site was replaced by a 
modified TEV protease site (ENLYFQ|C) where “|” indicates the proteolysed bond. Removal of 
the GST tag with TEV protease leaves an N-terminal cysteine residue. Tethered constructs of 
LMO4LIMs, Lhx1LIMs, Lhx2LIMs, Lhx3LIMs, Lhx4LIMs or Isl1LIMs with Ldb1LID (with Factor Xa 
protease sites in the linker) were subcloned into this plasmid. See Appendix C for details of 
protein sequences of tethered LIMs-LID constructs with Factor Xa-cleavable linkers used in this 
thesis. 
2.4.2 Plasmids used in yeast two-hybrid assays 
Constructs for yeast two-hybrid experiments were expressed as fusion constructs with the 
GAL4 DNA-binding domain (DBD) and GAL4 activation domain (AD). These fusion proteins 
were generated using NpGBT9 and pGAD10 vectors, respectively. NpGBT9 is a modified 
version of pGBT9 (Clontech, CA, USA) in which the BamHI and EcoRI sites within the MCS 
were reversed. 
2.4.3 Plasmids used in BiFC assays in yeast 
See Appendix D for DNA and protein sequences of BiFC plasmids used in this thesis and 
Appendix E for details of ADH1 promoters used in these plasmids. 
pW397 and pL397 plasmids were created by inverse PCR from the NpGBT9 and 
pGAD10 Y2H plasmids. The Gal4 domains and related NLS sequences were replaced with a 
NdeI restriction site. NGFPuv fragments with (GGGGS)2 linkers on either the N- or C- termini, 
generated by PCR, were cloned into pW397 (see Appendices B and C), allowing N- or C-
terminal tagging of inserted proteins (pW397-NGFPN and pW397-NGFPC plasmids). The 
NGFPN fragment was cloned between the NdeI and BamHI sites, whereas the NGFPC contained 
the stop codons and was cloned between the EcoRI and PstI sites. CGFP fragments with 
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(GGGGS)2 linkers on N- or C- termini, generated by PCR, were cloned into the pL397, allowing 
N-or C-terminal tagging of inserted proteins (pL397-CGFPN and pL397-CGFPC plasmids). The 
CGFPN fragment was cloned between the NdeI and BamHI sites, whereas the CGFPC contained 
the stop codons and was cloned between the EcoRI and BglII sites. LMO4LIMs and Ldb1LID 
constructs with or without the stop codons were subcloned into the appropriate plasmids, 
producing 8 possible combinations of fusion construct pairs. Other LIM-domains and ZnFs were 
subcloned only into the pW397-NGFPN plasmid, and their binding partners were subcloned into 
pL397-CGFPC. Full-length LIM-HD proteins Lhx3a and Isl1α were subcloned into pW397-
NGFPN and pL397-CGFPC, respectively. 
pW397-NGFPN/C and pL397-CGFPN/C plasmids were modified by replacing the short 
ADH1 (yeast alcohol dehydrogenase 1 gene) promoter (397 bp) with the full-length ADH1 
promoter (1472 bp), creating pWAFL-NGFPN/C plasmids and pLAFL-CGFPN/C plasmids. Full-
length Lhx3a and Isl1α constructs were subcloned into these plasmids. pW397-NGFPN and 
pL397-CGFPN plasmids were modified to make pW397-NLS-NGFPN and pL397-NLS-CGFPN 
plasmids in which an SV40 NLS sequence, created by PCR, was inserted into the NdeI site that 
codes for the N-terminus of each related GFP-fragment. LMO4LIMs and Ldb1LID constructs were 
cloned in these plasmids, respectively. 
PCR mutagenesis (QuickChange PCR) was used to modify the NGFPuv fragment in the 
pW397-NGFPsolN and pW397-NGFPsolC plasmids through introduction of F64L and S65T 
mutations in the NGFPuv fragments. Full-length Lhx3a and Isl1α constructs were subcloned into 
both of these plasmids. 
Finally, pW397-His-GFPsol and pL397-His-GFPsol plasmids were created by inserting 
the full-length GFPsol construct, created by overlap extension PCR (see section 2.3.1.4), 
between the NdeI and BamHI sites in the plasmids, with the 5' primer containing the His-tag. 
2.5 Yeast two-hybrid (Y2H) assays 
2.5.1 Preparation of yeast competent cells  
Yeast was cultured overnight at 30 °C with shaking (200 rpm) in 50 mL YPD media and 
then added to 300 mL YPD and grown for 4–5 hours under the same conditions. Cells were 
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collected in 7×50 mL falcon tubes by centrifugation at 1000 × g for 5 min. The cells were 
washed in 25 mL sterile water, centrifuged, collected and resuspended in 3–4 mL of fresh sterile 
1×TE/LiAc buffer. Competent yeast cells were stored at 4 °C and used within 4 days. 
2.5.2 Transformation of yeast competent cells  
Plasmid DNA (~0.5 μg) and salmon sperm DNA (~100 μg) were combined with 0.1 mL 
of competent yeast, 0.6 mL of PEG/LiAc (40% PEG-4000, 100 mM LiAc, 10 mM Tris (pH 8.0), 
1 mM EDTA) and then mixed by vortexing. The cells were incubated at 30 ºC with shaking (200 
rpm) for 30 min. DMSO (70 μL) was added and the mixture inverted 3–4 times. The cells were 
heat shocked at 42 ºC for 15 min with gentle mixing every 5 min. The cells were chilled on ice 
for 2 min and pelleted by centrifugation (15 000 × g) for 5 s. The supernatant was removed and 
the cells were resuspended in 300 μL of sterile 1×TE buffer (10 mM Tris (pH 8.0), 1 mM 
EDTA), spread onto appropriate selective SD-agar plates and incubated at 30 ºC for 3–4 days. In 
all further protocols yeast were incubated at 30 °C, and liquid cultures were grown with shaking 
at 200 rpm, except where otherwise specified. 
2.5.3 Spot-tests with haploid yeast 
Experiments were carried out using inserts cloned into pGAD10 and NpGBT9 plasmids, 
which were co-transformed into AH109 cells (Clontech). Successfully co-transformed cells were 
selected by growth on media lacking leucine and tryptophan (SD-L-W). Yeast cultures were 
diluted to an absorbance of 0.2 at 600 nm in a 1 cm pathlength (OD600), and two serial 1-in-10 
dilutions were made for each sample. Yeast suspensions (2 μL) were spotted in arrays on 
different solid selection media (Table 3.1) and reporter activation was followed and analysed 
over the next several days.  
2.5.4 Y2H mating arrays  
2.5.4.1 Replica plating  
Transfer of cells from one plate to another in mating arrays was done by replica plating 
(Figure 2.1). For this purpose, a metal stamp was constructed by the SMB workshop that fitted 
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140 mm petri dishes (plates). This stamp was covered with pieces of sterilized velveteen. The 
velveteen was carefully tightened over the stamp and fixed with rubber bands to prevent wrinkles 
in the fabric. Plates were dried prior to transfer and were gently pressed onto a stamp. 
 
2.5.4.2 Cross-mating and spot-mating Y2H arrays on solid media  
In yeast mating experiments AH109 cells were transformed with NpGBT9 constructs and 
Y187 cells were transformed with pGAD10 constructs. After a 72 h incubation colonies were 
picked from transformant plates and grown overnight in 3 mL of appropriate liquid SD media. 
Cultures of AH109 and Y187 cells at OD600 ≈ 1.0 were either: 
a) centrifuged for 5 min at 1500 × g, the supernatant removed and pellets streaked in 
parallel on a SD-W or a SD-L plate, with each streak representing a single transformant (Figure 
2.1, left). These plates were incubated for ~24 h, and then replica plated at right angles to each 
other on a mating (YPD) plate. Mating occurred at each crossover point after overnight 
incubation. 
b) spotted in small aliquots (0.5 µL) on top of each other in an array on a mating plate 
and incubated for ~16 h. Spots containing mated diploid cells were replica plated onto different 
interaction selection media (Table 3.1) and incubated for ~48 h (Figure 2.1, middle). In a short 
protocol, yeast was replica plated directly from the mating plate onto interaction selection plates. 
 
2.5.4.3 The 96-well mating arrays  
The 96-well Y2H mating array was carried out manually (Figure 2.1, right). Solid media 
was pipetted into each well (200–300 µL/well using 1 mL tips for easy transfer) while the media 
was still warm. SD-selective media broth was used to grow transformants overnight in a separate 
plate. A set of 8×12 pipette tips in a tip storage holder was dipped in wells containing one strain, 
and then dipped in wells containing YPD broth. The same procedure was repeated with fresh tips 
to inoculate transformants of the opposite mating type into the same plate for mating. After 
overnight cultivation, fresh tips were used to dip and replica plate the mated yeast on to the 
surface of the solid selection media in the 96-well plate. Colony growth and colour was followed 
for the next several days. 
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Figure 2.1. Flowchart of Y2H mating array protocols. Yeast is depicted as white spots or streaks on grey 
coloured media whereas arrows show transfers of yeast between media. Tubes and plates with liquid media are 
marked by purple frames. Colonies of AH109 strain (red) and Y187 strain (blue) transformants carrying a NpGBT9-
Ai plasmid (i=1→n) or a pGAD10-Bj plasmid (j=1→m), respectively, were picked with sterile pipette tips and 
appropriate liquid media were inoculated. In the cross-mating protocol (left), cell pellets of overnight cultures were 
streaked with the inoculation loop as parallel streaks on appropriate selection plates. Haploid yeast streaks were 
replica plated orthogonally to each other onto a mating plate, via a velveteen stamp. In the spot-mating protocol 
(middle), haploid yeast cultures were spotted on top of each other in an array of spots on a mating plate. Both cross-
mating and spot-mating protocols employed velveteen stamp replica plating in all subsequent steps. An alternative 
short protocol applied replica plating from the spot-mating plate directly onto interaction selection plates. In the 96-
well mating protocol (right), mating and diploid selection steps were performed in liquid media, whereas arrays of 
sterile pipette tips were used for replica plating. Note that interaction selection plates included SD-L-W-H plates 
with X-α-gal and different amounts of 3-AT or SD-L-W-H-A plates. 
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2.6 Bimolecular fluorescence complementation (BiFC) in yeast 
2.6.1 Yeast strain and culture media  
Yeast cells were co-transformed with pairs of complementary BiFC plasmids as 
described above (section 2.5.2). Transformed yeast was cultured on solid media as described 
above (section 2.5.3). Adenine hemi-sulfate salt (60 μg/mL) was added to the plates and liquid 
media to prevent auto-fluorescence of AH109 cells. Transformed cells were grown at 30 °C for 3 
days on SD-L-W plates. Yeast transformant colonies were used to inoculate liquid SD-L-W 
media, grown overnight at 30 °C with shaking, and used to inoculate fresh media. Protein 
expression was performed in secondary 10 mL overnight cultures until the OD600 = 1.0 (~ 20 h) 
[180].  
2.6.2 Yeast fixation 
Yeast cultures were centrifuged (1000 × g, 5 min at room temperature), supernatant was 
removed and cell pellets were resuspended in 1 mL pH 7.5 K-phosphate/sorbitol buffer (Table 
2.7). The resuspended cells were transferred to microtubes, centrifuged and pellets resuspended 
in 100 µL of yeast fixation solution. The cells were vortexed and incubated at room temperature 
for 15 min. This was followed by a wash with 1 mL K-phosphate/sorbitol buffer.  
2.6.3 Epifluorescence microscopy 
Detection and localization of BiFC fluorescence was carried out using epifluorescent 
microscopy on an Olympus BX51 System fluorescent microscope with a mercury UV-lamp, 
FITC and DAPI filter sets and a 100× objective was used for visualization. Yeast cells were 
either fixed (in trial experiments only) or were only washed with 1 mL K-phosphate/sorbitol 
buffer, without fixing. Cells were mixed in a 1:1 ratio with Mobial mountant on the microscopic 
slide. The best results were obtained when a dense 0.5–1 µL cell suspension was gently smeared 
by the cover glass and flattened into an approximately single layer of cells. Areas with tightly 
packed yeast cells in a single layer were analysed to standardize the cell density per slide. All 
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micrographs were created using the same magnification and scale bars were not added to 
micrographs. 
2.6.3.1 Image acquisition 
AnalySIS LS Starter software was used for image acquisition. Camera settings were 
controlled in the Camera Control window and the starting exposure was 100–200 ms. For some 
samples exposure times were increased to 500 ms or 1 s. The Intelligent Control feature was 
used to set the optimal signal intensity range. Micrographs were created on two (FITC and bright 
field) or three channels (FITC, bright field and DAPI) and composite images were generated by 
the software.  
2.6.4 Yeast lysis  
Yeast BiFC co-transformants were grown on selective media overnight. After confirming 
the BiFC fluorescence signal in positive controls using the epifluorescent microscope (section 
2.6.3), yeast were pelleted by centrifugation at 1000 × g for 5 min. The resulting pellets (1 
volume) were washed with 1 volume of water and dissolved in 3 volumes of Yeast breaking 
buffer on ice. Glass beads (4 volumes) were added and the samples were vortexed vigorously 
(5 × 1 min). The resulting extracts were either analysed directly using SDS-PAGE (section 2.8.1) 
or the cells were centrifuged in a microcentrifuge at 12000 × g for 2 minutes to separate the 
soluble and insoluble fractions.  
2.7 Overexpression and purification of recombinant proteins 
2.7.1 Protein overexpression in E. coli  
All proteins, except SNAP-tagged constructs, were overexpressed in BL21(DE3) cells; 
but some initial trials with GFP-labelled proteins were carried out in Rosetta 2 cells. Glucose 
(1%) was added all cultures for MBP-tagged constructs to repress the expression of bacterial 
amylases that tend to degrade amylose-based purification resins. The overexpression of His-
SNAP-LMO4LIMs-Ldb1LID in BL21-AI cells was induced with 0.001% arabinose. Small scale 
overexpression experiments (expression trials) were performed in order to find the optimal 
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conditions for overexpression, stability and solubility of each protein or class of proteins. These 
trials usually involved 10–15 mL bacterial cultures, in 50 mL conical centrifuge tubes. An 
overnight culture was started from a single colony in 10 mL LB broth with the appropriate 
antibiotic(s) and grown at 37 °C with shaking (180 rpm) for 16–18 h. The culture was diluted in 
fresh media to OD600 = 0.1 and grown to OD600 = 0.4, when the temperature was lowered to 18–
25 °C (usually 20 °C). Overexpression of BL21(DE3) cells was usually induced at OD600 of 0.5–
0.6 with 0.1 mM for GST-GFP-tagged proteins, 0.3 mM for MBP-tagged proteins, or 0.5 mM 
IPTG for other proteins. Overexpression continued at lower temperatures for 16–18 h (overnight) 
in order to minimize proteolytic degradation that is common in constructs expressed from pMal-
type vectors, and decrease aggregation/insolubility in other cases. Large scale overexpression 
experiments were usually carried out in 1L cultures, following scaled-up trial expression 
procedures.  
2.7.2 Bacterial cell lysis  
Bacterial cells were harvested by centrifugation at 5500 × g (12–15 minutes at 4 ºC) and 
thoroughly resuspended in appropriate lysis buffers. In large scale experiments lysis buffers were 
used at 4–40 mL/g cell pellet (usually 5 mL/g for GST- and His-tagged proteins, and 20–40 
mL/g for MBP-tagged proteins), and in small scale experiments at ~1 mL/10–15 mL culture. The 
suspension was then placed at -20 °C (to promote partial cell lysis through slow freezing) and 
lysed, either immediately or after storage at -20 °C, by 2–3 freeze-thaw cycles using liquid N2 for 
freezing and thawing in a water bath. Lysozyme (0.1 mg/mL) and Dnase I (10 µg/mL) were 
either present in the lysis buffer from the start or were added after thawing. Samples were 
sonicated on ice (3 series of 10 × 1 s bursts, with 1 min breaks between series) using a macrotip 
probe for large volumes or step tip probe for small volumes, at 70% the maximum sonicator 
output (Sonifier
®
 S-250A, Branson ultrasonics, CT, USA). The lysate was then incubated for 
>30 min at 4 °C with mixing, and the insoluble fraction removed by centrifugation at 20000 × g 
for 30 min at 4 °C. 
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2.7.3 Protein purification by affinity chromatography 
Small scale purification was performed using microtubes and large scale purification was 
performed in glass or plastic columns fitted with glass wool filters at the bottom of the column. 
All resins were first washed with 5 column volumes (CV, which corresponds to the volume of 
the resin in the column) of MilliQ water. After equilibration with the appropriate lysis buffer, the 
resin was mixed with the soluble fraction of the lysate and incubated in a sealed 
column/flask/tube for 1 h on a rotating wheel at 4 °C. The resin was then run through the 
column, at ~1 mL/min and the non-bound components (flow-through) collected. The same flow 
rate was used in subsequent washing and elution steps. Fractions containing purified protein 
were combined, concentrated, snap-frozen in liquid N2 and stored at -80 °C. 
2.7.3.1 GSH-affinity chromatography  
GSH resin (3–10 mL/L culture or 2 mL/g cell pellet, 50 µL for trials) was equilibrated by 
running 10 CV of GST-Lysis buffer through the column. After binding, the GSH resin was 
washed with 20 CV of GST-Wash buffer, followed by either elution from the column by 3–5 × 
CV of GST-Elution buffer (some GST-tagged proteins in trial experiments), or washing with 10 
CV of an appropriate GST-Proteolysis buffer prior to proteolysis step (most preparations). GSH 
in the GST-Elution buffer competes with the resin for binding the GST-tag, thereby specifically 
releasing a GST-tagged construct from the resin. 
2.7.3.2 Native Ni-affinity chromatography  
All His-tagged constructs of TEV protease and SNAP-LMO4LIMs-Ldb1LID were initially 
purified by Ni-NTA affinity chromatography under native conditions. Resin was used at the ratio 
of 2 mL resin per 1 L of culture. Ni-NTA-Lysis buffer included 20 mM imidazole to minimise 
non-specific binding of different bacterial proteins to the Ni-NTA resin, as the imidazole 
competes with His for Ni-binding. Relatively higher concentrations of NaCl (0.4–1 M in the Ni-
NTA buffers compared with 300 mM in GST-purification buffers) served a similar purpose. The 
purification was carried out as described for GSH-affinity purification, except that 4 × 2 CV Ni-
NTA-Wash buffer was used for washing and 4 × 2 CV of Ni-NTA-Elution buffer was used for 
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elution steps. Size exclusion chromatography (SEC) was used to remove imidazole and finely 
purify the protein. 
2.7.3.3 Amylose-affinity chromatography  
MBP-only and MBP-Ldb1LID constructs were initially purified by amylose-affinity 
chromatography. Amylose resin (~15 mL per 1 L culture) was equilibrated with 8 CV of MBP-
Lysis buffer. After binding, the resin was washed with 12 CV of the MBP-Wash buffer and the 
protein was eluted with 3 × CV of the MBP-Elution buffer. Maltose from the MBP-elution 
buffer competes with the amylose resin for MBP-binding, thereby specifically releasing a MBP-
tagged construct from the resin. Elution fractions containing the protein were concentrated, 
exchanged into a 20 mM Tris-Cl pH 8.0 buffer (no NaCl) with PD-10 columns, and further 
purified using anion-exchange chromatography. No additional purification steps were required 
for MBP-only.  
2.7.4 Protein cleavage by proteases  
Affinity tags were removed by proteolysis. In most cases, this step was carried out when 
the protein was still immobilised on the affinity resin. The resin was mixed with ~2 CV of a 
proteolysis buffer and the appropriate amount of enzyme in the purification column, which was 
sealed and incubated as indicated on a rotating wheel. After treatment with the protease as 
described below, the freshly cleaved samples were collected and more cleaved protein was 
further washed off from the resin with proteolysis buffer (~2 CV). For some experiments 
proteolysis was carried out in solution, after the protein was eluted from the affinity resin. 
Fractions containing cleaved or eluted proteins were combined, concentrated and purified further 
or snap-frozen in liquid N2 and stored at -80 °C. 
Proteolysis of GST-GFP-tagged constructs was conducted with the HRV3C protease. 
HRV3C protease (50 µL of in-house product) was used per 1 mL resin for 4–5 h for trials or 
overnight for large scale experiments at 4 °C.  
Constructs expressed from pGEX-TEVC plasmids were treated with ~50 µg of TEV 
protease per 1 mL of resin, and incubated overnight, at room temperature. 
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2.7.5 High Performance Liquid Chromatography (HPLC) 
Most proteins were further purified using size-exclusion chromatography (SEC) and/or 
ion exchange chromatography. All samples were passed through 0.22 μm filters prior to loading. 
The major fractions containing purified proteins were combined and stored at 4 ºC for immediate 
or short term use, or snap-frozen and kept at - 80 ºC for long-term storage. 
2.7.5.1 Size-exclusion chromatography (SEC) 
HiLoad Superdex 75 16/60 or HiLoad Superdex 200 16/60 size-exclusion columns (GE 
Healthcare) were used for preparative SEC of concentrated, affinity-purified samples (1–5 
mL/injection), at a flow rate of 1 mL/min on a BioLogic DuoFlow (Bio-Rad Laboratories Inc., 
CA, USA). Elution of target proteins was monitored by absorbance at 280 nm.  
2.7.5.2 Anion-exchange chromatography 
A 6 ml, prepacked monolith ion exchange column UnoQ6 (BioRad) was used for 
purification of MBP-Ldb1LID, fluorescein-labelled and GFP-tagged tethered constructs. Protein 
samples were desalted into Anion-exchange chromatography buffer A and loaded onto the 
column that was equilibrated in the same buffer. The proteins were eluted using different buffer 
B gradients of 0–100% over 20 min, with a typical flow rate of 1 mL/min in the gradient and 2 
mL/min in other steps of the program. Elution of target proteins was monitored by absorbance at 
280 nm or 215 nm. 
2.7.5.3 Reverse-phase (RP) chromatography 
Reverse phase high performance liquid chromatography (RP-HPLC) was used by Dr 
Brendan Wilkinson (from the research group of Prof. Richard Payne, School of Chemistry, 
University of Sydney) for purification of the fluorescein-2MES. The reagent was purified by 
applying a 0–100% methanol gradient with 0.1% (v/v) trifluoroacetic acid (TFA) on a Waters 
Symmetry C4 column with 0.2 mL/min flow rate. Fluorescein 2-MES eluted at ~40% methanol. 
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2.7.6 Buffer exchange, desalting and removal of low MW components 
2.7.6.1 Protein dialysis  
Samples were loaded into dialysis buttons (100 µL to 5 mL), microtube lids (≤100 µL) or 
dialysis bags (larger volumes). Dialysis membranes (SnakeSkin® dialysis tubing 3.5 or 10 kDa 
molecular weight cut off) pre-wetted in new buffer were used to cover the samples in buttons or 
lids and make dialysis bags. Samples were sealed inside the buttons with O-rings, in lids with the 
tubes with the bottom cut-out, and the bags were sealed with specialized dialysis clips 
(Spectra/Por Closures). These apparatuses were placed in buffer using buffer-to-sample volume 
ratios of ≥250:1 for >3 h with gentle stirring at the desired temperature. The buffer was changed 
2–3 times with the final dialysis step generally being carried out overnight at 4 °C. 
2.7.6.2 Gravity flow PD-10 columns  
Gravity flow PD-10 columns (GE-Healthcare) were used to rapidly exchange buffers and 
remove unbound reagents in NCL labelling reactions (section 2.10.2.4) according to the 
manufacturer's instructions. 
2.8 Analytical methods for protein detection and quantification 
2.8.1 SDS-polyacrylamide gel electrophoresis (SDS-PAGE)  
Protein samples were mixed with 4×LDS loading dye (Table 2.7), heated at ~85 °C for 5 
min (except for fluorescein-labelled and GFP-tagged proteins), loaded into precast SDS-PAGE 
gels (Table 2.12) and run at 170–200 V in 1×MES SDS-PAGE running buffer for 45–60 min, or 
until the dye front had reached the bottom of the gel. Gels were fixed with Gel fixing and 
destaining solution for 20 min, stained with Coomassie blue stain solution for ~1 h and destained 
in Gel fixing and destaining solution (Table 2.7). 
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2.8.2 Western blot analysis 
Western blot analysis was performed with yeast lysate samples from BiFC assay cultures. 
Following SDS-PAGE, the yeast lysates or soluble fractions were transferred onto Biotrace
TM
 
NT nitrocellulose membranes using a Hoefer TE22 Mini Tank Blotting Unit (Fisher Scientific) 
in Western blot transfer buffer. Transfer took place at 200 mA for 2–3 h at 4 °C. After transfer 
the membrane was blocked in 5% skim milk powder in TBST overnight with rocking at room 
temperature. The membrane was washed with TBST (15 min), and incubated with polyclonal 
anti-GFP antibody diluted 1:1000 in TBST with rocking for 1 h at room temperature. The 
membrane was then washed in 10 mL TBST (4 × 15 min), and subsequently incubated with the 
secondary anti-rabbit HRP-conjugate antibody diluted 1:4000 in TBST for 1 h with rocking at 
room temperature. Final washing was carried out in TBST (4 × 15 min). Antibody detection was 
carried out using the ECL Western Blotting Substrate kit, and chemiluminescence was detected 
by exposure to X-ray film (10 s to 2 min). The film was then developed using Kodak reagents. 
2.8.3 Spectrophotometric determination of concentration  
Protein and DNA concentrations were determined via UV-spectrophotometry using a 
ND-1000 spectrophotometer (NanoDrop Technologies Inc., 3411 Silverside Road, Wilmington, 
DE 19810, USA). Buffers were used as blanks. The absorbances of protein samples were 
measured at 280 nm and concentrations were calculated using the Beer-Lambert equation:  
   Aλ = ελ·c·l             (Equation 2.1)  
where Aλ is the sample absorbance at wavelength λ, ελ is the molar extinction coefficient (M
-1
 
cm
--1
) at wavelength λ, c is the concentration of the sample (M) and l is the path length (cm). 
Molar extinction coefficients were estimated using the program ProtParam [181] and are shown 
in Appendix C (Table C.1).  
For protein constructs that did not contain tryptophan residues the concentration was 
calculated using the Equation 2.2 [182]:  
   144·(A215 nm – A225 nm) = protein μg·mL
–1
   (Equation 2.2) 
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Concentrations of plasmid solutions and other dsDNA samples were determined by 
absorbance readings at 260 nm using the same spectrophotometer, assuming ε260nm = 50 
ng/µL/cm. 
2.8.4 Matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF)  
Mass spectrometry analysis was done using the Matrix-assisted laser 
desorption/ionization - time of flight mass spectrometry (MALDI-TOF) method on the Voyager 
DE STR MALDI-TOF instrument (Applied Biosystems Inc., Foster City, CA USA) at the 
Sydney University Proteome Research Unit (SUPRU)/ Mass Spectrometry Core Facility 
(MSCF).  
To generate peptides for protein identification by MALDI-TOF, bands were excised from 
Coomassie-stained SDS-PAGE gels, destained in gel fixing and destaining solution (Table 2.7), 
washed with 100% acetonitrile, dried, and then incubated with 15 µL of sequencing grade 
trypsin (12 ng/µL in 50 mM NH4HCO3) for 1 h at 4 °C. Excess trypsin was removed and the 
sample digested at 37 °C overnight in 15 µL 20 mM ammonium bicarbonate. All samples were 
desalted with C18 ZipTips. Subsequently, targets on the MALDI plate were first spotted with 
1 µL of the appropriate matrix solution, CHCA for trypsin digest samples (peptides) and with 
sinapinic acid for proteins. Several concentrations of protein and peptide samples were prepared 
(1/10 dilutions in Matrix Solution, starting from ~ 1 µM), spotted on top of the previously 
deposited matrix on the MALDI plate, and mixed with matrix by pipetting. After drying 
(~30 min), the plate was loaded into the instrument for data acquisition. The results were 
analysed in Data Explorer (Microsoft), and Mascot Server (Matrix Science) was used for the 
identification and characterisation of proteins based on trypsin fingerprinting.   
2.8.4.1 C18 ZipTips desalting  
MALDI-TOF samples were desalted with C18 ZipTips (Millipore). The C18 tips were 
preincubated with 10 µL of Wetting Solution, washed with 10 µL Wash solution, and the 10 µL 
of protein/peptide solutions were bound to columns by pipetting them through the tip 5–10 times. 
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After washing the column 1–3 times with Wash Solution, the samples were eluted with 1.3 or 
10 µL Matrix Solution by pipetting it through the tip 1–5 times. 
2.9 Methods for protein characterisation 
2.9.1 Far UV-Circular Dichroism (CD) spectropolarimetry  
Samples for Far UV-CD experiments (13 μM protein in 20 mM Na-phosphate buffer pH 
7.5, 20 mM TCEP) were placed in a 1-mm path length quartz cell seated in a peltier temperature 
controlled cell holder. CD spectra were recorded at 25 ºC on a Jasco J-815 spectropolarimeter 
(Jasco Inc., Easton, MD, USA). CD data were collected over the wavelength range 260–190 nm 
in a continuous scanning mode, with a speed of 20 nm/min, step resolution of 1 nm, bandwidth 
of 1 nm and a response time of 1 s. Data were omitted if the total signal at any given wavelength 
exceeded 500 V. Final spectra were the average of three scans, which was then baseline 
corrected. The corrected data were converted to mean-residue ellipticity ([θ], deg/cm2/dmol) 
using the following equation: 
    [θ]
M, λ 
= M·θ
λ
/(10·d·c)       (Equation 2.3) 
where M is the mean residue weight, θ
λ
is the observed ellipticity (mdeg) at the wavelength λ, d is 
the path length (cm), and c is the concentration (g/mL).  
2.9.2 Multi-angle laser light scattering (MALLS)  
Analytical SEC for SEC-MALLS experiments was performed using a Superose 12 
column on an Äkta Basic liquid chromatatography system (GE Healthcare) at a flow rate of 0.5 
mL/min in Competition Assay Buffer. Protein samples of 250 µL at ~2 mg/mL were used. The 
SEC setup included an in-line miniDAWN light scattering detector and an interferometric 
refractometer (Wyatt Technologies, CA, USA). Light scattering analysis was performed using a 
690 nm wavelength laser. Voltage and light scattering intensity were calibrated with toluene 
yielding a constant of 8.534 × 10
-6 for this experiment. Molecular weights were estimated using 
ASTRA software (Wyatt Technologies). MALLS analysis of monomeric BSA was also 
conducted to check the calibration of the instrument 
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2.9.3 Nuclear magnetic resonance (NMR) spectroscopy of fluorescein-2-
MES 
The sample contained 2.7 mM fluorescein-2-MES in 20 mM Na-phosphate buffer pH 7.5 
to which 5% (v/v) D
2
O and 2 μM DSS (Table 2.1) were added. 1D 
1
H-NMR spectra (64 scans) 
were recorded with a spectral width of 12 ppm at 25 ºC on an Avance III 800 MHz Bruker 
spectrometer (Bruker AXS GmbH, Karlsruhe, Germany) equipped with a 5 mm triple-resonance 
TCI cryoprobe and processed using Topspin 2.1 (Bruker). Water suppression was achieved using 
pulsed-field gradients. Spectra were processed using TOPSPIN (Bruker) running on Linux 
workstations. Spectra were referenced to DSS at 0.00 ppm. 
2.10 Site-specific protein labelling with synthetic fluorophores 
2.10.1 Labelling of SNAP-tagged proteins 
pT7-His-SNAP-LMO4LIMs-Ldb1LID was overexpressed in BL21-AI cells, and purified by 
Ni-affinity chromatography (see section 2.7.3.2), followed by anion-exchange chromatography 
(see section 2.7.5.2). The protein was labelled with BG-488 reagent in SNAP-tag labelling 
buffer, according to the manufacturer's instructions (protocol for labelling in solution, SNAP-
Cell Starter Kit, New England Biolabs). Dialysis (see section 2.7.6.1) was performed to remove 
free reagent from solution and the degree of labelling was estimated (see section 2.10.3). 
2.10.2 Labelling of proteins by Expressed Protein Ligation (EPL) 
2.10.2.1 Production of the fluorescein-2MES reagent 
5-(and 6-)Carboxyfluorescein succinimidyl ester (96 mg) and sodium 2-
mercaptoethanesulfonate (375 mg) were combined and dissolved in 10 mL of 100 mM Na-borate 
buffer, pH 8.7. The reaction was stirred at room temperature for 2 h and the product purified by 
RP-HPLC (see section 2.7.5.3). 
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2.10.2.2 Production and purification of TEV protease 
The S219V mutant of TEV protease was overexpressed as a His-tagged protein in 
BL21(DE3) cells. In the initial stages of the project the protein was purified only by Ni-affinity 
chromatography as described previously [183, 184]. In later stages of the project the enzyme was 
additionally purified by SEC. After purification, the enzyme was concentrated to ~0.5 mg/mL, 
diluted with glycerol to ~0.25 mg/mL (50% glycerol stocks), snap-frozen as 100 µL aliquots, and 
stored at -80 °C. 
2.10.2.3 Production and purification of proteins with an N-terminal cysteine 
residue 
Tethered LIMs-LID constructs and the DEAF1 construct in pGEX-TEVC vectors were 
overexpressed in BL21(DE3) cells, purified by GSH-affinity chromatography, treated with TEV 
to remove the tag and expose the N-terminal cysteine residue, and subsequently purified by 
anion-exchange chromatography. 
2.10.2.4 Native chemical ligation (NCL) reaction  
Labelling of N-terminal cysteines with fluorescein was performed by native chemical 
ligation (NCL). Tethered constructs with an exposed N-terminal cysteine residue were 
concentrated to 1–4 mg/mL in NCL buffer and the solutions used to resuspend dry fluorescein 2-
MES reagent to a final concentration of 0.2–0.5 mg/mL. MESNA (or MPAA) thiol in buffer 
(0.4 M) was added to this tube to a final concentration of 20–100 mM thiol. The reaction was 
incubated in the dark at room temperature as indicated (5–92 h). Long reactions (>48 h) with 
MESNA were used to obtain products without significant levels of nonspecific binding (Figure 
6.13). The reaction was stopped by adding 1 volume of buffer containing 100 mM DTT and 
incubated for 30 min at room temperature. Unreacted reagents were removed, and the buffer 
changed to anion-exchange buffer A, using PD-10 desalting columns (section 2.7.6.2). Samples 
were analysed by SDS-PAGE and fluorescence scanning on Typhoon FLA9000 scanner (GE 
Healthcare), and absorbances at 280 nm and 494 nm measured on the ND-1000 after each step.   
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2.10.3 Calculating the degree of labelling 
Purified labelled protein was diluted in buffer, and absorbance was measured at 280 nm 
(A280) and 506 nm (BG-488-labelled proteins, section 2.10.1) or 494 nm (fluorescein-labelled 
proteins, section 2.10.2.4) and the concentration of labelled protein calculated using Equation 
2.4: 
   cp=1/ε280·(A280 - CF·Aexc)·dilution factor   (Equation 2.4) 
where ε280 is the molar extinction coefficient of the unlabelled protein at 280 nm (for specific 
values see Appendix C), Aexc is the absorbance measured at the appropriate excitation 
wavelength (506 nm for BG-488-labelled and 494 nm for fluorescein-labelled proteins), and CF 
is a correction factor (~0.3 for most proteins), which compensates for absorption of the bound 
fluorophore (fluorescein) at 280 nm. The degree of labelling was calculated using the following 
equations: 
   dye per protein = Aexc/(εexc·cp)    (Equation 2.5) 
or   % labelled protein = 100·Aexc/(εexc·cp)   (Equation 2.6) 
where εexc is the extinction coefficient of BG-488 at 506 nm or fluorescein at 494 nm (~70 000 
M
-1
cm
-1
 for both). 
2.11 Quantitative competition binding assays 
2.11.1 The proteolysis of tethered complexes 
Factor Xa was used to cut the specific IEGR|G site in tethers that connect the LIMs and 
LID domains in tethered complexes. The reaction was usually performed with 1–5 µM protein in 
the appropriate proteolysis buffer (Table 2.7), containing 20 µg/mL Factor Xa, for 6 h at room 
temperature. The reaction was stopped with 1 mM PMSF. 
2.11.2 Fluorescence anisotropy (FA) 
All solutions used in fluorescence spectroscopy were filtered through 0.22-μm filters to 
remove light-scattering particles. Increasing concentrations of MBP-Ldb1LID were mixed with 
solutions containing <10 nM of Factor Xa-cleaved, fluorescent LIMs:LID complexes in 300 µL 
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reaction volumes, and incubated at room temperature for at least 30 min up to several hours. 
Each sample was transferred to a quartz cuvette and the fluorescence intensity monitored: 
excitation at 475 nm and emission at 510 nm for GFP-tagged constructs; excitation at 492 nm 
and emission at 520 nm for fluorescein-labelled constructs. Data were recorded in order from 
low to high MBP-Ldb1LID concentration samples. The Fluorescence spectrophotometer (Cary 
Eclipse, Varian Instruments, Mulgrave VIC) was fitted with a manual polariser (Varian 
Instruments), and Long Pass filters (Coherent Scientific Pty. Ltd.) for excitation and emission. 
The temperature was maintained at 25 ºC using a block temperature controller (Varian 
Instruments, Mulgrave, VIC), slit widths were set to 10 nm and each data point was averaged 
over 15 s. In control assays, MBP-only was used instead of MBP-Ldb1LID to evaluate non-
specific binding. 
Anisotropy values (r) were calculated from the formula 
   r = (Ivv - G·Ivh)/(Ivv + 2·G·Ivh)     (Equation 2.7) 
where: 
 Ivv = emission light intensity when both the excitation and emission filters transmit vertically 
polarized light  
 Ivh = emission light intensity when the excitation filter transmits vertically polarised and the 
emission filter transmits horizontally polarised light  
Any bias towards vertically or horizontally polarised light caused by the fluorescence 
spectrophotometer was corrected by including a G-value: 
   G = Ihv/Ihh,       (Equation 2.8) 
where: 
 Ihv = emission light intensity when the excitation filter transmits horizontally polarised and 
emission filter transmits vertically polarised light  
 Ihh = emission light intensity when both the excitation and emission filters transmit 
horizontally polarized light.  
 
The G-value was 1.7–1.9 for different FA competition assays performed in this study. 
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2.11.3 Fluorescent gel shift assays  
Fluorescently labelled LIMs-LID tethered constructs were treated with Factor Xa to cut 
the linker between the LIMs and LID domains, generating un-tethered (or cut) complexes for use 
in competition binding assays. Increasing concentrations of MBP-Ldb1LID were added to 
compete with Ldb1LID from the original construct for binding to the LIM domains. The ~42-kDa 
MBP tag means that newly formed complexes are larger, which can be detected in different 
binding assays.  
2.11.3.1 Native gel electrophoresis (protein gel shift assays) 
Samples of cut GFP-tagged LIMs:LID complexes were mixed with increasing 
concentrations of MBP-Ldb1LID in a total reaction volume of 0.5 mL. Following incubation for 
1 h at room temperature, these samples were mixed with the Native gel loading buffer and 
loaded into wells of a precast gradient native gel (NativePAGE Bis-Tris gel system, Life 
Technologies). The gels were subjected to electrophoresis at 4 °C in the dark, in Blue Native 
PAGE or Clear Native PAGE formats, according to the manufacturer's instructions. In both 
formats Bis-Tris-Tricine buffer was used, but in the Blue Native format the cathode buffer 
contained 0.4% Coomassie Brilliant Blue G-250. After 1 h of electrophoresis at 150 V, the 
voltage was increased to 250 V and the gel was run for a further 45–50 min.  
2.11.3.2 Detection and quantification of fluorescence 
Blue and clear native gels were scanned on a Typhoon FLA9000 imager (GE Healthcare 
Life Sciences) using EGFP excitation/emission settings. The Clear Native gels were 
subsequently stained with Coomassie blue stain solution. The obtained images were saved in 
TIFF format and ImageJ [185] was used to analyse these images and quantify the intensity of 
signal in each shifted fluorescent band. These values were plotted to obtain binding curves in 
Origin9.1 (OriginLab, Northampton, MA). Calculation and curve fitting is explained in more 
detail in Appendix F. 
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2.12 Bioinformatics, structure models and image processing 
ProtParam, PeptideCutter and some other Expasy online tools [181] were used to predict 
characteristics, structure, and identify proteins analysed in this study. NCBI BLAST search tools 
Clustal W2 and Clustal Omega alignment were used to compare protein sequences of different 
proteins and find conserved residues and motifs [186, 187]. The STRING protein-protein 
interaction database was used to investigate functional connections and possible interactions 
between LIM-HD proteins and their partners [116]. The Weblogo online tool was used to 
generate a diagram of conserved residues in HDs of LIM-HD proteins 
(http://weblogo.berkeley.edu; [188]). Data on gene positions, clusters, paralogues and 
ortologues, phylogenetics, protein isoforms, mutations etc. was obtained from the UCSC 
Genome Browser (http://genome.ucsc.edu) [189] and ENSEMBL database [190]. Protein 
expression and localization data was obtained from the mouse Gene Expression Database (GXD) 
[86], Gene Expression Evolution database (Bgee) [191], or the Human Protein Atlas [192]. 
Figures in this thesis were made with Adobe Illustrator CC (Adobe Systems) and 
CorelDraw Graphics Suite X7 (Corel Corporation) software packages. Image models of various 
structures were analysed and prepared in the PyMOL Molecular Graphics System, version 
1.7.6.3 (Schrödinger, LLC.) Where available, RCSB protein data bank (PDB) accession codes 
were indicated [193]. 
 
Chapter 3 63 
 
 
 
Chapter 3    Optimising Y2H mating arrays for interactions 
between LIM-HD proteins 
3.1 Introduction 
This chapter describes experiments aimed to detect protein-protein interactions between 
all LIM-HD proteins and specifically if LIM-HD proteins other than Lhx3/4 and Lmx1a interact 
with Isl1/2.  
Protein-protein interactions in this chapter were exclusively investigated by yeast two-
hybrid analysis. For this reason, the approach and the two ways the approach was used in this 
chapter are explained in detail. More information on yeast strain genotypes, yeast plasmid maps, 
media composition and experimental procedures can be found in the Materials and Methods 
section of this thesis. 
3.1.1 General approach 
Yeast-two hybrid (abbreviated hereafter as Y2H) has been a standard in vivo method for 
detecting protein-protein interactions for more than 20 years [194]. The approach is based on the 
idea that if you express two interacting proteins fused to specific complementary active domains, 
upon binding, this hybrid complex will generate some detectable output in vivo. For standard 
Y2H, this function is the transcriptional activation of reporter genes. Many related two- (and 
three-) hybrid methods in yeast and other organisms have been developed that are based on 
enzyme activity, fluorescence and various other functions [195-198]. 
3.1.2 Plasmids, yeast strains and reporter genes 
The experiments presented in this chapter used the well-defined Gal4 system (Figure 3.1). 
In this system, the two domains to be tested are cloned as fusion constructs with each of the 
DNA-binding domain (DBD) and activating domain (AD) of yeast transcription factor Gal4. 
Each construct is present in a separate expression vector. DBD-fusion constructs were expressed 
from the NpGBT9 plasmid, and AD-fusion constructs were expressed from the pGAD10 
Chapter 3 64 
 
 
 
plasmid, both from a short ADH1 promoter (396 bp) that gives very low levels of constitutive 
expression during the exponential growth phase [199].  
 
Figure 3.1. The Gal4 yeast two-hybrid system. The DNA-binding domain (DBD) of the Gal4 yeast transcription 
factor is fused to protein A and the activating domain (AD) of Gal4 is fused to protein B. The two fusion constructs 
are co-expressed in a yeast cell and localized in the nucleus. If proteins A and B interact, reconstituted Gal4 dimers 
bind UAS sites and activate the HIS3, MEL1 and ADE2 reporter genes, used in this thesis. Inserted yellow table 
shows which of the reporters are present in AH109 and Y187 strains.   
 
The assays used commercially available (Clontech) strains of yeast Saccharomyces 
cerevisiae AH109 (in all experiments) and Y187 (in mating arrays only). These yeast strains 
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have both been made auxotrophic (cannot grow in the absence of a given substance) for the 
amino acids leucine (L), tryptophan (W) and histidine (H), and the nucleobase adenine (A). 
NpGBT9 and pGAD10 contain selective markers (genes that express the missing 
enzymes) that allow growth on tryptophan-deficient (-W) and leucine-deficient (-L) media, 
respectively. When transformed with both types of plasmids, AH109 and Y187 strains should 
grow on SD-L-W media. The AH109 genome also carries reporter genes that compensate for 
auxotrophy in histidine (HIS3) and adenine (ADE2) biosynthesis. Both AH109 and Y187 carry 
the colourimetric reporter gene MEL1, which encodes an α-galactosidase that creates a blue 
product from the substrate X-α-Gal.  
Upstream activating sequences (UAS) in promoter regions of these reporter genes contain 
binding sites for the Gal4 protein. When the test proteins interact, the hybrid complex will be 
recruited to Gal4-binding sites via the Gal4DBD and interact with the basal transcriptional 
machinery via the Gal4AD. The hybrid complex activates transcription of reporter genes, 
allowing growth on selective media without histidine and adenine (Table 3.1). Up to 100 mM of 
3-aminotriazole (3-AT), a competitive inhibitor of the HIS3 reporter product, is often added to 
media to increase selection pressure. In this thesis, 0.5–10 mM 3-AT was added to interaction 
selection plates (Table 3.1). However, 3-AT was not used to further increase selection pressure 
under double selection conditions.  
 
Table 3.1. Yeast selection conditions used to detect an interaction. Different media were classified according to 
their assumed selection pressure into weak, moderate or double selection media. All media require activation of the 
HIS3 auxotrophic reporter while double selection media requires the additional activation of the ADE2 auxotrophic 
reporter. Weak selection media does not contain 3-AT. Moderate selection media contains 3-AT (0.5–10 mM). X-α-
Gal, a substrate for the MEL1 colourimetric reporter was added in weak and moderate selection media. Any single 
assay used a subset of these conditions. SD media content is listed in Table 2.16. SD-L-W-H(-A) is SD media 
lacking amino acids L, W, H (and adenine nucleobase). 
Weak selection SD-L-W-H, X-α-Gal 
Moderate selection SD-L-W-H, X-α-Gal, 0.5–10 mM 3-AT 
Double selection SD-L-W-H-A 
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Yeast growth and MEL1 reporter activation were followed in parallel in all experiments 
except the double selection conditions where X-α-Gal was not included in the media. However, 
colour is used to report on a given interaction only when differences in colour development 
could not be explained by differences in growth, or when the growth was not consistent.  
3.1.3 Background growth: causes, inhibition and controls 
In all Y2H experiments positive and negative controls were included on every plate. The 
main negative controls comprised each of the DBD- and AD-fusion proteins tested against the 
AD-only or DBD-only domains, respectively, expressed from the appropriate 'empty' plasmids 
(i.e., the AD or DBD are produced in the absence of a fusion partner). Where a negative control 
gave rise to yeast growth it was considered as assay background for the related interaction. Yeast 
spots that did not grow significantly above background were classified as false positives. Weak 
background growth can be caused by leaky expression of the HIS3 reporter in the absence of 
Gal4 activity. Indeed, under weak selection conditions this was often observed, so most 
experiments reported use 3-AT (i.e., moderate selection conditions) to eliminate this 
phenomenon.  
 Some proteins, when expressed as DBD-fusion constructs, can directly activate 
(‘autoactivate’) reporter genes and lead to false positive results. Autoactivation can also be 
caused by AD-fusion constructs of DNA-binding proteins that bind non-specifically to promoters 
of reporter genes [198, 200, 201]. Autoactivation is the most common cause of false positives 
and can be confirmed using additional negative control experiments in which a single plasmid 
containing either an AD- or DBD-fusion construct of a protein in question is transformed into 
yeast. Several moderate selection conditions were used in this work to compensate for different 
levels of autoactivation caused by some of the tested constructs. 
When testing a pair of constructs A and B for an interaction, the Y2H assay commonly 
uses two combinations of fusion constructs: DBD-A vs. AD-B; and, DBD-B vs. AD-A. 
Although carrying out experiments that test both combinations is preferred, autoactivation can 
often prevent detection in one of the combinations. 
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3.1.4 Yeast mating 
There are two strategies for inserting both DBD- and AD-containing plasmids into yeast 
cells: co-transformation (adding both plasmids during transformation) and mating [202, 203]. 
The latter method takes advantage of the ability of haploid yeast S. cerevisiae to exist in either of 
two complementary mating types, MATa or MATα. The two mating types can mate with each 
other and thereby fuse into a diploid form (Figure 3.2). In this study AH109 (MATa) cells were 
transformed with DBD-containing plasmids and Y187 (MATα) with AD-containing plasmids. 
The haploid transformants were mated to create diploid yeast cells that co-express both fusion 
constructs. A big advantage of mating is the simplification of transformation when large numbers 
of interactions are tested [204, 205].  
 
Figure 3.2. Yeast mating. Haploid strains of opposite mating types are each transformed with one of the 
complementary Y2H plasmids. MATa and MATα cells fuse together to make a diploid yeast cell (i.e., with two sets 
of 16 yeast chromosomes) that carries both Y2H plasmids. 
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3.1.5 Arrays and replica plating 
Y2H mating arrays often test defined numbers of known protein constructs against each 
other in an ordered matrix of spots on the same plate [206-208]. Mating arrays can also be used 
for library screens [209]. In mating arrays, replica plating is used to transfer yeast from haploid 
plates to a mating plate, and then transfer diploid yeast to different selection plates. Replica 
plating maintains the relative positions of yeast colonies, spots or stripes from starting plates 
('master' plates) on the subsequent plates (replica plates) [209, 210]. Where appropriate, in these 
experiments manual velveteen stamp replica plating was used in which a sterile piece of 
velveteen cloth is applied to the first plate and then touched onto the replica plates.  
3.2 Identification of autoactivating domains and experimental design   
Full-length (or near full-length) constructs of several mouse LIM-HD proteins in Y2H 
assays were first tested for autoactivation as previous studies in the laboratory have indicated that 
autoactivation is a potential problem for this family of proteins. All constructs showed some 
level of autoactivation, although the extent of autoactivation varied. For example, when 
expressed as a DBD-fusion construct, Lhx3a showed strong background growth in the negative 
control under all selection conditions (Figure 3.3A) and background growth when expressed as 
an AD-fusion construct only under weak selection conditions, as did most other members of the 
family (e.g., Figure 3.3B). This autoactivation likely arises from the C-terminal regions of these 
proteins as several LIM-HD proteins are reported to contain transcriptional activation domains in 
this region [136, 211-213], although the HDs also appear to contribute to this affect (data not 
shown). In contrast, although DBD-fusion constructs of tandem LIM domains (LIMs) can show 
background growth under weak selection, this is generally eliminated by the inclusion of up to 
10 mM 3-AT in the media, as shown for DBD-Isl2LIMs, and DBD-Lhx2LIMs (Figure 3.3C). Other 
LIMs constructs have been used previously in Y2H experiments as DBD-fusion constructs, with 
little or no background growth [18, 156, 167].  
The tests confirmed that DBD-full-length LIM-HD constructs can cause background 
growth that could make weak interactions difficult to detect. Therefore it was decided to use only 
LIMs constructs in DBD-fusion constructs and test them for binding against full-length 
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constructs expressed as AD-fusion constructs (DBD-LIMs vs. AD-full-length combination). 
There is good precedent for using these constructs, as Lhx3LIMs mediates an interaction with the 
Isl1LDB domain. It should be noted that with this assay design non-LIM mediated interactions 
within the LIM-HD family cannot be assayed. The mating arrays were carried out with up to 10 
mM 3-AT on moderate selection plates, and on double selection plates.  
 
Figure 3.3. False positives from autoactivation. (A) Autoactivation produced by DBD-Lhx3a in the presence of 
the Gal4 AD on moderate (SD-L-W-H, X-α-Gal, 1 mM 3-AT) and double (SD-L-W-H-A) selection plates. (B) 
Autoactivation produced from AD-LIM-HD fusion constructs. Yeast transformants expressing AD-Lhx3a, AD-
Lhx4 or AD-Lhx8 (but not the DBD-domain), spotted on weak (SD-L-H, X-α-Gal) selection plates. (C) Yeast co-
expressing AD-only with either DBD-Isl2LIMs on the left or DBD-Lhx2LIMs on the right on SD-L-W-H + X-α-Gal 
plates with a range of 3-AT concentrations. Y2H autoactivation and negative control assays (A-C) were performed 
using cell-normalized dilution spot-tests. 
 
3.3 Preliminary experiments 
Prior to the start of this thesis project, a series of Y2H spot-test assays were carried out to 
test possible interactions between some LIM-HD proteins [169]. These experiments covered only 
some of the possible interactions within the family of LIM-HD proteins as not all protein 
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constructs were available at the time. The results of these assays are presented in Table 3.2, and 
showed previously detected interactions between Isl1α, and Lhx3LIMs and Lhx4LIMs. In addition 
this work reported some novel, apparently weaker interactions between Lhx3a and the tandem 
LIM domains of several LIM-HD proteins, and between Lmx1aLIMs and Isl1LBD. Some of these 
apparently weaker interactions could not be detected by an Honours Student in the laboratory, 
Kim Tieu, at a later date [214]. This disparity possibly arose because weaker interactions often 
give varying levels of growth from experiment to experiment as they are close to the limit of 
detection. Small variations in media, growth conditions and handling can push them either side 
of the detection limit. Y2H assays on weak selection plates are particularly sensitive to these 
effects. It is also possible that some of these interactions were in fact false positives due to 
additive autoactivation effects of DBD-LIMs and AD-Lhx3a fusion constructs. 
 
Table 3.2. The results of preliminary Y2H spot-test assays from [169]. The table shows a summary of relative 
yeast growth “on SD-L-W-H plates containing X-α-Gal and 3-AT (0.5 mM or 1 mM). (+++) indicates strong growth 
and blue colour, (++) signifies growth and faint/absent blue colour; (+) indicates weak growth and no blue colour; (-
) indicates absence of yeast growth on SD-L-W-H plates containing X-α-Gal and 3-AT (1 mM)” [169]. The scaling 
system used for these results was different from the system applied in experiments performed for this thesis. Light 
grey fields mark the constructs and interactions that were not tested. 
 
 
3.4 Advantages of a larger scale approach with appropriate controls  
To minimise experimental variation, an aim of this project was to simultaneously test all 
mouse LIM-HD proteins (including all Lhx6 isoforms), for pair-wise interactions. Given the 
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large number of possible interactions and corresponding controls, a Y2H mating array was 
designed that would take advantage of replica plating and enable all the interactions to be tested 
at the same time, on a single plate. Hits from this screen would be confirmed using Y2H spot-
tests. 
Since the Ldb1LID interacts with LIM domains of all LMO and LIM-HD proteins, it was 
used as a positive control (both DBD- and AD-Ldb1LID) in all arrays. Isl1LBD was chosen as a 
second positive control because it is known to interact with Lhx3LIMs, and to determine if other 
LIM-HD proteins could interact with this domain. DBD- and AD-fusion constructs of rat Pit1 
protein, a putative partner of Lhx3 [215], were included in some of the assays but this interaction 
is not a focus of this thesis. Human SSB1 protein, which was shown previously not to interact 
with LMO proteins in Y2H assays (Dr Liza Cubeddu, personal communication) was used as a 
non-related protein control. Protein isoforms and constructs used in the assays are described in 
Chapter 2.  
3.5 Y2H mating arrays 
3.5.1 A cross-mating array 
NpGBT9 constructs were individually transformed into AH109 yeast maintained on SD-
W media, whereas pGAD10 constructs were individually transformed into Y187 cells 
maintained on SD-L media. The first rounds of mating arrays were performed using a cross-
mating procedure (section 2.5.4.1). On mating plates, horizontal stripes from the AH109 
transformants were pink compared with mostly cream coloured vertical stripes of the Y187 
transformants (Figure 3.4A). The red pigment is an oxidized intermediate of adenine synthesis 
(AIR) and is known to appear in yeast strains that carry the ade2 and/or ade1 mutant genes [216-
219] or the ade2 gene replaced by the ADE2 reporter (as in AH109 strain, [220]), when growing 
on media with low but permissive adenine content. The Y187 strain does accumulate the same 
red pigment, but probably at a different rate than AH109. 
Only spots with mated diploid yeast that carried auxotrophic selection markers for both -
L and -W grew on the diploid selection plate (Figure 3.4B). Yeast cells that were transferred but 
did not grow because they lacked appropriate plasmids were visible as opaque spots on the 
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diploid selection plate after incubation. The same effect can be seen on all interaction selection 
plates. The negative mating controls showed no yeast growth, as expected, because the two 
mating partners carried the same plasmid type, and the resulting diploid cells had only one of the 
two auxotrophic markers necessary for survival on the SD-L-W plate. Diploid yeast were further 
replica plated onto 1 mM and 10 mM 3-AT moderate selection plates (Figure 3.6). Double-
selection conditions were also used in cross-mating arrays (not shown) but since the resolution 
(separation between neighbouring spots) became unacceptable after two replica platings from the 
same diploid selection plate, moderate conditions were given priority. 
 
Figure 3.4. Cross-mating and diploid yeast selection. Black arrow shows the replica plating direction and the 
small photograph behind the arrow shows the replica plating apparatus (velveteen stamp). Note that although the 
figure emphasizes strains and plasmids with LIMs and full-length LIM-HD constructs, the empty plasmids and other 
controls were included in this array as explained in the text. (A) Cross-mating plate showing both haploid strains 
(and mated diploids at crossing points) growing on a YPD plate after being replica plated from each of the single-
plasmid selection plates with streaks arrayed orthogonally to each other. The yeast was left to grow and mate 
overnight at 30 °C. (B) Cross-mated yeast was replica plated on to SD-L-W medium to select for diploids containing 
both plasmids. Mating controls are indicated by rectangles. Blue rectangles show the position of Y187 yeast 
transformed with an empty NpGBT9 plasmid and transferred onto the YPD plate from the horizontally streaked 
SD-W plate. Red rectangles show the position of AH109 yeast transformed with an empty pGAD10 plasmid and 
transferred onto the YPD plate from the vertically streaked SD-L plate. A purple arrowhead points to a positive 
mating control spot (B). A yellow star indicates the horizontal streak of AH109 transformed with NpGBT9-Isl2LIMs 
(A). 
 
In the cross-mating arrays, the final selection plates (1 and 10 mM 3-AT moderate 
selection conditions) were scanned every day for 4 days. Each of the two plates were analysed 
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(scored for interactions) at incubation times that were the most informative (i.e., gave the best 
signal-to-noise ratio and resolution). Background growth made 1 mM 3-AT moderate selection 
plates difficult to analyse after 2–3 days. Fortunately, most positive controls could be detected on 
day 1 of the incubation. 
Although replica plating is a well-established method for this type of interaction array, 
several issues were noted. The amount of yeast cells transferred to each spot by velveteen stamp 
replica plating cannot be normalized prior to transfer and is probably much higher than the 
highest amounts commonly used in Y2H spot-tests (~10
4
 cells). Therefore, it is likely that in the 
absence of autoactivation all weak interactions detectable in a particular Y2H system would 
appear on weak selection plates using this method.  
Yeast spot size on an interaction selection plate is determined by spot size on the previous 
plate, efficiency of replica plating transfer and media consistency, in addition to reporter 
activation. Consecutive replica plating steps led to decreased resolution of yeast spots. Based on 
initial observations of how closely spaced streaks could be prior to fusion of spots and/or 
diffusion of blue pigment to neighbouring spots, this cross-mating protocol was estimated to 
have an upper limit of 16 streaked lines per column/row in a 140 mm plate. However, the 
complete LIM-HD vs. LIMs array needed at least 18 columns for all AD-fusion constructs and 
controls. 
3.5.2 A spot-mating Y2H array 
To improve the resolution of the assay, instead of streaking and crossing the yeast 
streaks, small aliquots of overnight cultures of AH109 and Y187 transformants in the appropriate 
selective media were spotted manually on top of each other on a mating plate (section 2.5.4.2.). 
Mating control was not deemed necessary in this version of the assay. Mated yeast spots were 
then replica plated on to a diploid selection plate (Figure 3.5), which was used as a template for 
replica plating onto interaction selection plates. The interaction spots were scanned every 24 h 
(Figures 3.7 and 3.8). 
The spot-mating arrays showed improved resolution, which allowed analysis of up to 20 × 20 
spots in 140 mm plates. Using relatively drier YPD and selection plates allowed cleaner transfers 
and did not negatively affect the yeast growth but improved resolution of spots. At this point 
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attempts were made to identify additional weaker interactions under weak selection conditions. 
A variation of the spot mating protocol was attempted to further reduce the loss in resolution 
induced by consecutive replica plating. In the short protocol (Figure 3.5, green arrow) replica 
plating was done only once to transfer yeast spots directly from the YPD plate on to the 
interaction plates. The resolution was slightly improved but the overall growth rate of yeast on 
the weak selection plate was still very high, which made the background growth in all spots 
appear early in the incubation period. For this reason, this plate was monitored for only 48 h 
(Figure 3.7C and D). 
 
Figure 3.5. Y2H spot-mating flowchart. Haploid strains were manually spotted on top of each other on a YPD 
mating plate and incubated for 24 h at 30 °C. AH109 transformants expressing DBD-fusion constructs (rows) were 
mated with Y187 transformants expressing AD-fusion constructs (columns) (A). The successfully mated diploid 
yeast spots were selected on a SD-L-W plate (B). Standard (black arrows) and short (green arrow) protocols were 
performed for transferring yeast to the various interaction selection plates (C). The small photographs represent 
replica plating. Note that although the figure emphasizes strains and plasmids with LIMs and full-length LIM-HD 
constructs, the empty plasmids and other controls were included in this array as explained in the text. 
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3.6 Results from the cross-mating and spot-mating Y2H arrays 
The following section summarises all of the interaction data taken from Figure 3.6 (cross-
mating method; 1 and 10 mM 3-AT moderate selection), Figure 3.7A–B (spot-mating, standard 
protocol; 1 mM 3-AT moderate selection) and Figure 3.8 (spot-mating, short protocol; double 
selection). Note that references to colour only refer to weak and moderate selection plates, where 
X-α-Gal was included in the media. 
3.6.1 Controls 
In terms of interpreting the interaction plates, it was first necessary to evaluate the 
negative and positive controls to establish if constructs show different levels of background 
growth in diploid cells compared to the haploid cells that were tested for autoactivation in 
section 3.2, and to establish if known interactions were detected by this method.  
Examination of DBD negative controls (expressing DBD-fusion constructs and AD-only) 
confirmed the results from the preliminary autoactivation assays. The pattern of reproducible 
background growth on 1 mM 3-AT moderate selection plates was consistent with that expected 
from preliminary autoactivation assays.  
DBD-Isl2LIMs autoactivation was particularly strong in these arrays and the corresponding 
yeast grew on the 10 mM 3-AT moderate selection plate but did not develop colour (Figure 
3.6B). This construct, as well as DBD-rPit1, allowed some weak growth due to autoactivation 
under double selection conditions (Figure 3.8). Of the full-length fusion constructs, AD-Lhx1, 
Lhx2, Lhx3a and Lhx4 showed low levels of growth when tested against DBD-only (AD 
negative controls) under 1 mM 3-AT moderate selection conditions in the streak-mating method, 
which was eliminated under 10 mM 3-AT moderate selection conditions. Other negative controls 
in this combination were essentially clear. 
For the positive controls: the interaction plates showed evidence of an interaction (yeast 
growth and evolution of blue colour in the presence of X-α-Gal) between all AD-full-length 
LIM-HD constructs and DBD-Ldb1LID. Thus, all of the longer AD-full-length constructs appear 
to have reasonable levels of expression and stability, with each containing functional LIM-
domains. Similarly, AD-Isl1α and AD-Isl2 showed evidence of an interaction with DBD-
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Lhx3LIMs and DBD-Lhx4LIMs, indicating that AD-Isl1α and AD-Isl2 are stably expressed, with 
each containing a functional LBD. Apart from the Lhx1 and Lhx5 interactions (which appeared 
to be weaker under some conditions, with variability from experiment to experiment), all DBD-
LIMs constructs showed evidence of an interaction with AD-Ldb1LID. Note that some early 
experiments (e.g., Figure 3.6) used Lhx1*LIMs, which was found to extend only as far as the last 
zinc-coordinating aspartate residue, D117. LIM domains tend to have ~4–6 structured residues 
beyond this point, so an extended construct (to S123) was generated and used in later 
experiments and is referred to as Lhx1LIMs. 
 
 
Figure 3.6 Results of a cross-mating Y2H array. A SD-L-W diploid selection plate was replica plated onto SD-L-
W-H with X-α-Gal and with either 1 mM (A) or 10 mM 3-AT (B). DBD-fusion constructs (horizontal) were tested 
against AD-fusion constructs (vertical). AH109 transformants are shown in red and Y187 transformants are shown 
in blue. Ldb1LID and Isl1LBD were used as positive controls in both combinations. DBD-fusion constructs of Lhx1LIMs 
and Lhx6LIMs were tested in duplicate. The 1 mM 3-AT moderate selection plate (A) is shown at day 2 and the 10 
mM 3-AT moderate selection plate (B) is shown at day 4. Red and blue font colours differentiate the two mating 
strains used. AD-full-length and DBD-LIMs fusion constructs of LIM-HD proteins are shown in black boxes; Yeast 
spots that correspond to interactions between these constructs are shown in green boxes. The Lhx1*LIMs construct 
extends only as far as the last Zn-coordinating residue and was replaced in later assays by a longer construct. 
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To assess reproducibility within an experiment for the streak mating experiments (Figure 
3.6) duplicates of DBD-Lhx1LIMs and DBD-Lhx6LIMs expressing yeast were generated from 
separate colonies from the same transformation plates. Both pairs of replicates displayed 
identical results.  
3.6.2 LIM-HD vs. Ldb1LID interactions 
As noted above, evidence for interactions were observed between all full-length AD-
LIM-HD proteins and DBD-Ldb1LID, and all DBD-LIMs constructs and AD-Ldb1LID. It was 
noted that despite extending the DBD-Lhx1LIMs construct, both Lhx1 and Lhx5 appeared to 
interact less strongly that the other LIM-HD proteins, as evidenced by weaker growth and/or 
slower colour development under some conditions, and variability between experiments, which 
are characteristics of weak interactions analysed by Y2H as noted above (section 3.3). The 
pattern of apparent interaction intensities (based on colour development) in spots with DBD-
LIMs fusion constructs did not exactly reflect the apparent interaction intensities in spots with 
respective AD-full-length fusion constructs (Figures 3.6–3.8). Lhx1 and Lhx5, whose DBD-
LIMs fusion constructs gave the weakest activation, resulted in strong activation when AD-full-
length fusion constructs were tested. A similar effect was observed for Lhx3a/4, Lmx1a/b and 
Lhx8. This resembles results from Y2H spot-test experiments with LIMs vs. LID/LBD 
interactions from our laboratory, where interactions with DBD-LIMs vs. AD-LID/LBD gave 
weaker reporter activation than with the AD-LIMs vs. DBD-LID/LBD combination [18, 19]. The 
opposite effect was observed for Lhx2, the DBD-LIMs fusion of which interacted very strongly 
but the AD-Lhx2 fusion of which did not produce such high levels of reporter activation. Also, 
AD-fusion constructs of Lhx6 isoforms produced noticeably lower activation of MEL1 compared 
to DBD-Lhx6LIMs.  
3.6.3 LIM-HD vs. LIM-HD interactions 
All previously identified interactions between AD-Isl1α/Isl2 full-length and DBD-
Lhx3/4LIMs fusion constructs and between the DBD-Isl1LBD and AD-Lhx3/4LIMs fusion 
constructs, were detected in these mating assays. However, AD-Isl2 gave rise to a more intense  
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Figure 3.7 Results of a spot-mating Y2H array. Standard protocol (A and B): The YPD plate with spot-mated 
yeast spots was first replica plated onto the SD-L-W plate. After 24 h at 30 °C, the spots were replica plated on to 
the SD-L-W-H plate with X-α-Gal and 1 mM 3-AT. The figure shows scans after 48 h (A) and 96 h (B). Short 
protocol (C and D): The YPD plate with spot-mated yeast was replica plated directly on to the weak selection SD-L-
W-H plate with X-α-Gal, The figure shows scans after 24 h (C) and 48 h (D). Red and blue font colours differentiate 
the two mating strains used. AD-LIM-HD and DBD-LIM-HDLIMs constructs are shown in black boxes; Yeast spots 
that correspond to interactions between these constructs are shown in green boxes. 
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activation in the interaction assays than AD-Isl1α, with the former showing increased levels of 
blue colour under weaker selection conditions plus growth under double selection conditions for 
both DBD-Lhx3LIMs and DBD-Lhx4LIMs, compared to less colour under weaker selection 
conditions and no growth under double selection conditions for AD-Isl1α. In contrast, the 
interactions involving the isolated Isl1LBD (AD-Isl1LBD) showed good levels of colour and robust 
growth under the same conditions (Figures 3.6–3.8). It is possible that the full-length Isl1α 
protein interacts more weakly with Lhx3/4LIMs compared to the isolated LBD domain due to 
intramolecular contacts between the LIMs and LDB in Isl1α that could compete for 
intermolecular binding events [162]. On the other hand, Isl2 has a slightly different LBD that 
might not form weak intramolecular interactions. As was the case with Ldb1LID interactions, AD- 
Lhx3a/4 vs. DBD-Isl1LBD were apparently stronger than interactions of DBD-Lhx3/4LIMs with 
AD-Isl1LBD. 
 
Figure 3.8. Results of a spot-mating Y2H array on a double selection plate (short protocol). The YPD plate 
with spot-mated yeast spots was replica plated directly on to the double selection SD-L-W-H-A plate. The plate was 
scanned after 48 h. Red and blue font colours differentiate the two mating strains used. AD-full-length and DBD-
LIMs constructs of LIM-HD proteins are shown in boxes; Yeast spots that correspond to interactions between these 
constructs are shown in the green box. 
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DBD-Lmx1aLIMs and DBD-Lmx1bLIMs showed some evidence of an interaction with AD-
Isl1LBD, with limited growth, but no blue colour being evident on the 1 mM 3-AT moderate 
selection plate. The DBD-Lmx1aLIMs/AD-Isl1α spot was also evident on the 10 mM 3-AT 
moderate selection plate in the streak-mating array. Neither set of diploid transformants grew 
under double selection conditions.  
AD-Lhx8 appeared to interact with all DBD-LIMs constructs with weak to moderate 
intensity (but not with other constructs), as evidenced by some growth but no colour 
development on both plates. In contrast, AD-Lhx8LIMs did not show evidence of interaction with 
other full-length LIM-HD proteins.  
Pit1 did not show evidence of an interaction with any construct in the arrays. This was 
later followed up by additional spot tests with Lhx3a and Lhx3LIMs (not shown) and although 
weak selection conditions allowed some growth in the interaction between Lhx3LIMs and POU-
domains of Pit1, this interaction could not be confirmed. 
3.7 A 96-well Y2H mating array 
Towards the end of this project, another version of the Y2H mating array was assessed 
that used a 96-well plate format with liquid and agar-based media [210]. This method avoids 
both smearing of the template and target plates, and loss of resolution from successive replica 
plating steps.  
In this 96-well mating protocol, singly-transformed strains were grown overnight at 
30 °C/ 220 rpm in the appropriate media, as in the previous mating assays. Then 96-well plates 
containing rich liquid media (YPD) were co-inoculated with 2-µL aliquots from appropriate 
pairs of overnight cultures, and left to mate for up to 16 h at 30 °C/ 220 rpm. Replica plating was 
performed by dipping a set of EasyLoad 200-µL tips into the plates containing the liquid rich 
media culture, and inoculating a new 96-well plate containing liquid SD-L-W media for selection 
of diploid yeast. After overnight incubation, the yeast was replica plated using the same method 
onto 96-well plates containing 0.5 mM 3-AT moderate selection media (agar). The plate was 
scanned every 24 h for 4 days to monitor yeast growth and blue colour development.  
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In this mating array, in addition to the LIMs and full-length LIM-HD constructs, the four 
mouse LMO proteins were also included as DBD-fusion constructs and tested against the AD-
full-length LIM-HD constructs. As each yeast transformant is grown in a separate well of the 96-
well plate, there are no opportunities for cross-contamination during transfer, fusion of 
neighboring spots, or diffusion of blue pigment over time. These properties can allow the 
successful scoring of different intensity interactions on the same plate over a longer time period 
(e.g., up to 5–7 instead of 1–2 days). The use of multiple sets of 96-well plates also presents an 
advantage over the spatial limitation of 20 × 20 arrays in a single Petri dish.  
Figure 3.9 shows the growth and colour of yeast in the wells after 4 days, estimated to 
best represent the relative differences in signal intensities from different wells. Overall these 
interaction data are very similar to the plate method, with the following exceptions:  
1) Previously detected false positives (such as the DBD-Lhx2LIMs with all LIM-HD 
proteins in Figure 3.9) were difficult to confirm here due to lack of growth in the controls, likely 
because of inefficient yeast transfer.  
2) The AD-only negative controls for DBD-Lhx4LIMs that grew on the plates did not 
appear here. It is possible that there were inefficiencies or inconsistencies associated with simple 
manual transfer method to the selection plates. These possible issues might be overcome in the 
future by using a robotics approach with measured drop sizes.  
3) DBD-Lmx1bLIMs showed evidence of an interaction with both full-length AD-
Isl1α/Is12 protein constructs while the DBD-Lmx1aLIMs did not, whereas the Lmx1a interactions 
were apparently stronger in the cross-mating and spot-mating methods. This may be a problem 
with drop size variability, or may simply be indicative of weak interactions for both Lmx1a and 
Lmx1b with Isl1α and Isl2.  
4) AD-Lhx6 showed a weak propensity to interact when tested against some LIMs 
constructs, as was seen previously in the plate assays only for AD-Lhx8. AD-Lhx8 showed 
evidence of an interaction with many LIMs constructs, with apparently stronger interactions with 
the LMO proteins that were additionally tested in this approach. Note that these preliminary data 
need to be retested using precise drop sizes before they could be considered significant. 
5) Manual replica plating likely resulted in the lack of growth in some controls, which 
made some interactions/false positives difficult to confirm on the basis of this assay alone. 
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Figure 3.9. Results of the 96-well plate-based Y2H mating array. The figure shows AD-fusion constructs in rows 
interacting with DBD-fusion constructs in columns of the plate. The 96-pipette tip set was dipped in the 96-well 
plate with overnight mated yeast cultures growing in SD-L-W media. The tips were gently brought in contact with 
the agar in the 96-well 0.5 mM 3-AT moderate selection plate. The agar plate was incubated at 30 ºC for 4 days and 
then scanned. The figure was pieced together from two plates made with the same media and incubated together and 
white lines show where those pieces were connected. Green circles indicate known interactions detected in previous 
studies that were confirmed in this assay. Red circles indicate false positives detected in this plate (significant 
growth in AD-only control). White, yellow and blue circles indicate very weak, colourless and coloured yeast spots 
respectively.   
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3.8 Discussion 
The experiments presented in this chapter show that among the mammalian LIM-HD 
proteins, high affinity interactions appear to be mediated only between the LBD domains from 
Isl1 and Isl2 with the LIM domains from Lhx3 and Lhx4. In addition to Lmx1a, Lmx1b protein 
was also found to exhibit some IslLBD-binding activity, but these interactions were apparently of 
much weaker affinity. These interactions are summarised and the likely biological relevance of 
interactions between LIM domain proteins is discussed in sections 8.2 and 8.3. The discussion in 
this section is restricted to technical details of Y2H assays. 
Overall Y2H mating arrays proved to be a useful technique for performing larger scale 
experiments and this method could be further improved by the use of robotics and 96–768-well 
plates to standardize experiments, prevent manual errors, reduce assay-to-assay variability, and 
allow medium-to-high throughput experiments [210, 221].  
Slight differences between results from the yeast mating arrays and Y2H spot-tests could 
result from differences in expression profiles or different properties between cells transferred 
from a colony compared with cells spotted from an overnight culture, or differences in diploid 
versus haploid states of Y2H transformants. For example, diploid yeast are said to be more 
vigorous than haploid strains and can better tolerate expression of toxic proteins [222]. A 
previous report suggested that yeast mating reduces background caused by autoactivation [203]. 
Only AH109 carries the auxotrophic HIS3 and ADE2 reporters, so diploid nuclei contain twice 
as much DNA per copy of these reporters, reducing the likelihood of their activation. In contrast 
the MEL1 reporter is present in both strains and should have resulted in stronger activation in 
diploid cells.  
3.8.1 Key limitations of Y2H assays for detecting LIM-HD interactions 
The restriction of possible interactions to the LIM domains of the LIM-HD proteins was 
necessary to minimize background growth in the assay.; This prevented detection of interactions 
that are not mediated by LIM domains. It should be noted that the Y2H system holds several 
limitations that could have prevented detection of LIM-HD vs. LIM-HD interactions including: 
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the sensitivity of the assay, stability of heterogenous proteins in yeast and non-native 
posttranslational modifications. 
It has been reported that Y2H is not sensitive enough to detect interactions weaker than 
Kd ≈ 10
-6
 M [222, 223]. However, the ability of a reconstituted Y2H construct to activate HIS3, 
MEL1 or the ADE2 reporter might not be directly related to Kd values of tested protein pairs 
[223], and there are some reports of interactions with Kd values close to 10
-4
 M being detected by 
the Gal4 Y2H system [224, 225]. The ADH1-derived promoter used in the vectors used to date 
drives very low constitutive expression, so it might be possible to enhance the detection of weak 
interactions by increasing the copy number of the plasmids used and/or use promoters that give 
higher levels of expression of fusion proteins. Such an approach would probably simultaneously 
increase autoactivation, which was already common in this system, but if higher levels of 3-AT 
were used to compensate for autoactivation, the remaining HIS3 activity could conceivably still 
be higher and more easily detected. 
The ability to detect an interaction will likely also depend on the stability in yeast of the 
proteins being tested and steric hindrance resulting from fusion constructs to the Gal4 domains. 
For example, intrinsically disordered regions of proteins can give rise to false negatives, possibly 
caused by proteolytic degradation of these constructs. Stabilization of these constructs by 
additional structured elements can sometimes lead to higher stability and allow detection [163, 
164, 226]. This type of approach might be useful for testing interactions involving the C-terminal 
domains of LIM-HD proteins. 
 Steric hindrance could prevent the formation of functional Y2H complexes. In some of 
these cases, interactions might be detected by finding the optimal combination(s) of fusion 
constructs. There are alternative Y2H plasmids that allow DBD-/AD-fragments to be fused to C-
termini of tested proteins so that 6 additional combinations can be tested [227, 228]. An example 
of this type of optimization is described in the context of a modified assay in Chapter 5. 
Budding yeasts, including the strains used for Y2H, lack complete families of important 
tyrosine kinase genes present in vertebrates and therefore have a limited ability to phosphorylate 
tyrosines [229, 230]. SH2 domains that recognize phospho-tyrosines (present in some Ub-protein 
ligases) are also absent, possibly preventing further modifications [231, 232]. If tyrosine 
phosphorylation is required for an interaction, that interaction will not be detected by Y2H. In 
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other cases, the lack of appropriate posttranslational modifications could affect protein lifetimes 
and effective concentrations in yeast cells. At present, there is no data to suggest that 
posttranslational modifications affect interactions of LIM-HD proteins in vivo. 
In an ideal Y2H system, an increase in binding affinity of tested proteins would result in 
a corresponding increase in reporter activation (Figure 3.10). Unfortunately, this is often not the 
case [222, 223], possibly in part due to autoactivation and the attempts to reduce it. However, 
some classes of interactions could be quantified through the activation of colourimetric 
LacZ/MEL1 reporters or fluorescent yEGFP reporters in well-plates combined with 
colourimetric scanning or flow cytometry [233-235]. This type of approach might provide a 
better way of quantifying LIM-HD interactions. 
3.8.2 Autoactivation and false positive interactions in LIM-HD proteins 
The autoactivation seen in Y2H assays with full-length LIM-HD proteins could arise 
from two main sources. The first source is the DNA-binding activity of the HDs. These domains 
target AT-rich sequences, more than 10 of which exist in the GAL1 promoter, suggesting that the 
HDs could directly target these sites to trigger autoactivation. The second source is the 
transactivation-like domains in the C-terminal regions (tails) of the LIM-HD proteins. Protein 
sequences likely to cause transactivation as DBD-fusion constructs in yeast are often acidic, 
acidic amphipathic helices, and/or are rich in proline or glutamine residues [236]. Tails of LIM-
HD proteins are rich in prolines and four proteins contain glutamine clusters (Isl1α, Isl2, Lmx1a 
and Lmx1b) which could explain some of the observed effects. In most cases it has not been 
established if these regions have transcriptional transactivation activity in nature.  
It should also be noted that proteins that have evolved as part of obligate complexes like 
LIM-HD proteins are often naturally 'sticky' and can cause false positives by non-specific 
interactions with many different targets, likely through exposed hydrophobic surfaces [237]. 
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3.8.3 Possible explanations for differences in reporter activation between 
two combinations of fusion constructs (vectors) 
As reported in this chapter, interactions between LIMs and LID/LBDs often appear 
stronger in one combination of yeast vectors. The same phenomenon has been reported for other 
systems (e.g., Myc and Max bHLH-LZs; [223]). A possible explanation extends a mechanism 
that was proposed to explain the difficulties in detection of parallel coiled coil homodimers by 
Y2H [238, 239]. Gal4DBD forms homodimers [240, 241], and homodimerization of that domain 
was thought to promote the specific homodimerization of the coiled-coil domains and thereby 
prevent interactions with AD-fusion partners, thereby lowering reporter activation (Figure 3.10) 
[238, 239]. In a similar manner, Gal4DBD homodimerisation could promote non-specific binding 
of LIMs and thereby prevent interaction with the AD-LIDs. As the 2µ plasmids that carry the 
TRP1 selection marker were reported to give higher expression of Y2H fusion constructs than 
those that carry the LEU2 marker [242], the concentration of DBD-LIMs could be higher than 
that of AD-LID, and that could increase the negative effects of Gal4DBD homodimerisation. 
The structured DBD domain could also provide some protection of intrinsically 
disordered LIM domain partners from proteolysis, and increase the lifetimes of reconstituted 
Y2H complexes on DNA. In contrast monomeric AD-fusion constructs of LIM-partners which 
are likely to be unstructured are likely to be more accessible to proteolysis [164]. Thus, DBD-
LID/LBDs vs. AD-LIMs interactions would appear stronger than in DBD-LIMs vs. AD-
LID/LBDs interactions.  
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Figure 3.10. Homodimerization of hypothetical constructs in the Gal4 Y2H system. The example shows Y2H 
tests with hypothetical green and black proteins that can form homodimers (specific or unspecific) as well as 
heterodimers (green-black, green or black coiled coils). DBD-fusion constructs (E) can dimerize via DBD (F), 
dimerize via tested protein (A), or bind AD-fusion constructs to reconstitute the full Gal4 protein (H). These 
reconstituted Gal4 monomers can dimerize via DBD (I) and all complexes with dimerized DBD domains (I, F and 
B) can bind UAS elements but activation of RNAPII requires bound AD-fusion constructs (J). Reconstituted Gal4 
complexes (free or bound to a UAS element) are shown in green fields (H, I and J), while fusion protein 
homodimers are shown in red (A, B and D). Chelate effect (cooperative binding) between DBD-fusion constructs 
would tip the equilibria towards a species that cannot cause activation (B). Figure is adapted from Hu et al., 2000 
and extended to include all species and complexes. 
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Chapter 4    The contribution of individual LIM domains in 
binding to Ldb1 
4.1 Introduction 
It is generally considered that both of the tandem LIM domains of LIM-HD and LMO 
proteins are required for high affinity binding to Ldb1 (Figure 4.1), but in some cases either one 
LIM domain or the other has been shown to be more important for the interaction [131, 136]. It 
was decided to use the spot-mating Y2H array (as described in sections 2.5.4.2 and 3.4) to 
investigate modular binding of Ldb1LID for the whole panel of individual LIM domains from 
LIM-HD proteins to determine if there are patterns to the LIM-specific binding across this family 
of proteins.  
 
Figure 4.1. A scheme showing tandem (A) and separate LIM domains (B and C) binding the Ldb1LID. LIM 
domains are represented as ovals and Ldb1LID (LID) as a ribbon. Binding segments of the LID peptide are 
represented by thicker segments of the ribbon. N- and C-terminal ends of each partner are labelled. 
 
4.2 Assay design 
Individual LIM domain (LIM1 or LIM2) constructs were designed to contain six flanking 
residues at either end of the first and last zinc-coordinating residues, meaning that the constructs 
overlap by 3 or 4 residues between LIM1 and LIM2 depending on the length of the intervening 
sequence (Figure 4.2). Previous experiments with separate LIM domains of LMO2, LMO4 and 
Lhx3 indicated that these intervening sequences help maintain structural integrity of separate 
domains but do not directly contribute to binding of Ldb1 [18, 156]. These constructs were 
generated by PCR and cloned as both DBD- and AD-fusion constructs. Interactions between 
tandem and the individual LIM domain constructs were tested for binding to Ldb1LID in both 
combinations (i.e., as DBD-fusion constructs as shown in Figure 4.3, and AD-fusion constructs 
as shown in Figure 4.4). In addition, AD-Isl1LBD and AD-Isl2 were tested for interaction with the 
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LIM domain constructs from Lhx3 and Lhx4 as shown in Figure 4.4. Three levels of selection 
conditions were used to assess the interactions: weak, moderate (with 1 mM 3-AT) and double 
selection (as in Table 3.1). However, only moderate and double selection conditions were used in 
the DBD-LIM/AD-(LID/LBD) arrays. Weak selection conditions were not used for this 
combination because autoactivation tests (section 3.2) showed that DBD-LIMs fusion constructs 
gave rise to background growth under weak selection conditions.  
 
Figure 4.2. Design of individual LIM domain constructs. (A) The LIM1 and LIM2 domains are shown in red and 
blue, respectively. These constructs were designed to contain six residues before the first and after the last Zn-
ligating residues, with the exceptions that the N-terminal 'extension' is (*) 4 residues in Lhx5, 3 residues in Lhx1 and 
2 residues in Lmx1a LIM1 and LIMs constructs, and there were no residues (**) beyond the last Zn-ligating residue 
in Lhx1 LIM2 and LIMs constructs. The overlap between separate LIM constructs was 3–4 residues, depending on 
the spacing between the LIM domains in each protein. (B) The LIM domains from the structure of Lhx3LIMs-Isl1LBD 
(2RGT) coloured as in panel A.  
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4.3 Comparison of relative strengths of LIM1 and LIM2 interactions with 
LID/LBD domains 
DBD-LIM vs. AD-LID combination. The spot-mated yeast on selection plates were 
initially scanned after three days of incubation. At this time the moderate selection plate showed 
evidence of interactions of Ldb1LID with all tandem LIM constructs, but not with any individual 
LIM domain (Figure 4.3A). The yeast growth seen for the Lhx2LIM1 construct in the interaction 
spot control matched that of the empty vector and was disregarded. Some background growth 
was also detected for the Isl2LIMs construct but reporter activation in the interaction spot was 
much stronger. A longer incubation time resulted in the loss of resolution on this plate and no 
additional interactions could be detected (not shown). On the double selection plate, only a 
subset of spots were visible after 3 days, corresponding to interactions of Lhx2LIMS, Lhx6LIMs, 
Lhx8LIMs, Lhx9LIMs, Lmx1bLIMs, Isl1LIMs and Isl2LIMs with Ldb1LID (Figure 4.3B). These double 
selection plates were scanned again after 6 days of incubation, when spots corresponding to 
interactions of Lhx3LIMs, Lhx4LIMs, Lmx1aLIMs with Ldb1LID, appeared. After 14 days of 
incubation, the spots for Lhx1LIMs and Lhx5LIMs also appeared, as well as that for Isl2LIMs 
background in the negative control. The strongest growing and the earliest appearing spots were 
considered the strongest interactors.  
Interactions of Lhx3LIMs and Lhx4LIMs with both Isl1LBD and Isl2 were detected on the 
moderate selection plate after 3 days of incubation (Figure 4.4). On the double selection plate, 
both Lhx3LIMs and Lhx4LIMs interacted with Isl2 while only Lhx3LIMs interacted with Isl1LBD and 
resulted in yeast growth after 6 days. A few colonies appeared for the Isl1LBD interaction with 
Lhx3LIMs, but only after 14 days of incubation. The individual LIM domain interactions were not 
detected on any plate. 
AD-LIM vs. DBD-LID combination. Under double selection conditions, yeast growth for 
all AD-LIMs fusion constructs vs. DBD-Ldb1LID appeared by day 2 of incubation and developed 
into strong spots by day 5 (Figure 4.5, bottom panel). Of the tests with separate LIM domains, 
only the LIM1 domains of Isl1 and Isl2 showed a robust interaction with Ldb1LID on the double 
selection plate, while the interaction with Lhx2LIM2 was lower and with Lhx9LIM2 produced only 
a few colonies. The AD-Lhx3LIMs/Lhx4LIMs vs. DBD-Isl1LBD interactions showed several  
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Figure 4.3. Y2H spot-mating array for DBD-LIM vs. AD-LID. All LIM-domains were expressed as DBD-fusion 
constructs and tested for interaction against AD-Ldb1LID. The figure compares the Y2H mating arrays on moderate 
(A) and double (B) selection media and displays the chronological appearance of signals on the double selection 
plate. (C) DBD-fusion constructs of the Lhx3 and Lhx4 domains were also tested for interaction against AD-Isl1LBD 
and AD-Isl2 on both selection plates.  
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colonies by day 2, which developed into spots by day 5. Under moderate selection conditions 
(Figure 4.5, top panel), all interactions that later appeared on double selection plates were visible 
after overnight incubation. Later, interactions between Ldb1LID and Lhx2/9LIM2 also appeared, 
followed by interactions of Ldb1LID with Lmx1a/bLIM2 and Lhx6/8LIM2. Some growth was also 
detected for Lhx2LIM1 and only a few colonies for interactions between Lhx4LIMs and Ldb1LID or 
Isl1LBD.  
 
Figure 4.4. Y2H spot-mating array for DBD-LIM vs. AD-LID. DBD-fusion constructs of the Lhx3 and Lhx4 
domains were additionally tested for interaction against AD-Isl1LBD and AD-Isl2 on moderate and double selection 
plates.  
 
Under weak selection conditions (Figure 4.6), after 2 days of incubation, the same pattern of 
growth was observed as on the moderate selection plate after 5 days, but with an additional yeast 
spot detected for the Lhx3LIM2 interaction with Ldb1. Under this selection condition reporter 
activation for the Lhx3LIMs interactions were similar to that of Lhx4LIMs. Again, none of the 
separate LIM domains from Lhx1 and Lhx5 showed strong evidence of an interaction under any 
conditions at day 2. Longer incubation (5 days) resulted in some background growth in all spots 
expressing the DBD-Ldb1LID fusion construct and in the appropriate negative control as well. 
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Minor evidence of an interaction was detected for Ldb1LID with Lhx1LIM2 due to some colour 
development. An interaction between Lhx3LIM2 and Isl1LBD was indicated by weak growth 
compared to no growth in the DBD-Isl1LBD negative control. 
 
 
Figure 4.5. Y2H spot-mating array for AD-LIM vs. DBD-LID. All LIM-domains were expressed as AD-fusion 
constructs and tested for interaction against DBD-Ldb1LID. The LIM domains from Lhx3 and Lhx4 were also tested 
for interaction against DBD-Isl1LBD. DBD-only and AD-only controls were included ('-'). The top panel shows the 
moderate selection plate and the bottom panel shows the double selection plate after 5 days of incubation at 30 °C. 
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Arrays with AD-LIM vs. DBD-(LID/LBD) combination of fusion constructs showed 
greater sensitivity than the opposite (DBD-LIM vs. AD-(LID/LBD)) combination of fusion 
constructs. This observation is in line with previous experiments in our laboratory [18, 19], and 
some results from the previous chapter (section 3.7.2). This increased sensitivity revealed a 
binding preference of Ldb1 and Isl1/2 for individual LIM domains. The negative controls were 
free of significant background growth, except on weak selection plates after 5 days of incubation. 
 
 
Figure 4.6. Signal development under weak selection conditions for AD-LIM vs. DBD-LID in Y2H spot-
mating arrays. The figure shows the spot-mating array of tandem and separate LIM domain AD-fusion constructs 
vs. the DBD-Ldb1LID fusion construct. The LIM domains from Lhx3 and Lhx4 were also tested for interaction 
against DBD-Isl1LBD and included in the figure. Results from day 3 and day 5 of incubation at 30 °C are shown. 
DBD-only and AD-only controls were included ('-'). 
Y2H spot-tests using the mated yeast diploids were carried out (without serial dilutions) 
to ensure equal loading of yeast cells and better gauge the relative apparent binding affinities. 
The selection data are largely identical, but in this spot-test form are easier to visualise (Figure 
4.7). Apparent interaction intensities were classified according to growth rates and colour 
development in spots on different selection plates. All tandem LIM vs. Ldb1LID interactions and  
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Figure 4.7. Y2H spot-tests of tandem and separate AD-LIM fusion constructs vs. the DBD-Ldb1LID in diploid 
cells. Yeast growth on double selection plates on day 5 of incubation (top panel) and yeast spots on low and 
moderate selection plates, on the third day of incubation (middle and bottom panel). '-' indicates DBD domains 
expressed from empty vectors. The yeast cultures were normalized to OD600 ≈ 0.2 before 2 µL aliquots of yeast cell 
suspensions were spotted onto the plates (a single spot per interaction). All plates were incubated for 3 days at 30 
°C. 
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Isl1/2LIM1 vs. Ldb1LID interactions were strong as shown by robust growth under double selection 
conditions for all proteins except Lhx1, which showed more modest yeast growth. Moderate 
interactions were seen between Ldb1LID and LIM2 domains of Lhx2, Lhx6, Lhx8, Lhx9, Lmx1a 
and Lmx1b (1 mM 3-AT moderate selection conditions) and weaker interactions were seen for 
Lhx3/4LIM2 vs. Ldb1LID. Weak interactions were detected in tests between Ldb1LID and LIM1 
domains of Lhx2, Lhx6 and Lmx1b (under weak selection conditions). 
4.4 The red-white selection based on the ADE2 reporter activation 
Activation of the ADE2 reporter was additionally assessed by the colour of spots growing 
on rich YPD media that was not supplemented with adenine (Figure 4.8). Under these conditions  
 
Figure 4.8. A YPD plate spotted with indicated yeast transformants. The plate was spotted with transformants 
and incubated for 3 days at 30 °C. The white spots are diploid yeast (derived from the mating of AH109 and Y187 
cells) expressing the interacting constructs that activate the ADE2 reporter. DBD-Lmx1aLIMs vs. DBD-only control 
did not grow on this plate (white cross). 
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there is no selection pressure so all the transformants grew, but only yeast that activated ADE2 
turned white (section 3.5.1). The assay reports the same interactions as seen under double 
selection conditions in Figure 4.7, with the additional observation of a slight pigment reduction 
for Lhx2LIM2 vs. Ldb1LID. The colour differences appeared early, after overnight incubation. The 
colour was followed for two additional days as the differences became more pronounced, but 
because the pigment accumulated quickly in the absence of stronger interactions, no additional 
interactions could be detected with prolonged incubation. As this method didn't provide 
additional information, it wasn't further used. 
4.5 Summary of results 
The results of Y2H arrays presented in this chapter show that most LIM-HD proteins 
appear to have a tighter (or dominant) binding and a weaker binding LIM-domain in interactions 
with Ldb1LID (Table 4.1). In most LIM-HD proteins the dominant binder is LIM2, except for 
Isl1/2 where LIM1 is the dominant binder, and Lhx1/5 where no significant binding was 
observed for either individual domain, indicating that if there is a dominant binder the affinity of 
binding lies below the detection limit of the assay. The LIM domains from paralogous pairs of 
LIM-HD proteins show similar modes and affinities of binding to Ldb1LID in Y2H assays. Based 
on the assays described in this chapter the tandem LIMs of Isl1/2 and Lhx2/9 have the strongest 
binding overall, followed by Lhx6/8, Lmx1a/b and Lhx3/4, with Lhx1/5LIMs constructs being the 
weakest binders. Isl1/2LIM1 appeared to be the strongest interacting single domains, which were 
consistently detected under double selection conditions. Somewhat weaker interactions of 
Lhx2/9LIM2 were detected under double selection conditions only in one combination of fusion 
constructs. Lhx6/8LIM2 and Lmx1bLIM2 apparently bound more strongly to Ldb1LID than 
Lmx1bLIM2 and Lhx4LIM2, followed by Lhx3LIM2.  
Some apparent binding of LIM1 domains was detected for proteins where LIM2 was the 
dominant domain (Lhx2LIM1, Lhx6LIM1 and Lmx1bLIM1) as evidenced by growth and colour 
development under 1 mM 3-AT moderate selection (Lhx2LIM1 only) and weak selection 
conditions. Isl1LBD interactions with Lhx3/4LIMs resulted in reporter activation at levels lower 
than that for Ldb1LID with Lhx3/4LIMs and only slightly lower than that for Ldb1LID interaction 
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with LIM1 domains of Isl1/2. Finally, the range of interactions detectable by red-white selection 
was shown to be similar to interactions detected on double selection media. 
The potential biological relevance of the LIM domain contributions are discussed in 
section 8.4. 
 
Table 4.1. Summary of Y2H array results testing the abilities of separate LIM-domains to bind Ldb1LID. For 
this comparison, reporter activation was quantified by a scale from 1 (lowest under weak selection conditions) to 12 
bars (strongest under moderate and double selection conditions) based on growth and colour development in all 3 
selection conditions, using both combinations of Y2H fusion constructs. Dashed bars indicate potential interactions 
that caused yeast growth at or slightly above background level on weak selection plates. Interactions consistently 
detected under double selection conditions in at least one combination are shown in yellow fields and interactions 
detected only under weak selection conditions are in light grey fields. Red bars indicate interactions which were 
detected in both combinations of fusion constructs, and black bars indicate interactions which were detected only in 
the AD-LIMs vs. DBD-LID combination. The column on the right shows which LIM domain is dominant (if any) in 
interactions with Ldb1LID. 
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Chapter 5    Development of a bimolecular fluorescence 
complementation (BIFC) assay for detecting interactions of 
LIM-domain proteins 
5.1 Protein-fragment complementation assays (PCAs) 
It has been known for decades that some proteins can fold into native or native-like 
tertiary structures when the protein has been split into two separate polypeptides fragments [243-
245]. This idea is referred to as protein complementation. Johnsson and Varshavsky developed 
an in vivo assay based on this approach for detecting protein-protein interactions through 
complementation of split-ubiquitin fragments [246]. Since then, a number of similar methods 
have been developed (reviewed in [198, 247-250]). They are commonly known as protein-
fragment complementation assays (PCAs) or split-protein assays (Figure 5.1A). PCAs rely on 
direct interactions between the split-protein fragments. Note that the interactions involve protein 
binding and folding rather than docking of pre-folded fragments [248].  
The types of signal generated in PCAs can include transcriptional activation, survival 
selection, enzyme activity, bioluminescence or fluorescence. Common PCA methods employ 
split ubiquitin, DHFR, intein, luciferase and GFP (Figure 5.1B). The latter is referred to as 
Bimolecular Fluorescence Complementation (BiFC). 
5.2 BiFC 
BiFC is based on the Aquarea victoria green fluorescent protein (GFP) and its numerous 
variants. These fluorescent proteins (FPs) have a β-barrel structure comprised of 11 anti-parallel 
β-sheets, surrounding a deformed helical sequence that stretches through the interior to form an 
autocatalytic fluorophore that is created only when the protein is folded (Figure 5.2A and B). 
Fluorophore maturation involves residues S(T/G)65, Y66 and G67 undergoing a series of 
cyclization, dehydration and oxidation reactions to create a functional fluorophore [251, 252]. 
After maturation, the FP fold is practically irreversible under physiological conditions [253]. In 
BiFC two test proteins are expressed as fusion constructs of complementary fragments from an 
FP. Binding of the test proteins induces folding of the two complementary fragments and 
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creation of the fluorophore (Figure 5.2C). Split GFPs are usually split in the loops between the 
sheets 7 and 8 (this study), 8 and 9, or, 10 and 11 (Figure 5.2B). In some cases, the 
complementary fragments have an overlap as in the case for NYFP1-172 and CYFP155-238 [254]. 
Studies investigating GFP folding indicated that N-terminal fragments could be partially folded 
when expressed independently, but the C-terminal fragment likely does not form secondary 
structure prior to complementation [255, 256]. BiFC assays have now been carried out in a wide 
variety of cells from bacteria, mammalian cells, Fungi, Nematoda, fruitfly and plants (reviewed 
in [247, 257]).  
 
Figure 5.1. Protein complementation assay (PCA). (A) The principle of PCA. Two proteins (A and B) fused to 
non-functional fragments of a reporter protein interact with each other to facilitate the association and folding of 
non-functional fragments into a functional reporter protein. (B) Split-proteins commonly used in PCA experiments 
(taken from Kerppola, 2006). Two colours in backbone cartoon representations show two complementary fragments 
in their folded/bound state. Magenta indicates overlap between fragments. The fluorophore from GFP variants is 
shown in yellow. 
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Figure 5.2. Split-GFP and the mechanism of Bimolecular Fluorescence Complementation (BiFC). (A) Cartoon 
representation of GFP (pdb code: 1B9C). The fluorophore atoms are indicated by yellow spheres inside the β-barrel. 
(B) Topology map of GFP showing secondary structure where arrows with numbers show β-sheets, helices show α-
helical regions and line segments show loops. In this study the split site immediately followed residue 158. (C) BiFC 
mechanism as described in the above text based on cartoon representations of FP fragments and the complete FP 
protein. The yellow star shows the position of the fluorophore. In (A) and (B) the split-GFP structure is shown with 
its N-terminal (NGFP, dark green) and C-terminal (CGFP, grey) fragments. β-sheets are numbered according to 
their position in the primary sequence. Black triangles mark the commonly used split sites.  
 
Our laboratory wanted to explore using a yeast-based BiFC assay to try and overcome 
two problems associated with the standard Y2H assay for LIM-HD proteins. The first problem is 
that the Y2H assay is a transcription based assay that can show high levels of background 
activation for transcription factors, which was particularly problematic for many LIM-HD 
proteins (see section 3.2), and prevented comprehensive screening of interactions that could be 
mediated by the C-terminal domains of the LIM-HDs. Whereas Y2H assays take place in the 
yeast nucleus, BiFC assays can be cytoplasmic and potentially avoid the problem of background 
transcriptional activation. The second problem is that it can be difficult to detect weak 
interactions. Because the final BiFC product is a stable molecule, it may be better suited to the 
detection of weaker interactions. Of the possible eukaryotic systems that could be used, S. 
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cerevisiae was selected for use because it is relatively simple and has proven to be a good 
platform for testing LIM-HD interactions in the past (apart from the previously mentioned 
problems, see section 3.8.1). 
5.3 Plasmid editing and protein fusion constructs  
A split-GFP sequence that coded for an optimized form of GFP (GFPuv, alphaGFP) was 
obtained. This version belongs to the same spectral group as the wild type protein, but contains 
the mutations F99S, M153T and V163A [258]. It has similar folding kinetics to wild type GFP 
but is less prone to aggregation resulting in higher yields and improved relative fluorescence at 
37 °C [252, 259, 260]. The protein was split between residues 158 and 159, in the loop between 
β-sheets 7 and 8, into non-overlapping NGFP (1–158) and CGFP (159–238) fragments. The 
assay design involved the use of modified Y2H vectors in which the Gal4 domains were replaced 
with NGFP and CGFP. Two NpGBT9-based BiFC vectors were generated: pW397-NGFPN, 
which contained NGFP and a linker (NGFPN) upstream of the cloning site to generate N-
terminally tagged constructs; and, pW397-NGFPC, which contained a linker followed by NGFP 
(NGFPC) downstream of the cloning site to generate C-terminally tagged constructs. Similarly 
two pGAD10-derived BiFC vectors were generated: pL397-CGFPN and pL397-CGFPC, to 
generate N- and C-terminally tagged constructs, respectively (Figure 5.3). The 10-residue linker 
(GGGGS)2 is designed to allow flexibility, enhance solubility, and was used successfully in 
earlier BiFC studies [261].    
As part of this process two additional empty vectors that lacked any GFP-tags (pW397 
and pL397) were created. An NGFP-CGFP fusion construct in which the GFP fragments were 
connected by a 24-residue long linker (contains 4 repeats of the GGGGS sequence, see Appendix 
B) was cloned into each of these plasmids for use in control experiments. As the complementary 
GFP fragments are joined by the linker, this construct was expected to display maximal 
fluorescence intensity. Note that it was not expected that the same levels of fluorescence 
intensity would be reached by actual BiFC interactions as such signals are typically < 10% of the 
full-length GFP [247]. 
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Figure 5.3. BiFC plasmids and fusion constructs. Plasmids are shown on the left and the corresponding constructs 
are shown on the right. Each yeast BiFC plasmid has the 2µ origin, a truncated ADH1 promoter (397 bp), and was 
modified to contain a GFP fragment cDNA plus a linker before, or after, the BamHI-EcoRI cloning site. pW397 and 
pL397 plasmids contain the trp1 and leu2 auxotropic section markers, respectively. The N or C in the subscript of 
the plasmid name indicates that the GFP fragment is expressed N-terminal or C-terminal of the tested protein. In this 
figure only a subset of the test proteins constructs are depicted as each of A and B are cloned into each vector.  
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5.4 Autofluorescence  
The Y2H AH109 yeast cells, which contain the optimal auxotrophic markers required for 
the designed BiFC plasmid system, showed high levels of autofluorescence in the initial tests 
compared to some other strains such as EGY48 (Figure 5.4). This autofluorescence was localized 
mainly in the vacuole and comes from the red AIR pigment that accumulates due to a mutation 
in ade2 under adenine-depleted conditions (section 3.5.1). By supplementing the media with 
adenine-hemisulfate (60 µg/mL) and by growing the transformants in two consecutive overnight 
cultures, it was possible to significantly reduce autofluorescence, although some older and dying 
cells still displayed autofluorescence [262]. Several other studies have reported the successful 
use of ade2 mutant yeast strains in BiFC experiments, supporting this as a reasonable approach 
[263-265]. 
 
Figure 5.4. Autofluorescence in yeast. (A) Cartoon of a yeast cell. The vacuole, nucleus, mitochondria, cytoplasm 
and cell wall are labelled. (B) Micrograph of the untransformed AH109 strain (ade2 mutant) showing strong 
vacuolar autofluorescence. (C) Untransformed EGY48 (ade2 wt) strain showing no autofluorescence. Both strains 
were grown on YPD plates without added adenine. The images are composites of FITC (green) and bright field 
(blue) micrographs. 
 
5.5 Optimization of the LMO4LIMs:Ldb1LID interaction in the BiFC system 
The well characterised interaction of LMO4LIMs vs. Ldb1LID [152, 156, 167] was selected 
as a model system for BiFC assay development. Because BiFC requires that complementing 
fragments are brought together in an orientation that favours folding of the GFP, the first step in 
optimizing BiFC for previously untested groups of proteins is to find the combination of fusion 
constructs that gives the highest increase of BiFC signal over controls (i.e., an optimal signal to  
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Figure 5.5. Models of possible assemblies formed from protein fusion constructs shown in Figure 5.3. The 
combinations or assembly modes are numbered. GFP fragments are shown as parts of the folded GFP in dark green 
(NGFP) and grey (CGFP). The flexible linkers are shown as black lines, LMO4LIMs as tandem red ovals, and Ldb1LID 
as a blue rod.  
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noise ratio, S/N) [254]. Eight combinations of fusion constructs that could allow for eight 
different assembly modes were tested (Figure 5.5).  
Every interaction pair was compared to its two relevant negative controls (a NGFP- or 
CGFP-tagged test protein against CGFPN/C or NCFPN/C, respectively). All NGFP- and CGFP-
only pairs were tested for self assembly in the absence of interacting test proteins. An 
autofluorescence control was also included in which cells were co-transformed with pW397 and 
pL397 (i.e., did not contain any GFP fragments). The results of these assays are presented in 
Figures 5.6 and 5.7. 
 
Figure 5.6. Optimizing the orientation of GFP-fragment tags for the LMO4LIMs vs. Ldb1LID BiFC assay. 
Combinations 1–4. Yeast cells were visualized with a 100× objective and FITC filter at 200 ms exposure, unless 
otherwise indicated. Representative images are composites of FITC (green) and bright field (blue) micrographs. The 
NGFP-CGFP fluorescence control is shown at 100 ms exposure. No GFP refers to pW397/ pL397 (i.e., no GFP 
fragments). The 16 images below show combinations 1–4 (on the left, numbered) and the rest are appropriate 
controls. Combination 1 and its controls are shown in the red rectangle.  
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Importantly the self assembly and autofluoresence controls showed no significant 
fluorescence. Except for combination 4, BiFC fluorescence was detected in all sets of 
LMO4LIMs/Ldb1LID interaction pairs with the average fluorescence intensity of BiFC-positive 
cells being at least an order of magnitude weaker than that of the NGFP-CGFP positive control 
(Figure 5.6, top left). The combinations in which LMO4LIMs was fused to NGFPC or CGFPC gave 
relatively weaker BiFC signals compared to LMO4LIMs fused to NGFPN or CGFPN. This is 
particularly evident for combinations involving the LMO4LIMs-NGFPC fusion construct 
(combinations 3 and 4). The strongest signals were detected for combination 1 involving 
NGFPN-LMO4LIMs and CGFPN-Ldb1LID (magenta rectangle in Figure 5.6) and combinations 2, 5 
and 7. Combination 1 was chosen as a benchmark for other LIM-domain interactions and was 
further characterized. 
 
Figure 5.7. Optimizing the orientation of GFP-fragment tags for the LMO4LIMs vs. Ldb1LID BiFC assay. 
Combinations 5–8. Presentation is the same as Fig. 5.6, but for combinations 5–8. The images are composites of 
FITC (green) and bright field (blue) micrographs. 
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All tested combinations and the NGFP-CGFP control showed BiFC signals with the same 
cytoplasmic-nuclear localization. This was confirmed with Hoescht staining of the cells on the 
slide and visualization under a DAPI filter to detect nuclear DNA (Figure 5.8B). Interestingly, 
the cells that exhibited stronger BiFC were less likely to take in the Hoescht stain. 
 
Figure 5.8. Localization of BiFC signal in the LMO4LIMs vs. Ldb1LID interaction. AH109 yeast cells co-
transformed by NGFPN-LMO4LIMs vs.CGFPN-Ldb1LID.(A) Composite image made of bright field (blue) and FITC 
(green) micrographs (B) Composite image made of DAPI (red) and FITC (blue) micrographs of the Hoechst-stained 
yeast slide.  
 
5.6 Selectivity and sensitivity of the assay  
In order to test the selectivity of BiFC assays for detecting strong LIM-LID interactions 
an Ldb1LID mutant that had previously shown to completely disrupted the growth of yeast in the 
Y2H assay [167] was tested for interaction against LMO4. The m30 variant of Ldb1LID is a 
double mutant (V339A/I358A) in which the mutations affect binding to LMO4LIM2 and 
LMO4LIM1, respectively. The orientation of GFP fragments was NGFPN vs. CGFPN as selected 
above. Cells expressing m30 had very little fluorescent complementation signal compared to the 
cells expressing wild type Ldb1LID (Figure 5.9A and B). Since the fixation procedure in trial 
experiments produced lower BiFC fluorescence, higher autofluorescence and often disrupted 
vacuolae and nuclei (not shown), the cells were not fixed before microscopy. Therefore, the cells 
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were used fresh to minimize degradation and were not additionally incubated to allow recently 
formed BiFC complexes to mature. As this procedure was sufficient for the full-length GFP 
protein to show fluorescence in appropriate positive controls, it was estimated that the relatively 
slower growth of yeast in SD media at 30°C (~140 min doubling time), allowed enough time for 
maturation. However, when the m30-expressing cells were incubated for 5 h at 4 °C, the 
fluorescence increased to reach a similar level to that of the wild type Ldb1LID (Figure 5.9C), 
which itself did not significantly change (not shown). The data indicates that this BiFC system 
can discriminate between LIM:LID interactions with wild type sequences and interactions 
involving specific mutants designed to affect binding, but that temperature and time of 
incubation are important factors in distinguishing interactions of differing affinity. These 
properties are consistent with the temperature-dependence of the GFP fluorophore maturation 
and the apparent irreversibility of complementation [252, 254]. Previous studies have similarly 
used lower temperatures and longer maturation times prior to detection to increase fluorescence 
signal [264, 266]. 
The binding of m30 for LMO4 (binding affinity is not known) can be detected by low 
moderate selection conditions by Y2H but not double selection conditions [156]. Previous 
reports of high sensitivity in BiFC assays (down to 1 mM) were attributed to the accumulation of 
reconstituted BiFC complexes [253, 267].  
 
Figure 5.9. Selectivity of the BiFC assay for a LIM:LID interaction and the effect of cold incubation. 
LMO4LIMs was tested against (A) wild-type Ldb1LID (no incubation) and (B) the m30 mutant of Ldb1LID containing 
V339A/I358A double mutation (no incubation). (C) The NGFPN-LMO4LIMs/CGFPN-m30 combination was 
incubated at 4 °C for 5 h and re-visualized. The images are composites of FITC (green) and bright field (blue) 
micrographs. 
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To further explore the sensitivity of this system in the context of LIM family and related 
proteins, a study was carried out in which the ability of several ZnF domains (including LIM 
domains) to interact with their binding partners in the yeast BiFC assay was tested (Figure 5.9). 
These interactions cover a range of previously reported binding affinities stretching from Kd ≈ 
10
-8
 M to ≈ 10-4 M (Table 5.1). The experiments were repeated with some variation in 
fluorescent signal intensities, especially for the lower affinity interaction with the U-shaped ZnFs 
1 and 9 (USHF1 and USHF9) with the N-terminal ZnF from Pannier (PNR-NF). Overall, the 
LMO4-Ldb1 interaction appeared to give the strongest signals by a small margin and other LIM-
LID interactions were of similar average intensity (Figure 5.10). The fluorescence intensity was 
lowest for the weakest interaction involving USHF9. Overall, these data show that BiFC in yeast 
can detect interactions in a wide range of binding affinities, including weak interactions of close 
to Kd = 100 µM. 
 
Table 5.1. Binding affinities of construct pairs tested in the BiFC yeast system. Binding affinities are expressed 
in the form of dissociation constant Kd. All interactions were previously detected with Y2H and the Kd values were 
determined by biophysical methods in vitro.  
 
Proteins (domains) Kd(M) Reference 
Detected 
by Y2H 
LMO4LIMs Ldb1LID 10
-8
 [167] yes 
LMO2LIMs Ldb1LID 2 × 10
-8
 [167] yes 
Lhx3LIMs Ldb1LID 3.4 × 10
-8
 [18] yes 
Isl1LIMs Ldb1LID 9 × 10
-8
 [18] yes 
USHF1 PNR-NF 10
-4
 to 6.9 × 10
-6
 [268] yes 
USHF9 PNR-NF 10
-4
 to 5.2 × 10
-5
 [268] yes 
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Figure 5.10. Sensitivity of the BiFC assay in protein-protein interactions mediated by ZnFs from LIM, GATA 
and FOG proteins. Mouse LMO4LIMs, LMO2LIMs and Isl1LIMs constructs were tested for interaction against Ldb1LID, 
whereas USF1 and USF9 were tested against PNR-NF. Only the FITC signal is shown. All micrographs on the left 
(magenta box) show tests between NGFPN-tagged and CGFPN-tagged proteins. Other micrographs show the 
appropriate controls with the relevant GFP fragment. The reported binding affinities of interactions decrease from 
top (low Kd) to bottom (high Kd) as shown by the triangle on the left.  
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5.7 Full-length LIM-HD proteins in the BiFC assay and the impact of a 
stronger promoter      
The well characterised Lhx3 vs. Isl1α interaction (section 1.8) was chosen as a model to 
test full-length LIM-HD proteins in BiFC. Lhx3a was cloned into the pW397-NGFPN vector, 
whereas Isl1α was cloned into the pL397-CGFPN vector. Lhx3LIMs and Isl1LBD were also cloned 
into appropriate plasmids to provide a domain vs. domain interaction control for comparison 
with the full-length protein interaction. Full-length protein vs. Ldb1LID interactions were also 
tested as a comparison. The domain-domain interaction NGFPN-Lhx3LIMs vs. CGFPN-Isl1LBD was 
detected (Fig 5.11C), but no fluorescence signal was detected for the full-length proteins 
(NGFPN-Lhx3a vs. CGFPN-Isl1α) under the same experimental conditions (Figure 5.11F). It was 
noted, however, that all tests involving the CGFPN-Isl1α fusion construct failed to develop 
fluorescence (Figure 5.11F, D and H), which could indicate a problem with the expression and/or 
stability of this construct. In contrast, tests of NGFPN-Lhx3a with CGFPN-Ldb1LID and (to a 
lesser extent) CGFPN-Isl1LBD showed nuclear localization of signal in some cells (Figure 5.11G 
and E).  
A western blot using a polyclonal anti-GFP antibody was carried out to test for proper 
expression of full-length LIM-HD and LMO4/Ldb1 constructs (Figure 5.11I). A strong band 
corresponding to the NGFP-CGFP construct was detected, but no GFP-fragments were detected 
in other samples, despite detection of GFP fluorescence in the cells containing NGFPN-
LMO4LIMs/CGFPN-Ldb1LID and NGFPN-Lhx3LIMs/CGFPN-Isl1LBD plasmids. The non-detection 
of protein suggests that GFP-fragments and fusion constructs in yeast cells have much lower 
levels of stable expression than that of the full-length GFP (NGFP-CGFP).  
The 397 bp ADH1 (truncated) promoter that was part of the parent vectors was designed 
to give low levels of constitutive expression. The 397 bp promoter was replaced with a 1473 bp 
full-length ADH1 promoter from the pGADT7 plasmid in the relevant BiFC plasmids to 
generate pWAFL-NGFPN and pLAFL-CGFPN (where AFL indicates the full-length ADH1 
promoter) to try and increase expression levels of GFP-fusion proteins and the experiment was 
repeated. This promoter should give high expression in mid-log phase under aerobic conditions 
(Clontech, Yeast Protocols Handbook). The modified plasmids did result in significantly 
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Figure 5.11. Investigating interactions between Lhx3a and Isl1α proteins. (A) Fluorescence control. (B) Positive 
interaction control. (C) interaction between isolated Lhx3LIMs and Isl1LBD domains, (D) and (E) show tests between 
isolated domains and full-length proteins, (F) test between full-length proteins, (G) and (H) tests between Ldb1LID 
and full-length proteins. All proteins were expressed using the 397 bp ADH1 promoter. BiFC images (A), (B), (D) 
and (G) are composites of FITC (green) and bright field (blue) micrographs while other images show only FITC 
channels. Exposure times are shown in the bottom left corner of every image. Images framed in red show no or very 
weak fluorescence and images framed in green detect nuclear localization of fluorescence (I) Western blot of yeast 
lysates from indicated transformants. NGFP-CGFP construct (28.6 kDa; circled). Rabbit Anti-GFP polyclonal 
primary Ab and goat anti-rabbit secondary Ab was used. An unspecific band is seen in all lanes of the gel at higher 
MW that does not correspond to any GFP-fragments or complemented proteins.  
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higher levels of fluorescence for yeast cells expressing the NGFP-CGFP control, the NGFPN-
LMO4LIMs vs. CGFPN-Ldb1LID BiFC control and NGFPN-Lhx3LIMs vs. CGFPN-Isl1LBD (Figure 
5.12A–C). In the case of full-length Lhx3a and Isl1α BiFC, a weaker signal that was 
predominantly localised to the nucleus was observed (Figure 5.12D–E). Full-length Lhx3a tested 
against CGFPN-Ldb1LID gave rise to nuclear localization (Figure 5.12F) as was observed 
previously (Figure 5.11G). These observations suggested that some full-length Isl1α and Lhx3a 
proteins are being directed to the nucleus where the interaction may take place. However, the 
levels of fluorescence were very low compared to interactions between separate domains. In 
some replicate experiments cells expressing both fusion constructs failed to grow, which could 
imply the toxicity due to higher expression levels. 
A western blot of samples from this experiment showed higher levels of background, but 
more importantly, showed clear bands that correspond to the expected sizes of several NGFP-
fragments (Figure 5.12G). For example, NGFP-CGFP (28.6 kDa) in lanes 1 and 6, NGFPN (20.4 
kDa) in lanes 2 and 4, and NGFPN-LMO4LIMs (33.2 kDa) in lane 5 were seen. However, no 
bands corresponding to CGFP-containing fragments were evident. Possible degradation products 
of the NGFP-CGFP were also detected in lanes 1 and 6. These data indicate that the stronger 
promoter did result in higher levels of protein expression, but suggest that at least some of the 
protein constructs are susceptible to degradation. 
A new set of plasmids for expression of His-tagged GFP-fusion constructs in yeast were 
designed (pWAFLHisGFP-Lhx3a and pLAFLHisGFP-Isl1α) to permit visualisation of 
localization of individual proteins while facilitating their detection with anti-His-tag antibodies 
in a western blot. Unfortunately, yeast transformed with these plasmids failed to grow, or grew 
very slowly, which suggested that the His-GFP-Lhx3a and His-GFP-Isl1α constructs were 
probably toxic. Yeast transformed with pLAFLHisGFP-Isl1α displayed very weak fluorescence 
in a majority of cells, indicating low expression or misfolding of constructs. The signal in these 
cells was stronger in the cytoplasm and slightly depleted in the nuclei (Figure 5.13). Yeast 
transformed with pWAFLHisGFP-Lhx3a showed nuclear fluorescence in a small percentage of 
cells, but most cells showed no signal. When two proteins were co-expressed, the result was 
similar except that some cells showed weak cytoplasmic fluorescence. The apparent toxicity of  
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Figure 5.1. The effects of the full-length ADH1 promoter on fluorescence intensity. Constructs under the control 
of the full-length ADH1 promoter were expressed from pWAFL-NGFPN and pLAFL-CGFPN vectors. (A-D) BiFC 
images are composites of FITC (green) and bright field (blue) micrographs. (E-F) BiFC signal localization. FITC 
(blue), DAPI (red) and bright field (green) micrographs were overlayed. Purple indicates nuclear localization of 
complexes. Exposure times are shown in the bottom left corner of every image. (G) Western blot of yeast cell 
lysates from indicated transformants using an anti-GFP polyclonal antibody as the primary antibody. Relevant bands 
(see text) are indicated with green ovals. 
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His-tagged constructs prevented any meaningful comparison in expression levels, so no western 
blot experiments were carried out for these constructs. 
In previous studies, a BiFC signal in yeast was detected by fluorescence methods using 
flow cytometry [264, 269-273]. This approach filters out and/or rapidly quantifies background 
cells that are not fluorescent because of a lack of interaction, in contrast to Y2H assays where 
those cells do not grow. As an alternative approach, solution state fluorimetry was used to try 
and distinguish between samples that contain interacting proteins and negative controls. Intact 
yeast cells that co-expressed NGFPN-LMO4LIMs and CGFPN-Ldb1LID under the control of full-
length ADH1 promoter were resuspended in PBS buffer, normalised for cell density and scanned 
for bulk fluorescence in solution, and compared with a NCFP-CGFP positive control and a 
NGFPN vs. CGFPN self-assembly control (Figure 5.14). There was no evidence of GFP-
fluorescence in the self-assembly control and GFP-fluorescence at 510 nm was more than 3-fold 
weaker in the NGFPN-LMO4LIMs vs. CGFPN-Ldb1LID interaction sample than in the NGFP-
CGFP positive control. These results showed that the interaction was detectable by standard 
fluorimetry, and confirmed that the average BiFC fluorescence in case of a strong interaction 
was only ~30% of the wtGFP (NCFP-CGFP). 
 
Figure 5.2. Fluorescence in cells expressing His6-GFP-tagged full-length proteins from the full-length ADH1 
promoter. The proteins were either expressed separately (A) and (B) or co-expressed (C). White arrows indicate 
some nuclei with depleted fluorescence and yellow arrows indicate cells with mostly cytoplasmic fluorescence.  
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Figure 5.3. In vivo detection of a BiFC interaction. All constructs were expressed under the control of full-length 
ADH1 promoter. The yeast cell suspensions were excited at 475 nm and the emission spectra was recorded from 
480–550 nm. The emission spectra for NGFPN-LMO4LIMs vs. CGFPN-Ldb1LID interaction and NGFP-CGFP positive 
control are shown in green and the NGFPN vs. CGFPN self-assembly control is in black. The cell suspension buffer 
was used as the blank. 
 
5.8 Nuclear BiFC 
The interactions between the full-length Lhx3a and Isl1α were associated with nuclear 
localisation (Fig 5.12 and 5.13). Whereas Lhx3a did seem to localize to the nucleus (Fig 5.13B), 
Isl1α did not (Fig 5.13B). Differences in sub-cellular localization are obvious features that could 
give rise to false negative results. For example, if one partner is directed to the nucleus and the 
other to the cytoplasm, there is a possibility that GFP complementation would be below the 
detection level because the fragments have little or no opportunity to encounter one another. 
Thus, a nuclear-localized version of the BiFC assay was designed by introducing the SV40 NLS 
sequence at the N-termini of the pW397-NGFPN and pL397-CGFPN plasmids (Figure 5.15). The 
resulting plasmids were named pW397-NLS-NGFPN and pL397-NLS-CGFPN. 
 
Chapter 5 118 
 
 
 
 
Figure 5.4. NLS-containing BiFC plasmids (left column) and models of the resulting protein fusion constructs 
(right column). The SV40 NLS sequence is coloured purple. 
 
Yeast co-transformants containing NLS-NGFPN-LMO4LIMs and NLS-CGFPN-Ldb1LID 
and a self-assembly control, NLS-NGFPN vs. NLS-CGFPN, were tested for fluorescence (Figure 
5.16A and B). The resulting complexes showed strong and localized signals in the nuclei for 
both co-transformants. Unfortunately, however, the self-assembly control showed the same 
strong level of fluorescence in a similar proportion of the cell population. This phenomenon is 
presumably caused by the increased local concentrations of GFP-fragments leading to self-
assembly, and indicates that NLS-tagging was unsuitable for further experiments.  
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Figure 5.5. Co-localization-induced self assembly of the GFP-fragment fusion constructs. (A) NLS-NGFPN-
LMO4LIMs vs. NLS-CGFPN-Ldb1LID (B) NLS-NGFPN vs NLS-CGFPN self-assembly control. The images are 
composites of FITC (green) and bright field (blue) micrographs. Exposure in both was 0.2 s. 
 
5.9 Split-GFPsol variant in the BiFC system 
In an effort to improve the BiFC signal in these assays, a switch was made from using the 
split-GFPuv protein to a variant that contains the mutation S65T to improve the fluorescent 
properties of GFP, and F64L to increase the folding efficiency [252]. When these mutants are 
present on the background of the wild-type protein the resultant protein is called enhanced GFP 
(EGFP), and when on the background of GFPuv the resultant protein is referred to as GFPsol (or 
GFPuv3/GFP+). GFPsol is reported to have faster maturation and eight times more brightness 
than GFPuv [274, 275] and is more compatible with sensitive detection using standard FITC 
filters (Olympus BX51 System microscope manual). Thus, the mutations S65T and F64L were 
introduced into the split-GFPuv constructs in appropriate NGFP-containing vectors. The 
resulting vectors were named pW397-NGFPsolN and pW397-NGFPsolC. 
The GFPsol-BiFC system was used to retest the interaction between full-length Lhx3a 
and Isl1α. The NGFPsolN vs. CGFPN orientation that was optimal for the head-to-tail interaction 
between LIMs and LBD domains might not be compatible with the full-length constructs as the 
GFPsol fragments might be too far apart to be able to complement. Thus, all eight different 
combinations of the fusion constructs were tested to find the optimal orientation for this 
interaction. Unfortunately, all self-assembly controls showed detectable fluorescence in 
cytoplasm (Figure 5.17D, H, L and P), and some of the other controls had signals comparable or 
Chapter 5 120 
 
 
 
even stronger than those in the interaction tests (Figure 5.17G, O and Figure 5.18C, H, I and K). 
This background signal probably represents nonspecific interactions between a split-FP fragment 
and sticky full-length LIM-HD proteins (Figures 5.17 and 5.18).  
False positives were more common in cells with CGFP-containing fusion constructs of 
either protein compared to cells containing NGFPsol-fusion constructs (Figure 5.17G, O and 
Figure 5.18C, I), and they include all cases where Isl1α has a C-terminal tag (whether it be 
NGFPsol or CGFP). 
 
Figure 5.6. Optimization of orientations in the split-GFPsol BiFC assay - First four combinations. Interaction 
tests are shown in the first column on the left (light green background) and the relevant controls are in rows next to 
each interaction. The rightmost column (light blue background) contains self-assembly controls. Images showing 
nuclear-localised signals are in red rectangles. The images are composites of FITC (green) and bright field (blue) 
micrographs. Exposure was 1 s. 
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Figure 5.7. Optimization of orientations in the split-GFPsol BiFC assay - Last four combinations. Interaction 
tests are shown in the first column (light green background) on the left and the relevant controls are in rows next to 
each interaction. The self-assembly controls are shown in the previous figure. Images showing nuclear-localised 
signals are in red rectangles. The images are composites of FITC (green) and bright field (blue) micrographs. 
Exposure was 1 s. 
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Interestingly, nuclear localization was observed in interaction tests in all orientations, but 
only some controls showed a stronger ratio of nuclear to cytoplasmic signal. These controls all 
involved Lhx3a (Figure 5.18C, F, I and L). Fluorescing controls that involved Isl1α-containing 
constructs showed signals that were not specifically localized to the nucleus (i.e., were the same 
as the NGFP-CGFP construct alone).  
5.10 Discussion 
5.10.1 Comparison of BiFC and Y2H assays for detecting interactions 
between LIM-HD proteins 
In this chapter, a BiFC assay was developed for detection of interactions between 
heterologous proteins in yeast. This assay was successful in detecting known interactions across 
a broad range of binding affinities for mouse and insect ZnF proteins including LIM domains. 
Although BiFC was able to detect an interaction between full-length Lhx3a and Isl1α proteins, 
the signals were not as robust as those observed for interactions between isolated domains. In 
BiFC assays that attempted to detect interactions between full-length Lhx3a and Ldb1LID, full-
length Isl1α or Isl1LBD, fluorescent signals were predominantly localized in nuclei.    
Yeast BiFC assays appear to be a viable approach for detecting LIM-peptide interactions, 
but ultimately did not reach the selectivity, signal to noise ratio and reproducibility achieved by 
standard Y2H assays. The assays described in this chapter apply epifluorescent microscopy for 
detection of protein-protein interactions, which limits the throughput of this assay format, in 
contrast to high throughput potential of Y2H assays. Although BiFC assays can detect an 
interaction, low confidence should be given to any analysis of relative interaction intensities or 
analysis of small mutagenesis effects based on this assay. The reason for this lies in the multitude 
of factors influencing the assay output. The lack of growth selection, irreversibility of BiFC 
complexes, variable levels of self-complementation, variable fluorophore maturation of different 
BiFC complexes (Figure 5.9) [276], greater sensitivity to steric effects, lack of proper negative 
controls, and different intracellular localization effects make BiFC assays in yeast inferior to 
Y2H assays for detection of heterologous protein interactions.  
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BiFC assays in yeast can be used as an alternative when autoactivation prevents detection 
in Y2H assays. Results from this chapter show that well optimized BiFC assay in yeast can be 
applied to test if separate constructs of LIM-HD C-terminal regions interact with LIM domains. 
In contrast to HD-containing constructs, subcellular localization is unlikely to cause false 
negative or false positive results when BiFC fusion constructs of C-terminal and LIM domain 
constructs are used.  
5.10.2 Possible improvements of BiFC assays 
Since this project began, numerous BiFC assays have been developed, which may 
provide possible improvements for the BiFC assays associated with LIM-HD proteins. The main 
areas for consideration are cell-to-cell variation in levels of fluorescence, detection, stability of 
constructs, and further consideration of localisation effects. 
Cell to cell variation of fluorescence can be attributed in part to stochastic processes and 
in part to copy number variation from the multi-copy 2µ plasmids used in these assays [277, 
278]. Copy number variation could be limited through the use of CEN/ARS plasmids or 
chromosome-integrated genes, although this approach tends to also lower overall fluorescence 
[279]. The temperature and time of yeast incubation are important factors that affect fluorophore 
maturation in BiFC assays. Automated fluorescence microscopy could be applied in time course 
experiments to compare the development of fluorescence between samples. However, variations 
in fluorescence intensity observed between replicates could lead to ambiguity. Some studies 
suggest that the population of highly fluorescent cells is higher when tested proteins interact and 
that flow cytometry can be applied to detect such differences between yeast cultures, leading to 
detection of protein-protein interactions [264, 270-272].  
Levels of protein expression could be increased by optimizing the codon usage of the 
split GFP fragments for expression in yeast. The constructs used in this chapter had been 
optimised for expression in E. coli. Yeast-optimized split-yEGFP can give significantly higher 
expression levels [280] and was used in a previous BiFC study [281]. An additional approach 
would be to optimize the translation initiation site in BiFC plasmids [282]. Note, however, that 
overly high concentrations of fusion proteins can lead to self-assembly, which would lead to 
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more ambiguity in the assay outputs. Furthermore, high levels of recombinant proteins could be 
toxic to cells as might have occurred with His-tagged constructs in section 5.7. 
Improved detection and stability of constructs could also help in the identification of 
interactions between unstable or transiently interacting constructs. Some attempts were made to 
improve brightness of FPs in this study and lower the interaction detection limit. Faster folding 
FPs could provide more protection of unstable proteolysis-prone fragments but could also lead to 
higher self-assembly rates. In these cases proper controls for self-assembly would be particularly 
important. Split-EYFP (enhanced YFP variant) could be applied instead of split-GFP, as it is 
reported to give about two times higher fluorescence and have relatively low self-assembly rates 
[254, 283].  
Sub-cellular localisation. The main advantage of BiFC compared to Y2H experiments 
presented in chapters 3 and 4 is the potential for in situ, non-invasive, visual detection of protein 
interactions. Whereas Y2H vectors are directed into the nucleus via NLS tags from the plasmids, 
it is assumed (but usually not demonstrated) that both fusion constructs locate to the nucleus. In 
BiFC assays, the intrinsic properties of the proteins themselves play an important role for 
subcellular localisation. Fluorescence arising from interactions between domains that do not have 
known NLS sequences (LIMs vs. LID/LBD) were found in both the cytoplasm and the nucleus. 
Other constructs preferentially localised to the nucleus, most likely because of intrinsic NLS and 
HD sequences direct the protein into the nucleus where retention is enhanced by binding to DNA 
[284, 285]. In the case of full-length Isl1α:Lhx3a interactions, Isl1α could be protected from 
nuclear localisation because of intramolecular interactions (section 1.10) whereas Lhx3a is 
directed to the nucleus; different subcellular localisation prevents a robust interaction signal. 
Rather than promoting nuclear localisation, it might be possible to promote cytoplasmic 
localisation, through addition of nuclear export signals [286-288]. However, if some sequestered 
fusion constructs are reflecting in vivo protein localization, forced co-localization of such fusion 
constructs could only bring about biological artefacts (false positives that do not interact in vivo).  
Note that even if improvements could be made for the BiFC assay, it is important to 
confirm and quantify interactions identified by this approach by orthogonal methods. The 
following chapters focus on attempts to develop assays to quantify LIM-partner interactions in 
vitro. 
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Chapter 6    Site-specific labelling of a LIMs-LID construct with 
fluorescein and competition fluorescent anisotropy binding 
assays 
 
A part of this research focussed on determining the binding affinities of LIM-HD/LMO 
proteins for Ldb1. As the LIM domains of these proteins have limited solubility and tend to 
aggregate in solution, it was decided to take the approach of using fluorescence-based 
homologous competition assays based on tethered LIMs-LID complexes that contained protease 
sites in the linker (section 1.9.1). Thus, it was necessary to label the tethered LIMs-LID 
complexes. This chapter details the different strategies used to label the N-terminus of the LIM 
domains in the LIMs-LID constructs and attempts to use these proteins in fluorescence 
anisotropy experiments. 
6.1 Methods for labelling proteins with synthetic fluorophores 
The design of fluorescence-based assays requires selection of a fluorophore that is suited 
to monitor a particular property of a protein. For example, tryptophan fluorescence can be very 
useful to study the folding, conformational dynamics, and interactions of a protein, but it is 
limited to proteins that contain tryptophan residues and is complicated by the photophysical 
properties of tryptophan [289, 290]. The most frequent approach used to make fluorescent 
proteins is the attachment to the proteins of interest of fluorophores with emission spectra in the 
visible range of the electromagnetic spectrum. Another method is to use protein engineering to 
create a fusion construct in which an autonomously (intrinsically) fluorescent protein, such as the 
green fluorescent protein (GFP) or its variants, is tethered to the protein of interest (as described 
in Chapter 7). An alternative approach is to chemically attach a synthetic fluorescent compound 
to the protein. The advantage of this approach is that synthetic probes can be small, chemically 
stable and photo-stable. Compared to GFP proteins, they can have higher quantum yield 
(brightness), little-to-no nonspecific binding, are resistant to irreversible photobleaching, less 
sensitive to buffer conditions, and have simpler and better defined photophysical properties.  
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Table 6.1. Common methods for chemical labelling of proteins. Labelling of native functional groups. Reagents 
for labelling primary amines, thiols or carboxyl groups are shown. 
 
 
A large number of small fluorophores are commercially available, of which various 
fluorescein derivatives are most commonly used. Different derivatives have specific 
photophysical properties and contain specific reactive groups that target appropriate functional 
groups in proteins (Table 6.1) [291-293]. Fluorescein isothiocyanate (FITC) and NHS-
fluorescein are often used for labelling primary amines (N-terminal amine groups and lysine side 
chains) and fluorescein-maleimide is used for labelling cysteine side-chains. These, and several 
other compounds, label their target functional groups in native proteins but generally lack site-
specificity and may therefore not be optimal for investigating protein-protein interactions.  
There are several approaches that do allow for site-specific (usually N- or C-terminal) 
chemical labelling of proteins [290-292, 294]. This is achieved with the introduction of unique 
target groups, usually via expressed tags modified by an enzymatic or autocatalytic reaction 
(Table 6.2).  
The most common covalent labelling strategies involve native chemical ligation, different 
self-labelling enzymatic tags, enzyme-mediated labelling (especially with CP-tags and PPTase) 
or CLICK chemistries. Proteins can also be labelled site-specifically through non-covalent 
labelling by chelation of metal-/metaloid-dye conjugates (e.g., through His6 or tetracysteine tags) 
or other types of protein-ligand binding (e.g., enzyme-inhibitor interactions of DHFR). 
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Table 6.2. Site-specific chemical labelling of proteins. Target groups (tags) and reagents are shown. In green and 
red font are the two methods applied in this study for labelling LIMs-LID constructs in vitro. EPL and IPL stand for 
Expressed and Intein-mediated protein ligation, respectively. H and S in superscript mark azide-alkyne Huisgen 
cycloaddition and Staudinger ligation, respectively. 
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6.2 Specific labelling of a SNAP-tagged LIMs-LID construct 
The SNAP-tag was designed as a tool for the specific labelling of fusion proteins in living 
cells [295-297]. This labelling strategy depends on the ability of human DNA repair protein O
6
-
alkylguanine-DNA alkyltransferase (AGT), or its engineered version (SNAP-tag), to covalently 
label itself with a single molecule of an O
6
-benzylguanine (BG) derivative (Figure 6.1A). For the 
BG-88 reagent, excitation and emission maximum are specified to be 506 nm and 526 nm, 
respectively [298]. 
For this project a commercially available pSNAP-tag(T7) vector was modified to 
introduce a His-tag (to aid in purification) and a TEV-protease site (for removal of the His6-tag; 
Figure 6.1B) before the SNAP-tag. Both the original vector and the modified vector (named 
pT7HT-SNAP) appeared to be toxic to the standard cloning strain (DH5α), which made cloning 
very difficult (not shown). Successful transformants were extremely rare and any cell growth 
was slow, resulting in small colonies that often died. 
The LMO4LIMs-Ldb1LID construct was chosen for the initial labelling trials as it is stable 
and well characterized. The corresponding DNA construct was sub-cloned into the pT7HT-
SNAP vector (Figure 6.1B). Toxicity continued to be a problem in our standard bacterial 
expression strains, BL21(DE3) and Rosetta 2 cells, probably due to leaky expression. 
Fortunately, BL21-AI cells (Table 2.13 and section 2.3.2.4) were able to tolerate the vector and 
were successfully used in expression trials of the SNAP-tagged construct. The resultant protein 
was largely insoluble (estimated >80%; Figure 6.1C); however, some protein could be purified 
on Ni-NTA agarose beads. The His6-tag could not be cleaved on beads by TEV protease (not 
shown) so the tag remained on the protein in subsequent steps. Further purification using anion-
exchange chromatography resulted in >90% pure protein as estimated by Coomassie-stained 
SDS-PAGE (Figure 6.1C). Purified SNAP-tagged protein was labelled with the BG-488 reagent 
and the free reagent was removed by dialysis (section 2.10.1). Absorbances at 280 and 506 nm 
were measured and the labelling efficiency was calculated to be ~27% (section 2.10.3). 
A fluorescence emission spectrum was recorded for the 50 nM sample of the partially 
labelled protein (excitation wavelength 506 nm; Figure 6.1D). The first peak in each emission 
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Figure 6.1. SNAP-tag enzymatic labelling of the LMO4LIMs-Ldb1LID construct with the BG-488 reagent. (A) 
SNAP-tag labelling mechanism. SNAP-tag reacts with a benzylguanine derivative of a chosen fluorophore. Guanine 
is released and the SNAP-protein fusion construct becomes fluorescently labelled. (B) Amino acid sequence of the 
expressed protein construct His6-SNAP-LMO4LIMs-Ldb1LID. Different domains are colour coded: the His6-tag is in 
green font, the TEV protease site is in red font and the Factor Xa site is in blue font, SNAP-tag is highlighted in 
yellow, LMO4LIMs is highlighted in blue and Ldb1LID is highlighted in grey. (C) SDS-PAGE gels showing the 
solubility and purification of the construct with Ni-NTA agarose resin and anion-exchange chromatography. (D) 
Emission scans of the labelled and dialysed 50 nM sample, excited at 506 nm with different excitation slit widths. In 
both spectra, the first peak is an artefact of excitation and the second peak is the emission. 
 
Chapter 6 130 
 
 
 
spectrum at 506 nm was likely due to reflected excitation light whereas the second peak at 526 
nm is characteristic of the BG-488 label. The reflected emission peak, the intensity of which 
does not depend on the protein concentration, was significantly stronger than the emission peak 
at low labelled protein concentrations tested.   
Unfortunately, the production of His6-SNAP-LMO4LIMs-Ldb1LID could not be repeated in 
subsequent attempts (not shown). It was considered that the low solubility of the expressed 
protein was an indicator of poor stability, including a tendency to aggregate, prompting the use 
of alternative labelling strategies.  
6.3 Expressed protein ligation as a method for fluorescent labelling of 
proteins 
Native chemical ligation (NCL) is a method commonly used in solid-phase peptide 
synthesis to join two synthetic unprotected peptides through formation of a native peptide bond, 
thereby producing an extended polypeptide. The C-terminal thioester of one molecule reacts with 
an N-terminal cysteine of the other. The first step of this process involves a reversible 
transthioesterification that is followed by a second, irreversible, S→N acyl shift step (Figure 
6.2). Recombinant proteins can also be subjected to this general process in which case the 
method is called Expressed Protein Ligation (EPL). Both NCL and ECL are non-enzymatic, 
chemo-selective reactions that occur at physiological pH in aqueous solutions. These methods 
can also be used to attach fluorophores to protein termini in a site-specific manner [299]. 
Whereas C-terminal labelling involves attachment of a protein-thioester via a Cys-
fluorophore reagent, proteins with N-terminal cysteines can be N-terminally labelled with 
fluorophore-thioesters. The former method usually requires an intein-mediated step to generate 
the thioester. The rate-limiting step in native chemical ligation is transthioesterification with the 
thiol group of the N-terminal cysteine [300, 301]. The most common thioesters used in NCL 
reactions are alkyl-thioesters as they are easy to produce and less susceptible to hydrolysis but 
are less reactive in transthioesterification. 
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Figure 6.2. The mechanism of Native Chemical Ligation used for N-terminal protein labelling. The reaction 
consists of two consecutive steps: a reversible transthioesterification and an irreversible acyl shift. The thioester-
linked intermediate is in the red box. The blue box shows an optional step of thiol-thioester exchange when a thiol 
with a better leaving group is added to the reaction. 
 
Sodium 2-sulfanylethanesulfonate (MESNA) is a thiol reagent commonly used for 
making alkyl-thioseters. In NCL reactions it acts as a reducing agent and reverses any non-
productive transthioesterification with the thiol moieties of side chains from internal cysteine 
residues [300]. Added thiols, if more active than the one that generated the thioester, can also 
promote the in situ formation of thioesters with better leaving groups by thiol-thioester exchange 
(blue box in Figure 6.2) and thus increase the kinetics of ligation [301].  
Chapter 6 132 
 
 
 
The requirement for an N-terminal cysteine is a potential limitation of N-terminal 
labelling by EPL. Fortunately, such cysteine residues can be introduced in several ways. If the 
protein is expressed with a methionine at the N-terminus and a cysteine as the second residue 
endogenous methionylaminopeptidases (MAP) can remove the methionine leaving cysteine as 
the N-terminal residue. This approach has been achieved with variable efficiency depending on 
the downstream amino acid residues [302, 303]. For example, intein-mediated protein splicing 
can produce Cys-proteins (Figure 6.3A) if the inteins have been mutated to induce cleavage at 
the C-terminal splice junction [289]. However, the most common method for generating Cys-
proteins is the generation of fusion proteins in which modified protease sites for Factor Xa, 
tobacco etch virus (TEV) protease and some other proteases, are introduced into the linker at the 
N-terminus of the target protein (Figure 6.3B). These proteases will tolerate a cysteine residue in 
the P1’ site, so their proteolytic cleavage of constructs results in an N-terminal cysteine residue 
[289]. 
 
Figure 6.3. Methods for creating proteins with N-terminal cysteines. (A) Intein-mediated cleavage of expressed 
constructs on beads produces free Cys-polypeptides (green). (B) Modifications of FMDV 3C or TEV protease sites 
that generate an N-terminal cysteine upon cleavage, and the proteolytic cleavage of the GST-fusion constructs on 
beads. 
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6.4 Making the proteases and vectors 
Initially it was intended to use the Foot and Mouth Disease Virus (FMDV) 3C protease, 
which had been used previously to generate Cys-proteins (Figure 6.3B)[304]. However, attempts 
to express FMDV3C protease were not successful. Thus, TEV protease was used [305]. His6-
tagged TEV protease was expressed in BL21(DE3) cells and purified on Ni-NTA agarose beads 
followed by size-exclusion chromatography (Figure 6.4). Target proteins were generated by 
editing the pGEX-6P vector to replace the HRV3C site with modified cleavage sites for TEV 
protease (ENLYFQC site; pGEX-TVC vector; Figure 6.3A). For details see Appendix B.  
 
Figure 6.4. Purification of the His-tagged TEV protease. (A) Affinity purification on Ni-NTA agarose beads and 
elution with 250 mM imidazole. (B) Size-exclusion chromatography (SEC) of the His6-TEV construct on a 
Superdex 200 column. The blue trace shows absorbance at 280 nm. The inserted photo shows an SDS-PAGE of 
SEC fractions. 
 
6.5 Production of tethered constructs with N-terminal cysteines 
Cleavable LIMs-LID constructs that contained either LMO4, or Lhx1–4 (for later 
experiments) were sub-cloned into the pGEX-TVC vector. GST-tagged constructs were 
expressed in BL21(DE3) cells and purified on GSH-agarose beads. TEV was added to remove 
the GST-tags and the free Cys-LIMs-LID constructs were collected. Proteolytic cleavage by 
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TEV was confirmed by SDS-PAGE (Figure 6.5A). Subsequent anion-exchange chromatography 
resulted in >90% pure protein as judged by Coomassie-stained SDS-PAGE (Figure 6.5B). 
 
Figure 6.5. Purification of Cys-LIMs-LID constructs. (A) SDS-PAGE of samples from the affinity purification of 
GST-Cys-LIMs-LID constructs (labelled as GST-fusion constructs in this figure) immobilised on GSH-beads, 
subsequent overnight cleavage with TEV protease, and collection of untagged Cys-LIMs-LID constructs (labelled as 
Cys-polypeptides in this figure). Bw - fusion construct on beads after washing, Be - beads after cleavage, M - 
protein standard Mark12. (B) Anion-exchange chromatography of Cys-LMO4LIMs-Ldb1LID. Black trace is the 
absorbance at 280 nm and red trace shows % buffer B (with 1 M NaCl). Fractions 23–27 contained the pure protein, 
as indicated by SDS-PAGE (right).  
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Figure 6.6. Detection of the N-terminal peptide of Cys-LMO4LIMs-Ldb1LID by MALDI-TOF. (A) MALDI-TOF 
mass to charge (m/z) vs. % intensity diagram. (B) PeptideCutter prediction of peptides generated by the trypsin 
digest of Cys-LMO4LIMs-Ldb1LID. The CGSLSWK N-terminal peptide peak is indicated in each panel. 
 
To confirm that the proteolysis did generate an N-terminal cysteine residue, a band 
expected to contain the Cys-LMO4LIMs-Ldb1LID construct was excised from an SDS-PAGE gel 
and subjected to in-gel tryptic digestion and MALDI-TOF mass spectrometry. The MALDI-TOF 
spectrum showed a 780.4291 m/z peak that most likely corresponds to the 7-residue N-terminal 
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CGSLSWK peptide (highlighted in red; Figure 6.6A). This value agrees with the mass predicted 
by the PeptideCutter tool (779.91, highlighted in red; Figure 6.6B) [306].  
Cys-LMO4LIMs-Ldb1LID was characterized by far-UV circular dichroism (Figure 6.7A). 
The spectrum was essentially identical to spectra of similar tethered LIMs-LID complexes 
previously obtained in our laboratory, such as the spectrum of LMO2LIMs-Ldb1LID (Figure 6.7B), 
indicating that the N-terminal cysteine did not significantly alter the folding of Cys-LMO4LIMs-
Ldb1LID [19, 150, 307]. 
 
Figure 6.7. Characterisation of the Cys-LMO4LIMs-Ldb1LID construct by far-UV circular dichroism. (A) 
spectrum of Cys-LMO4LIMs-Ldb1LID. (B) The spectrum of LMO2LIMs-Ldb1LID recorded by Dr Daniel Ryan (D. Ryan 
PhD thesis, Sydney University, 2005) 
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6.6 Production and purification of Fluorescein-2MES  
The labelling reagent fluorescein-2MES (fluorescein-MESNA; Figure 6.8) was 
synthesised by combining 5-(6)-carboxyfluorescein succinimidyl ester (CFSE) with MESNA. 
 
 
Figure 6.8. Synthesis of the fluorescein-2MES reagent. CFSE reacts with the thiol MESNA to create the 
fluorescein-2MES product. 
 
Initial attempts at synthesis attempts and purification (Figure 6.8, more details in section 
2.10.2.1), included reverse-phase HPLC using a C18 column with different phase gradients of 
water-acetonitrile (0.1% TFA) or water-methanol (0.1% TFA). Under all conditions the 
separation of products was poor (Figure 6.9A), and MALDI-TOF mass spectrometry of collected 
samples showed the presence of multiple products, but not fluorescein-2MES. Given limited 
facilities for carrying out chemical synthesis in the laboratory, a collaboration was established 
with Dr Brendan Wilkinson (Payne laboratory, School of Chemistry, University of Sydney) to 
produce Fluorescein-2MES in DMF under an inert argon atmosphere, and subsequently purify 
the reagent using a C4 column with a water-methanol gradient (Figure 6.9B). Subsequent 
confirmation of the identity of the product by 1D 1H NMR was carried out as part of this project 
(Figure 6.9C).  
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Figure 6.9. Purification and detection of the fluorescent reagent fluorescein-2MES. (A) The reaction was 
performed as described in section 2.10.2.4 and the purification was attempted by reverse phase HPLC with a C18 
column in an 0–1 M acetonitrile (0.1% TFA) gradient. (B) Fluorescein-2MES was successfully purified using a C4 
column. (C) 
1
H NMR spectrum of the purified product. The chemical shifts in two ranges 2.4–4 ppm (bottom) and 
6.5–8.5 ppm (top) are shown. 
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6.7 Labelling and purification of fluorescein-Cys-LIMs-LID constructs 
Labelling of Cys-LMO4LIMs-Ldb1LID was initially performed as described in Gentle et al., 
(2004) [303] (see section 2.10.2), except that the protein was not lyophilized and subsequently 
re-solubilized to avoid possible folding problems associated with these steps. Fluorescence scans 
(using FITC filter sets) of the SDS-PAGE gels showed fluorescein-labelled Cys-constructs of 
approximately correct sizes (Figure 6.10, green stars). However, two strong fluorescent bands of 
low MW were also observed (red stars, Figure 6.10A).  
 
Figure 6.10. Removal of non-covalently bound fluorescent contaminants by anion-exchange chromatography. 
(A) Anion exchange chromatography of column-desalted, labelled Cys-LMO4LIMs-Ldb1LID. The upper panel shows 
a Coomassie-stained SDS-PAGE gel of anion exchange fractions; the lower panel shows the fluorescence scan of 
the same gel. Labelled Cys-LIMs-LID is marked with a green star. Red stars indicate fluorescent bands of lower 
MW. (B) Absorbance scans of protein samples before and after the desalting and ion exchange. Vertical lines mark 
absorbance at 280 nm and 494 nm.  
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Attempts were made to remove unligated dye and purify the protein from the reaction 
mixture by various approaches including RP-HPLC, dialysis, use of a PD-10 desalting column 
(GE Healthcare), and buffer modifications. The best results were obtained when the stopped 
reaction was desalted with a PD-10 column and then purified by anion-exchange 
chromatography. The procedure removed a high percentage of the contaminating species and 
showed that the peak containing the labelled protein eluted with higher salt than the unlabelled 
protein. However, SDS-PAGE in combination with Coomassie staining and fluorescence 
scanning following anion-exchange chromatography showed that only a small percentage of 
protein was labelled, as fractions that showed fluorescence could not be detected by Coomassie 
staining (Figure 6.10A). 
The labelled protein fractions were concentrated and absorbance scans at 280 nm and 494 
nm of the samples before and after anion-exchange chromatography were compared (Figure 
6.10B). The labelled protein now corresponded to ~40% of the total. Purified labelled proteins 
were desalted using Zip-tips (Millipore) and subjected to MALDI-TOF. Surprisingly, spectra 
showed only the unlabelled protein peaks (Figure 6.11). MALDI-TOF has been successfully  
 
Figure 6.11. MALDI-TOF spectra of labelled protein samples. (A) Labelled Cys-LMO4LIMs-Ldb1LID and (B) 
Labelled Cys-Lhx3LIMs-Ldb1LID. Spectra show only the unlabelled protein peaks. 
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used to detect other fluorescently labelled proteins [303, 304], so it is possible that fluoresein-
labelled LMO4-LID may not be readily detected by MALDI-TOF. ESI-MS may be a better 
approach for detection of labelled products [308, 309], but access to this approach was limited 
during this study. 
Labelling of other purified Cys-LIMs-LID constructs (Appendix C) has been attempted 
using the same approach, but all showed similar inefficiency of labelling and difficulties in 
unligated fluorescein removal. 
6.8 Labelling trial with a small unstructured protein 
To determine if the unexpectedly inefficient labelling and difficulties in removal of 
unligated dye was a result of problems with the protocol or the reagents used, or if it related to 
the proteins (Cys-LIMs-LID tethered constructs) being labelled, a smaller unstructured peptide 
was labelled under the same conditions. DEAF1404–438(T435D) [164] was cloned into the pGEX-
TVC vector, expressed and a Cys-tagged construct was purified as described above (Figure 
6.12A). In this case the labelling of the Cys-DEAF1 peptide was very efficient (Figure 6.12B). 
 
 
Figure 6.12. Fluorescent labelling of DEAF1 peptide by EPL. (A) Cys-DEAF1404–438(T435D) peptide sequence. The 
construct contains additional residues (in grey). (B) Scanned and Coomassie-stained gel with unlabelled and labelled 
peptide samples. Mark12 molecular weight markers were used. (C) MALDI-TOF of the labelled sample shows a 
single 4448.5 m/z peak corresponding to unlabelled Cys-DEAF1 peptide. 
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The desalted sample gave rise to a single strong band by SDS-PAGE corresponding to the 
expected size of the labelled protein, with a labelling efficiency estimated to be >90% (section 
2.10.3). 
The differences in labelling between the DEAF1 construct and tethered constructs could 
arise from the intrinsically disordered nature of the former, and the folded nature of the latter 
influencing the availability of the N-terminal cysteine. However, in the tethered constructs at 
least 4-5 unstructured residues separated the N-terminal cysteine and structured residues, making 
such an effect less likely. 
6.9 The effects of different thiol reagents and protein concentration 
The choice of a thioester type is an important factor for an NCL reaction rate (Figure 
6.13A) [301]. Although MESNA-thioesters are thought to represent a good compromise between 
stability and reactivity, NCL reaction rates can be increased by the addition of more potent 
thiols. The effects of different Cys-protein concentrations and thiol reagents on NCL reactions 
were tested. Different molar ratios of Cys-protein:fluorescein-2MES (1:2–1:5), reaction times 
(2–16 h) and thiol regents (MESNA and MPAA) were trialled.   
Labelling trials of Cys-LMO4LIMs-Ldb1LID were carried out in the presence of excess 
MESNA and MPAA in parallel for 5 h (Figure 6.13B). The more reactive MPAA gave higher 
levels of labelling, but also stronger signals attributed to non-covalently bound dye, or products 
of cross-reactions with buffer components [310, 311]. Some differences in the relative amounts 
of non-covalently bound dye and its separation from the protein in PD-10 columns are evident 
when different concentrations of Cys-proteins were used.  
Finally, a Cys-LMO4LIMs-Ldb1LID labelling reaction with fluorescein-2MES in the 
presence of MESNA was incubated for > 48 h at room temperature. SDS-PAGE analysis of the 
PD-10 column-desalted sample showed strong labelling of the construct without the low MW 
fluorescent components that were characteristic of previous reactions (Figure 6.13C). The 
labelling efficiency was estimated to be >90% (section 2.10.3). 
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Figure 6.13. SDS-PAGE of labelling trials for Cys-LMO4LIMs-Ldb1LID with MESNA or MPAA as thiol 
reagents. (A) A comparison of reaction rates of two different thioesters with a Cys-peptide (adopted from Johnson 
et al., 2006 [301]). The formulas of peptide X-MESNA and -MPAA thioesters are shown. Dashed lines mark yields 
observed after 5 h at room temperature. (B) SDS-PAGE gel of desalting column fractions F1 (and F2) obtained after 
labelling reactions with either MESNA or MPAA thiol present. The effects of incubation time as well as of a lower 
and a higher concentration of Cys-protein in the reaction are shown. The gel was scanned for fluorescence. The 
green star indicates labelled Cys-LMO4LIMs-Ldb1LID and red stars indicate fluorescent species from unreacted dye 
and side-reactions with buffer components. Note that the gel on the right was scanned at lower intensity setting. 
 
Although the yields of purified labelled proteins were low, a sufficient amount of Fl-Cys-
LMO4LIMs-Ldb1LID was obtained, which allowed the homologous competition binding 
experiments to be performed using fluorescence anisotropy. 
6.10 Fluorescence anisotropy 
Fluorescence-based methods are routinely used in protein binding affinity studies due to 
their ease of use, safety, sensitivity, time scale (in µs), reproducibility and adaptability to 
different assay formats [312]. Commonly used steady-state and time-resolved approaches 
include: fluorescence anisotropy (or polarization), fluorescence resonance energy transfer 
(FRET), fluorescence correlation spectroscopy (FCS) and related fluorescence cross-correlation 
spectroscopy (FCCS). 
Both fluorescence anisotropy assays (FA assays), which measure anisotropy values (r), 
and polarization assays (measure P) report the same phenomenon, and are interconvertable, but 
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are calculated in slightly different ways. The phenomenon involves excitation by polarized light, 
which results in a partially polarized emission of the sample because a proportion of excited 
fluorophores do not change orientation during the short lifetime of fluoroscence (~1–10 ns). 
Smaller species can rotate rapidly in solution meaning that a smaller proportion of the sample 
remains polarised (leading to lower anisotropy). Larger fluorescent species, such as complexes, 
tend to have higher anisotropies as they rotate more slowly in solution. The extent of the 
rotational diffusion depends on the size and shape of the rotating molecule [313]. Steady-state 
FA assays require that the complex has a significantly increased anisotropy compared to the 
anisotropy of a free fluorescently-labelled complex component (Figure 6.14). 
 
Figure 6.14. A diagram of the principle behind a fluorescence anisotropy assay. Larger complexes tumble more 
slowly in solution then their components so when the fluorescent tag is excited by a polarised light, complex-
associated fluorophores give more polarised light on average than free protein-associated ones. Figure adapted from 
http://www.hi-techsci.com/techniques/anisotropy/. The fluorophore is shown as a yellow star and polarisation filters 
are shown as blue rectangles with black stripes. Anisotropy of the complex AB is seen in the yellow rectangle. 
 
Assays presented in this chapter involve a specific version of the homologous 
competition assay where the small 4.3 kDa Ldb1LID peptide ligand is N-terminally tagged with a 
43 kDa MBP domain and tandem LIM-domains (LIMs, which are the receptors) are 
fluorescently labelled with either fluorescein or GFP (Figure 6.15A). Titration of the bulky 
MBP-Ldb1LID ligand should result in the formation of larger complexes that can be detected by 
changes in anisotropy (Figure 6.15B). 
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Figure 6.15. Homologous competition between different-sized LID constructs for fluorescently-labelled LIMs 
and the basis for an anisotropy assay. (A) An equilibrium between the Fl-LIMs:LID and Fl-LIMs:MBP-LID 
complexes, with colons representing protein-protein interactions. Fl-Cys-LMO4LIMs:Ldb1LID is a complex obtained 
by Factor Xa cleavage of the respective tethered construct. Green stars represent fluorescence, whereas Fl is short 
for fluorescein. (B) By adding MBP-LID, the equilibrium shifts towards the formation of a larger fluorescent 
complex, which is expected to exhibit a higher anisotropy. 
 
6.10.1 MBP-Ldb1LID and MBP 
For the purpose of the experiments described in this chapter Ldb1LID spanning residues 
331–375 was cloned into the pIH1121 vector. MBP-Ldb1LID and MBP-only were purified by 
amylose-affinity chromatography (section 2.7.3.3; Figure 6.16A). MBP-Ldb1LID was 
additionally purified by anion-exchange chromatography (section 2.7.5.2; Figure 6.16B). 
Initial tests showed that the vertically polarized fluorescence intensity of a sample 
containing 10 nM Fl-Cys-LMO4LIMs:Ldb1LID complex or the Fl-Cys-LMO4LIMs-Ldb1LID tethered 
construct dropped with every consecutive measurement (Figure 6.17A). In contrast, 5' 
fluoroscein-labelled 17 bp RNA (Dharmacon, Chicago, USA), obtained from Dr. Cuong 
Nguyen, and Fl-Cys-DEAF1, showed constant polarized emission intensities under the same 
conditions. When MBP-Ldb1LID was titrated into a solution containing Fl-Cys-
LMO4LIMs:Ldb1LID (10 nM), the anisotropy (r) increased from about 0.15 at the start of the  
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Figure 6.16. Purification of MBP-Ldb1LID. (A) Comassie-stained SDS-PAGE reporting the affinity purification of 
MBP-Ldb1LID on amylose beads. (B) Anion-exchange chromatography of MBP-Ldb1LID on a UnoQ6 column in 50 
mM Tris pH 8 buffer and a gradient of 0–1M NaCl. The peak containing MBP-Ldb1LID is marked in yellow. The 
grey line indicates % of buffer B, red line is conductivity and the blue line is the UV trace. 
 
titration to >0.26 at the highest concentrations of MBP-Ldb1LID, but displayed significant 
fluctuation (Figure 6.17B). However, the overall loss of fluorescence signal throughout the 
experiment made the anisotropy measurements unreliable.  
The protocol included inversion of the cuvette after each titration step to mix the 
solutions. After comparing mixing techniques including no mixing, inverting the cuvette in the 
presence and absence of BSA, and mixing by pipetting, it was concluded that the drop of 
emission intensities is caused by mixing, but this can be minimized by the addition of 100 µg/mL 
BSA (Figure 6.17C). BSA is a commonly used to minimize non-specific binding in ELISA and 
other in vitro bioassays [314-316], suggesting that signal loss was due to non-specific adsorption 
of the fluorescent LMO4LIMs-containing proteins to various surfaces during mixing. BSA was 
included in Competition assay buffer (Table 2.7) for all subsequent experiments. 
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Figure 6.17. LIM-domain specific loss of fluorescence signal. (A) VV-polarized emission intensity of different 
fluorescent samples measured after inverting the cuvette seven times at each point. Fl-RNA is 5’ fluorescein-labelled 
RNA. (B) Raw data for titration of MBP-Ldb1LID into a sample with Fl-LMO4LIMs:Ldb1LID complex. Anisotropy (r) 
and the polarised emission light intensities (Ivv and Ivh) are shown. The last 2 points are repeated measurements. Red 
arrows indicate the decreasing emission intensities with increasing MBP-Ldb1LID. (C) VV-polarized emission 
intensity of Fl-Cys-LMO4LIMs:Ldb1LID measured after different sample treatments. The sample containing 100 
µg/mL monomeric BSA in the buffer is marked. 
 
6.10.2 FA assay results and analysis 
Two experiments were carried out in which Fl-Cys-LMO4LIMs:Ldb1LID (10 nM) was 
titrated with MBP-Ldb1LID (1 nM to 2 µM). The r-values were normalized (rn, Appendix F) and 
plotted against the concentration of MBP-Ldb1LID (Figure 6.18A–B). The data was apparently 
monophasic and was fitted well by a 3-parameter SLogistic1 function. IC50 values of 24 nM 
(95% CI of 16–37 nM) and 31 nM (95% CI of 11–53 nM) were obtained for these two different 
experiments. The overlap of these data indicated that the experiment was reproducible. A control 
experiment with MBP-only titration was performed which did not show non-specific binding. 
Assuming a number of conditions are met, IC50 is approximately equal to Kd for 
homologous competition experiments. However, one of these assumptions is that the 
concentration of the ligand is in excess of the receptor so that the free and total ligand 
concentrations are essentially the same. At the initial stages of the titration, this assumption does 
not hold true for this experiment because prior to the addition of any MBP-Ldb1LID, the 
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concentrations of free Fl-Cys-LMO4LIMs and free Ldb1LID are the same. This phenomenon of 
ligand depletion can be accounted for using the Equation F.20 (Appendix F). The data from 
Figure 6.18A yielded a Kd of 14 ± 3 nM (the error is the reported standard error of the fit to a 
single data set; Figure 6.18C), but the second data set (Figure 6.18B) did not give a good fitto 
data. It appears that this approach could be a useful way to assess LIM-LID interactions, if 
problems associated with production of Fl-Cys-LMO4LIMs:Ldb1LID could be resolved. However, 
the lack of available material did not allow further assessment of the method using FA for this 
thesis and other binding assays were pursued. 
 
Figure 6.18. FA homogenous competition assays with the fluorescein-Cys-LMO4LIMs:Ldb1LID complex. (A) 
and (B) Two titration experiments were fitted in Origin9.1 with a sigmoid logistic function to yield IC50 values. (C) 
Data from titration shown in (A) was fitted with the Equation F.20 (Appendix F) to provide an estimate of Kd. 
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6.11 Summary 
Although the LMO4LIMs-Ldb1LID construct was initially labelled using the self-labelling 
enzymatic SNAP-tag with a commercial fluorescent dye, this approach was not reproducible. 
However, using EPL approaches, small amounts of LMO4LIMs-Ldb1LID were fluorescently 
labelled. The yield of the purified labelled protein was relatively low but it was still useful for 
assessing the use of fluorescence anisotropy to assay LIM-LID interactions. The homologous 
competition FA assay was used to obtain an IC50 of 24 nM (Kd = 14±3 nM for ligand depletion) 
in one assay and IC50 of 31 nM in the second assay for the LMO4LIMs interaction with Ldb1LID. 
The problems encountered in labelling, subsequent purification of LIMs-LID constructs and 
fluorescence measurements were specific to these constructs and were not encountered with Cys-
DEAF1 peptide. The nonspecific adsorption of LIMs-containing samples to cuvettes and other 
surfaces in the FA assays was minimized by including BSA in the Competition assay buffer. 
6.12 Discussion 
6.12.1 Fluorescent labelling of LIMs-LID constructs 
Although small amounts of several fluorescein-labelled Cys-LIMs-LID proteins were 
generated for use in binding studies, two key limitations of EPL labelling were noted: the long 
reaction times needed for Cys-LIMs-LID labelling compared to shorter peptide constructs; and, 
difficulties in removing the contaminating low molecular weight fluorescent species. In 
particular Cys-DEAF1-peptide labelling was much faster than Cys-LMO4LIMs-Ldb1LID labelling, 
suggesting that the labelling reagents and experimental conditions were fundamentally sound, 
but something about the Cys-LMO4LIMs-Ldb1LID construct affects the reaction efficiency. Burial 
of the N-terminal Cys, or interactions with hydrophobic residues of the LMO4LIMs-Ldb1LID 
complex might account for the observed lower reaction rates. Denaturants such as guanidium-
HCL (Gdn-HCL) or urea can often be used to prevent this type of problem and increase labelling 
efficiency [317]. Unfortunately, LIMs-LID constructs are not amenable to refolding, so such 
conditions could not be used.  
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Alternatively, zinc-coordination in the LIM domains could have contributed to poor 
labelling efficiency and slow reaction rates for Cys-LMO4LIMs-Ldb1LID. Although only the N-
terminal cysteine contains an α-amino group that reacts irreversibly with the thioester, trans-
thioesterification of exposed internal cysteine residues is a reversible side-reaction in NCL 
(Figure 6.2) and the cause of side-products [303, 308, 318]. The zinc-coordinating cysteine 
residues in LMO4 might become involved in this type of side-reaction, especially if any of the 
reducing agents used was able to displace cysteine side chains as zinc-coordinating groups. 
Displacing the zinc could also lead to protein unfolding and aggregation [319], which would 
likely reduce accessibility of the target and further reduce labelling efficiency. At least one ZnF 
protein has previously been semi-synthesised by EPL, but that protein was labelled under 
denaturing conditions and refolded [320]. As noted above, the same approach is not feasible for 
Cys-LMO4LIMs-Ldb1LID. 
Although MESNA thioesters, as used here, have been shown to rapidly label some targets 
[303] [304], other studies suggest that they can be slow, at least for some other targets, and that it 
may be possible to enhance labelling efficiency through the use of more reactive thioesters [321]. 
However, data from this chapter showed that although MPAA enhanced the reaction rate and 
improved labelling of LIMs-LID over MESNA, it resulted in higher levels of non-covalently 
bound dye. A compromise that might assist labelling efficiency but minimise problems with 
purification could be modulation of activity by lowering the temperature [309]. Similar types of 
contamination have been observed in the initial products from other labelling studies [322], but 
no purification problems were reported, so at this stage it is difficult to know how they could be 
avoided, or easily purified away from LIMs-LID constructs. 
Alternatively, other labelling techniques that require milder conditions, without the need 
for potentially denaturising chemicals, could be performed. For example, some enzymatic 
labelling techniques such as sortase-mediated labelling (Table 6.2) could allow for highly 
specific labelling under physiologic conditions. 
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6.12.2 Possible improvements in FA assays  
The preliminary FA assays that were carried out in this chapter suggest some potential 
improvements, if fluorescently labelled protein could be reliably generated. In order to prevent 
nonspecific binding of LIM-constructs to surfaces, PEG-coating of quartz cuvette walls could be 
a more effective alternative to BSA buffer additive [314]. A relatively small change in mass of 
the fluorescent species (21 kDa to 69 kDa, Figure 6.15) likely affected the reproducibility and 
reliability of the data. For this reason, future FA assays should be carried out using fluorescent 
N-terminally-labelled LID-LIMs complexes (i.e., with a cleavable tether between the C-terminus 
of Ldb1LID and the N-terminus of LMO4LIMs), using non-fluorescent MBP-tagged LID peptides 
as the competitors. The displacement of Fl-LID (5 kDa to 69 kDa change in mass of fluorescent 
species) would likely result in a larger drop in anisotropy (a wider dynamic range of the assay), 
giving improved signal-to-noise data. This type of experiment is also closer in design to classical 
'cold saturation' experiments, where the LID peptides take the place of labelled and cold ligands 
and the LIMs mimic unlabelled receptors. Data from this type of experiment may be fitted more 
easily with established binding equations [323]. However, rather than pursuing this approach, for 
this thesis it was decided to use an alternative approach to generating fluorescently tagged 
complexes, which is described in the following chapter. 
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Chapter 7    Competition assays with GFP-LIMs-LID constructs 
 
As an alternative to fluorescence anisotropy assays, it was decided to use native gel-shift 
assays to investigate LIM-LID binding and determine if this approach could be used to measure 
binding affinities using homologous competition experiments. Given that the site-specific 
labelling approach described in the previous approach was problematic, GFP-labelled proteins 
were generated. The first part of this chapter describes the production and characterisation of 
these proteins, and the second part of the chapter focuses on testing these proteins in blue native 
PAGE (BN-PAGE) and colourless native PAGE (CN-PAGE) gel shift assays. 
7.1 Protein Preparation 
GFPuv-tagged LMO4LIMs:Ldb1LID complex was used in blue native PAGE assays only. 
GFPsol-labelled complexes were used in colourless native PAGE (CN-PAGE) gel shift assays, 
with GFPsol-LMO4LIMs:Ldb1LID being used in FA assays. MBP-tagged Ldb1LID constructs were 
generated for use in all experiments and MBP-only was used as a control in gel shift assays.  
7.1.1 GFP-LIMs:LID complexes 
GFPuv was created from the split-GFPuv sequence used in experiments described in 
Chapter 5. The inserted linker was removed by PCR method to create pET15bBE-GFPuv, 
pHisGB1.3C-GFPuv, and pGEX6P-GFPuv vectors (see Appendix B for sequences). Into each of 
these vectors LMO4LIMs-Ldb1LID was subcloned to allow the expression of this protein with an 
N-terminal affinity tag (6×His, 6×His-GB1 from the pET15bBE-GFPuv and pHisGB1.3C-
GFPuv vectors, respectively, or GST from the pGEX6P-GFPuv vector) and a GFP moiety as 
indicated. The affinity tags could each be removed by treatment with thrombin (pet15bBE-
GFPuv) or HRV3C protease (all other vectors). Small scale overexpression and purification 
studies were carried out to determine which affinity tags resulted in the best overall yield and 
final purity. The GST-tagged protein showed the lowest level of contamination or degradation 
products in purification (Figure 7.1A). Thus, GST-GFPuv-LMO4LIMs-Ldb1LID was produced on a 
larger scale. The protein was purified by GSH-affinity chromatography, followed by on-bead  
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Figure 7.1. SDS-PAGE analysis of the affinity purification of GFP-LIMs-LID fusion proteins. (A) Small scale 
purification trials of GFPuv-LMO4LIMs-Ldb1LID constructs with different affinity tags. An overlay of Coomassie-
stained gel (pink) and its fluorescence scan (black). The names of corresponding vectors from which tagged 
constructs were expressed are shown. Note that proteins containing GFP proteins often show a double banding effect 
due to incomplete denaturation of GFP. The lower bands (black+pink) contain natively folded GFPuv (labelled N) 
while the upper bands (pink) contain the non-fluorescent denatured GFPuv (labelled D). BW - tagged-fusion 
construct bound to beads; BP - bound tagged-fusion construct cleaved with HRV3C protease to release the GFPuv-
LMO4LIMs-Ldb1LID from the beads; FTP - flow-through fraction with released soluble GFPuv-LMO4LIMs-Ldb1LID; 
White star - 6×His-GFPuv-LMO4LIMs-Ldb1LID; Red rectangle - purification of the GST-tagged fusion construct. (B) 
GFPsol-LMO4LIMs-Ldb1LID after affinity purification. A fluorescence scan detected GFPsol-only degradation 
product. (C) Purification of GFPsol-Isl1LIMs-Ldb1LID. (D) Purification of GFPsol-Lhx3LIMs-Ldb1LID.  
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HRV3C protease cleavage to remove the GST-tag, and elution of the GFPuv-fusion protein from 
the GSH-beads (Figure 7.1A). 
GFPsol was created from GFPuv by mutagenesis (section 2.4.1.2) and subcloned into the 
pGEX6P vector to make pGEX6P-GFPsol for expression of GST-GFPuv-LIMs-LID complexes 
and generation of GFPsol-LIMs-LID constructs, as described above for the GFPuv versions. 
Three different GFPsol-LIMs-LID constructs were created: GFPsol-LMO4LIMs-Ldb1LID, GFPsol-
Lhx3LIMs-Ldb1LID and GFPsol-Isl1LIMs-Ldb1LID (Figure 7.1B,C and D). Each of these constructs 
contained a Factor-Xa site in the linker between the LIM and LID domains for use in 
competition binding experiments. 
A common feature of the SDS-PAGE gels featuring GFP proteins is a double banding 
effect. This arises from incomplete denaturation of GFP under standard protocols (heating 
samples in SDS-containing sample loading buffer to 80 ˚C prior to sample loading). Although 
this protocol is sufficient to denature most proteins, the GFP-fold is very resistant to denaturation 
[324]. For example, when the gel in Figure 7.1A was scanned for fluorescence, it could be seen 
that the lower bands contained natively fluorescent GFP.  
Additional purification was carried out as required, and in all cases involved a SEC step 
to remove large aggregates and smaller degradation products (Figure 7.2A). In cases where there 
was significant contamination by GST or some degradation products close in size to the full 
constructs, as was the case for GFPsol-Lhx3LIMs-Ldb1LID (Figure 7.1D), an additional anion-
exchange chromatography step was carried out (Figure 7.2B). 
Purified GFPsol-Lhx3LIMs-Ldb1LID was subjected to MALLS analysis to confirm that it is 
monomeric and not aggregated in solution (Figure 7.3). The experimental weight average 
molecular weight was 47.5 kDa compared to a theoretic molecular weight of 48 kDa, indicating 
monomeric protein. Purified and concentrated GFPsol-LIMs-LID fusion proteins (Figure 7.4A) 
were diluted to 1 µM and cleaved by Factor Xa for 6 h at room temperature, or at 4 °C for 48 h 
to create the corresponding GFPsol-LIMs:LID complexes (note the use of a colon to indicate the 
cut complex versus a hyphen to indicated the uncut tethered complex). As longer incubation 
times showed some evidence of degradation and aggregation (Figure 7.4B), subsequent reactions 
were performed at room temperature for 6 h to generate the proteins used in fluoresecent gel shift 
assays. 
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Figure 7.2. Further purification of GFP-labelled fusion proteins. (A) SEC of GFPsol-Isl1LIMs-Ldb1LID using a 
Sephadex75 column in 20 mM Tris pH8 buffer, 150 mM NaCl and 1 mM DTT. Fractions containing non-
aggregated proteins were collected (yellow rectangle). (B) Anion-exchange chromatography purification of GFPsol-
Isl1LIMs-Ldb1LID was carried out using a UnoQ6 column in 20 mM Tris pH 8 buffer with 0–1 M NaCl gradient and 1 
mM DTT. The yellow rectangle indicates fractions containing pure protein. Blue traces in both chromatograms (A 
and B) show absorbance at 280 nm, grey traces show the % of buffer B and red traces show conductivity. 
 
Chapter 7 156 
 
 
 
 
Figure 7.3. SEC-MALLS chromatogram showing analysis of an uncleaved GFPsol-LMO4LIMs-Ldb1LID 
sample. Monomeric BSA protein was run for comparison and spectra overlayed. Yellow zone marks fractions of the 
aggregate-free protein that were collected. 
 
 
Figure 7.4. Concentrated GFPsol-fusion proteins and Factor Xa digestion of the linker. SDS-PAGE showing 
(A) Concentrated purified GFPsol-fusion proteins. (B) Factor Xa digestion of GFPsol-LMO4LIMs-Ldb1LID for 6 h at 
room temperature or 2 days at 4 °C. Note that the (~5 kDa) LID peptide is typically not visible in gels due to its 
small size and poor staining properties.  
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7.2 Fluorescent protein gel shift assays 
The binding of a labelled protein to an unlabelled partner protein can be detected through 
native (non-denaturing) PAGE, which separates bound (shifted) and unbound components. The 
labelled protein is held at a constant concentration while the second component is added at 
increasing concentrations. Binding affinities can be estimated by quantifying the band shifts at 
each concentration of the second component [325, 326].  
The migration of the free and bound complexes in classic native PAGE depends on the 
charge and shape of the species involved, and only proteins and complexes with pI < pHbuffer 
migrate towards the anode [327]. In contrast, Blue Native PAGE (BN-PAGE) uses Coomassie 
G-250 dye in the cathode and sample loading buffers, the dye to coat (but not denature) most 
proteins in a sample by binding non-specifically to exposed hydrophobic surfaces. This gives the 
proteins a net negative charge while maintaining their native conformation, allowing 
visualization of protein species and their separation according to differences in size and shape at 
near neutral pH (e.g., Figure 7.5) [328, 329].  
 
Figure 7.5. Homologous competition between different sized LID-constructs for GFP-labelled LIMs and the 
detection of the resulting complex. An equilibrium between the two complexes at a specific MBP-LID 
concentration. Colons represent protein-protein interactions in the complex. The size of the fluorescent-LIMs : LID 
complex dominant at low (left) or high MBP-LID concentrations (right).  
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Colourless PAGE (CN-PAGE) does not use the blue Coomassie dye throughout 
electrophoresis. Although it gives lower resolution than BN-PAGE or SDS-PAGE it omits 
additives that might interfere with protein binding and detection, and allows characterisation of 
complex formation under mildest possible conditions. BN-PAGE and CN-PAGE gel shifts were 
assessed to see if either was suitable for estimating LIMs-LID interaction affinities in 
competition style experiments. 
7.2.1 BN-PAGE gel shift with the GFPuv-LMO4LIMs:Ldb1LID 
Preliminary gel shift experiments using BN-PAGE were carried out using GFPuv-
LMO4LIMs:Ldb1LID and titrating in MBP-Ldb1LID as part of a competition assay. The addition of 
1 μM MBP-Ldb1LID to 100 nM GFPuv-LMO4LIMs:Ldb1LID resulted in a new GFPuv-
LMO4LIMs:MBP-Ldb1LID complex that appeared as a band well separated from GFPuv-
LMO4LIMs:Ldb1LID. However, even though the BN-PAGE gels showed excellent resolution, they 
did not provide the necessary sensitivity to detect shifts at lower concentrations (≤ 50 nM 
GFPuv-LMO4LIMs with ≤ 50 nM MBP-Ldb1LID) (Figure 7.6).  
 
Figure 7.6. Sensitivity of the BN-PAGE shift competition assays with the GFPuv-labelled complexes. 
Competition binding of GFPuv-LMO4LIMs with MBP-Ldb1LID was investigated on 3-12% polyacrylamide gels using 
BN-PAGE. The photographs show fluorescence scanned and Coomassie stained BN-PAGE gels. Two separate gels 
are shown: with 100 nM GFPuv-LMO4LIMs:Ldb1LID (left) and with 50 nM GFPuv-LMO4LIMs:Ldb1LID (right). 
Shifted bands are indicated; non-shifted bands are near the buffer front at the bottom of each panel.  
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Since the expected Kd for the LMO4LIMs vs. Ldb1LID interaction was around 10 nM, a 
titration would have to cover at least an order of magnitude above and below this concentration 
of MBP-Ldb1LID. Also, to minimize ligand depletion (section 6.10.2), labelled LMO4LIMs should 
be ≤ 10 nM. As this did not appear to be feasible for BN-PAGE with GFPuv-tagged attempts 
were made to use CN-PAGE.  
7.2.2 CN-PAGE gel shifts with the GFPsol-labelled complexes 
GFPS65T and related FP versions give more intense fluorescent signals so GFPuv-
LMO4LIMs:Ldb1LID was replaced with a GFPsol version for CN-PAGE gel-shift experiments. In 
the absence of MBP-Ldb1LID, GFPsol-LMO4LIMS:Ldb1LID appeared as multiple fluorescent 
bands that were not detected by Coomassie staining (Figure 7.7). These bands might correspond 
to GFPsol-LMO4LIMs:Ldb1LID, GFPsol-LMO4LIMs, GFPsol-LMO4LIMs-Ldb1LID and
 
GFPsol-only 
degradation product that was noted during early stages of purification (Figure 7.1). In samples 
containing MBP-Ldb1LID a single, well-resolved, shifted band was observed (Figure 7.7). In 
these initial experiments, glycerol (5%) was used to help sample loading. As glycerol could 
potentially affect protein interactions [330], it was replaced with 5% Ficoll in subsequent 
experiments. 
For initial experiments the samples were incubated for 15 min at room temperature prior 
to loading on the gel. These shifted bands had relatively low intensities compared to total 
fluorescence even at the highest concentrations of MBP-Ldb1LID. To assess the optimal time of 
incubation, samples containing 20 nM GFPsol-LMO4LIMs:Ldb1LID complex and 100 nM MBP-
Ldb1LID were incubated at times ranging from 0–60 min before electrophoresis (Figure 7.7A). 
Fluorescent bands were quantified and the fraction in complex was plotted against incubation 
time (Figure 7.7B). These data indicated that under the conditions used the exchange between 
Ldb1LID and MBP-Ldb1LID competition reaches equilibrium plateau by ~60 minutes (t1/2 ~30 
min). The fraction of shifted fluorescence increased from about 30% at 15 min to about 45% at 
60 min.  
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Figure 7.7. Optimization of fluorescent protein-based gel shift assays for competition binding analysis of 
MBP-Ldb1LID with GFPsol-LMO4LIMs:Ldb1LID. (A) Time course experiment with GFPsol-LMO4LIMs:Ldb1LID (20 
nM) and MBP-Ldb1LID (100 nM) detected by fluorescence scanning of the gel. The position of the shifted bands 
corresponding to GFPsol-LIMs:MBP-LID are marked with red rectangles. Bands corresponding to unbound 
GFPsol- LMO4LIMs-Ldb1LID construct are marked with a black box. The buffer front is indicated with a black dot. 
(B) The boxed areas from the time course gel scan were analysed in ImageJ (see sample inset for red box frmo panel 
A). The fraction of the total fluorescence in each lane that makes a shifted band was plotted against time. (C) 
Fluorescence scan comparing the effects of MBP-Ldb1LID and the MBP-only samples. (D) Coomassie-stained gel 
from (C). 
 
A control experiment was carried out in which 3–25 µM MBP and 1.5–12.5 µM MBP-
Ldb1LID were each titrated into GFPsol-LMO4LIMs:Ldb1LID. MBP by itself does not cause a band 
shift, but the overall fluorescence signal appears to be higher in the presence of MBP and the 
signal noticeably increases for MBP concentrations above 3 µM. A similar effect was detected 
for MBP-Ldb1LID (Figure 7.7C–D). This effect may be because MBP blocks non-specific 
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adsorption of the LIM-domain construct to surfaces. The gel shifts gave best results when ≥ 10 
nM GFPsol-LMO4LIMs:Ldb1LID complex was used because this allowed detection of the shifted 
complex even at low nM concentrations of MBP-Ldb1LID. Although this concentration is much 
lower than that required for the BN-PAGE experiments, it may still be too high for this type of 
analysis to be meaningful, especially using the IC50 as an indicator of Kd. 
Nevertheless, several exploratory experiments were carried out in which MBP-Ldb1LID 
was titrated into GFPsol-LMO4LIMs:Ldb1LID (Figure 7.8A and D), and the relative intensity of 
the shifted bands was determined (Figure 7.8B and E). These normalised data were fitted by the 
SLogistic1 equation to obtain estimates of IC50 (Figure 7.8C and F). Note that the first 
experiment suggests that the main binding event occurred in the early stages of the titration 
(Figure 7A–C). The second experiment included more points at the lower end of the 
concentration range. The same procedure was performed using additional titrations of MBP-
Ldb1LID into GFPsol-Lhx3LIMs:Ldb1LID and GFPsol-Isl1LIMs:Ldb1LID (Figure 7.9). 
The data were also fitted by the ligand depletion model to obtain estimates of Kd 
(Appendix F). Whereas the IC50 values for LMO4:Ldb1 interactions were similar (~10 nM), the 
data from the ligand depletion model differ more substantially and are associated with high 
errors (particularly for the second data set), Kd = 7 ± 2 and 0.48 ± 0.47 nM, respectively (Figure 
7.10A). Values of Kd were estimated based single experiments for Lhx3LIMs vs. Ldb1LID (Kd = 30 
± 6 nM; Figure 7.10B) and for Isl1LIMs vs. Ldb1LID (Kd = 81 ± 16 nM; Figure 7.10C). If these 
estimates are correct, then it is possible that the method is appropriate for a subset of interactions 
of this class. Unfortunately it was not possible to collect additional data for these constructs due 
to time constraints.  
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Figure 7.8. Gel shift assays with GFPsol-LMO4LIMs:Ldb1LID vs. MBP-Ldb1LID. (A and D) native gel scans show 
the shifted complexes (in red rectangles), characteristic additional bands (black stars) and the buffer front in (D) 
marked with black dot. (B and E) show ImageJ plots of band intensities. (C and F) Sigmoid logarithmic curves fitted 
to experimental data in Origin9.1 and the IC50 values obtained. The lowest MBP-Ldb1LID concentration was set to 
appropriately low values of 2 nM (C) and 0.1 nM (F), because log[0] is not mathematically defined. 
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Figure 7.9. GFP gel shift assays with LIM-domains from LIM-HD proteins. (A–C) GFPsol-Isl1LIMs:Ldb1LID vs. 
MBP-Ldb1LID. (D–F) GFPsol-Lhx3LIMs:Ldb1LID vs. MBP-Ldb1LID. (A and D) Native gel scans show the shifted 
complexes (in red rectangles). Bands corresponding to non-shifted GFP-fusion constructs are marked with black 
stars. The buffer front in (A) is marked with a black dot. (B and E) ImageJ plots of shifted band intensities. (C and 
F) Sigmoid logarithmic curves fitted to experimental data in Origin9.1 and the IC50 values obtained. In (F), the 
lowest MBP-Ldb1LID concentration was set to appropriately low value of 0.5 nM because log[0] is not 
mathematically defined. 
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Figure 7.10. GFP gel shift assays data fitted with the derived function for homologous competitive binding 
with ligand depletion. Calculated Kd values are shown. (A) Competition assays with GFPsol-LMO4LIMs:Ldb1LID, 
(B) GFPsol-Isl1LIMs:Ldb1LID and (C) GFPsol-Lhx3LIMs:Ldb1LID. In each case the standard error of the fit to a single 
data set is reported. 
 
7.3 Fluorescent anisotropy assays with GFP-tagged proteins 
In theory it should be possible to carry out FA experiments with GFP-LIM:LID 
complexes in the same manner as described in section 6.10 for Fl-LIM:LID complexes. 
Unfortunately, the intrinsic anisotropy of GFP-fusion proteins is already close to the theoretically 
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maximal anisotropy value of 0.4 [331, 332], meaning that change in anisotropy on binding is 
limiting (e.g., [333, 334]). Attempts to carry out such experiments confirmed high starting 
anisotropies for GFPsol-LMO4LIMs:Ldb1LID (r = 0.33–0.34) and YPet-LMO4LIMs:Ldb1LID (r = 
0.32). The r-values did not change with titration of the MBP-Ldb1LID competitor into the cut 
complexes (not shown), indicating that the approach was impractical.  
7.4 Discussion 
The experiments in this chapter show that LIMs-LID fusion constructs can be generated 
with an N-terminal GFP-based tag, and that these proteins can be used to generate binding curves 
for fluorescence gel-shift-based homologous competition experiments. Similar experiments 
could not be found in the literature suggesting that these are the first such experiments to be 
reported. However, there are some limitations to these assays that would need to be overcome 
before they could be used to assess LIM:LID interactions for the LMO and LIM-HD families. 
7.4.1 Limitations of fluorescence gel shift assays.  
One of the main limitations of this gel shift assay is that the concentrations of GFP-
labelled proteins required for detection are potentially too high for the accurate determination of 
Kd (see later for a more detailed explanation). In most previous reports of fluoresence gel shift 
experiments for protein:protein interactions concentrations were ≥ 0.5 µM for GFP-labelled 
proteins [325, 326, 333-341]. In this study it was possible to drop the concentration to ~10 nM 
using CN-PAGE and GFPsol-labelled proteins. By using brighter FP variants, this detection limit 
could potentially be lowered in future experiments. Apart from brightness of the GFP, the 
detection limit in native gels depends on their ability to focus protein bands during 
electrophoresis. It may be possible to do this using horizontal submarine polyacrylamide gels 
with larger wells. A modified version of BN-PAGE [342] using GFPsol-fusion constructs also 
hold some promise for improved resolution and sensitivity. Improved separation in clear native 
gel might be achieved with supercharged scGFP variants [343, 344].  
An important consideration is that this approach is that it is not a true equilibrium method 
- complexes with fast off rates can dissociate during electrophoresis [335]. While this problem 
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can be at least partly overcome by incubation at low temperatures (e.g., 4 °C) to reduce off-rates, 
it is probably not an issue for LIM-LID interactions. Indeed the reverse is probably the case. An 
approximate halflife of the initial LMO4LIMs:Ldb1LID complex was estimated to be about 30 
minutes, which represents a moderate-to-slow off-rate. In retrospect, the concentrations at which 
the half-life was measured were too high and could underestimate t1/2 of dissociation [345]. A 
recommendation of incubation time as 5 x t1/2 [345] suggests that reactions probably did not 
reach equilibrium within the 1 h incubation period. This discrepency could explain why the 
shifted band from the exploratory gel shift experiments did not reach 50% of total fluorescence. 
For all of the binding experiments in this and the previous chapter it would be reasonable to 
assume that with complete equilibration, the curves are likely to shift to the left, towards low nM 
Kd values or even lower. As different complexes could have different t1/2, each should be 
determined independently. 
Based on observations that MBP appeared to enhance overall fluorescence for GFP-
LMO4LIMS-Ldb1LID constructs (section 7.2.2), it may be generally useful to add BSA in the 
buffers for any binding assay using this class of proteins. 
7.4.2 A comparison of binding affinity studies 
Although the fluorescence based binding studies reported in this and the previous chapter 
are preliminary in nature, they were compared to existing data from our laboratory for this class 
of interaction [18, 167]. For consistency all of the original raw data from those papers were 
refitted using Origin9.1 using the same equation without fixing any parameters (Table 7.1). 
All of the estimates of IC50 are in general agreement. However, in analogy with standard 
cold homologous competition experiments, IC50 ≈ [starting complex] + Kd, meaning that if the 
concentration of the starting complex is high relative to the Kd, then the IC50 is not 
discriminatory. Aside from the possibility that data are compromised by insufficient equilibration 
times, ligand depletion will have occurred at low concentrations of titrant because of limits of 
fluorescence detection, making simple estimates of Kd from IC50 invalid [176]. Fitting the data 
for homologous competition assays with ligand depletion, should provide a better estimate of Kd, 
An alternative solution to the ligand depletion problem would be to carry out a series of titration 
experments at different concentrations of the labelled starting complex and carry out a global fit 
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by a single site competitive binding model. However, variability in the data obtained indicates 
that further optimisation of existing assays, including detection of more points in the initial 
stages of the titration to get more complete binding curves (as suggested in the previous section) 
are required. If this is not viable alternative methodological approaches will be required. 
 
Table 7.1. A comparison of IC50 values of LIM-LID interactions obtained by fitting previously reported and 
new data with binding curves through non-linear regression analysis. (*) The original raw data was 
standardized and fitted by a sigmoid logarithmic curve, yielding log10(IC50) and associated SE. IC50 values and CI 
95% were calculated as in Motulsky and Christopoulos, 2003 [176]. All experiments performed in this thesis used 
the same (10 nM) concentration of the labelled LIMs:LID complexes. This concentration was not determined for 
previously reported ELISA assays. 
.  
Binding to Ldb1LID 
IC50 
(nM) 
CI 95% (nM) 
Competitive 
binding assay 
Reported in 
LMO4LIMs 
8 3–26 ELISA [167]* 
19 7–51 
gel shift assay this study 
10 4–27 
24 16–37 
fluorescence 
anisotropy 
this study 
31 18–53 
LMO2LIMs 19 7–53 ELISA [167]* 
Lhx3LIMs 
38 9–171 ELISA [18]* 
44 16–124 gel shift assay this study 
Isl1LIMs 
192 43–856 ELISA [18]* 
89 30–269 gel shift assay this study 
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Chapter 8    Final discussion  
8.1 The biological implications of LIM-HD interactions 
A large portion of this thesis was focussed on trying to map interactions between LIM-
HD proteins. Y2H mating arrays from chapter 3 of this thesis showed that robust LIM-mediated 
interactions between LIM-HD proteins exist only between Lhx3/4 and Isl1/2 proteins (Figure 
8.1). Weaker interactions were identified between Isl1LBD and the LIM domains of Lmx1a/b, and 
the Isl2LBD and Lmx1b. BiFC experiments from Chapter 5 didn't give additional information 
about interactions. 
 
Figure 8.1. Schematic of interactions between LIM-HD proteins. Proteins are depicted as differently coloured 
lines, arranged in a circle. Tandem LIM domains are shown as small coloured circles. Interactions between proteins 
are represented by connecting lines. Black and grey lines represent interactions mediated by Isl1 and Isl2, 
respectively. Line width indicates apparent strength of an interaction detected by Y2H assays.  
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8.2 Additional evidence for Lmx1a/b vs. Isl1/2 protein interactions  
Interactions between Isl1/2 proteins and Lhx3/4 proteins have been highly characterised 
and are established as important in various developmental processes (section 1.8). According to 
the Mouse Gene Expression Database Lmx1a/b and Isl1/2 proteins are co-expressed in various 
tissues during development (Table 8.1) [86, 191], and in the adult mouse gut [346], but it is 
unclear if they are co-expressed in the same cells. 
 
Table 8.1 Co-expression of Lmx1a/b and Isl1/2 proteins in different stages of mouse development. Structures 
in which co-expression was detected are shown for embryonic stages E10.5–E15.5 and postnatal stages P(postnatal) 
and P1(postnatal day 1).  
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Lmx1a/b share a common ancestral gene with Lhx3/4 (Figure 1.3) and Lhx1/5. As 
Lhx3/4 and Lhx1/5 are more closely related than Lhx3/4 and Lmx1a/b, it is probably less 
surprising that Lmx1a/bLIMs exhibit some Isl1/2 binding activity than the fact that Lhx1/5LIMs do 
not. The interactions between Lmx1a/bLIMs and Isl1α/2LBD domains are apparently very weak 
compared to the interaction of Lmx1a/bLIMs with the widely expressed Ldb1LID, but it is not clear 
if Lmx1a/b can take part in ternary transcription factors complexes with Isl1/2. Additional 
experiments are required to confirm if interactions between Lmx1a/b and Isl1/2 are real and 
biologically relevant. It is possible that Lhx1/5 did not show interaction with Isl1/2 because some 
common core hydrophobic residues (positions 30, 90, 110 and 118 in Figure 1.10) are specific 
for Lhx1/5.  
8.3 Interactions involving Lhx8 
Lhx8 showed some evidence of a potentially weak interaction (some yeast growth but no 
colour development under routinely used selection conditions, except when extended incubation 
times resulted in the development of blue colour) with the LIM domains of all LIM-HD proteins 
(e.g., Fig 3.7). The AD-Lhx8 construct showed evidence of autoactivation under weak selection 
conditions (Figure 3.3), suggesting that most of the yeast growth probably stems from additive 
effects of autoactivation and sticky DBD-LIMs constructs. It is interesting to note that an 
interaction between Isl1α and Lhx8 in cholinergic cells was recently reported [347]. The authors 
of that paper used the results of GST-pulldown and co-IP experiments from cell lysates to 
suggest that Isl1α and Lhx8 form a complex similar to Isl1α and Lhx3 complex. The data 
presented in this thesis do not support those findings as DBD-Lhx8LIMs did not show any 
evidence of an interaction with any of full-length Isl1α, Isl2 or Isl1LBD (Figures 3.6 and 3.7). 
However, it is possible that the affinity of such an interaction lies below the limit of detection by 
Y2H, or that direct Lhx8:Isl1 interaction cannot be detected in yeast for various other reasons 
(see section 3.8.1). 
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8.4 Contribution of separate LIM domains to binding 
In Chapter 4 it was shown that both LIM domains of mouse LIM-HD proteins are 
required for high affinity binding to Ldb1LID, but that different subsets of LIM-HD proteins 
display higher levels of binding through their LIM1 or LIM2 domains. Note that the overall 
binding affinity is thought to result from negative cooperative binding of two LIM domains to 
Ldb1LID, as it is likely that KdLIMs > KdLIM1·KdLIM2 [167].   
A simple comparison of protein sequences between paralogous pairs of mouse LIM-HD 
proteins indicates that the dominant Ldb1-binding LIM domains are generally more conserved 
than the non-dominant domain, as defined by Y2H (Table 8.3). The exception here is for Lhx2/9 
where there are relatively few sequence differences. Note that Lhx1/5, for which no dominant 
domains were identified, have the same number of sequence differences between each domain. 
However, at this stage it is not known if any of these sequence differences are more relevant to 
Ldb1 binding.  
 
Table 8.3. The number of differences in the primary sequence of LIM1 or LIM2 domains between LIM-HD 
proteins in each paralogue pair in mice. Yellow fields mark domains which were shown to separately interact 
with Ldb1LID. 
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Some structure and sequence-based explanations have been previously put forward to 
rationalise the differences between LIM1 and LIM2 dominance in terms of Ldb1-binding [162]. 
However, to date only one LIM2-dominant LIMs-LID structure has been determined (compared 
with structures for several LIM1-dominant LIM-LID structures) and a full explanation of these 
differences is speculative until more information is available. 
Previous studies have shown that whereas Isl1LIM1 is the preferential Ldb1LID binder, 
Lhx3LIM2 preferentially binds both Ldb1LID and Isl1LBD [18]. In the same study strand exchange 
of Isl1LBD was observed for one molecule in the asymmetric unit of the crystal structure of 
Lhx3LIMs-Isl1LBD (i.e., Lhx3LIM2 binds the N-terminal half of Isl1LBD from one tethered complex 
but Lhx3LIM1 binds the C-terminal of Isl1LBD from a symmetry related molecule to form a 
symmetry related dimer: pdb code 2RGT, chain a). Given these properties and the modular 
nature of LIM-peptide binding, a putative mechanism for cofactor exchange for the switch from 
Lhx3:Ldb1 complexes to Lhx3:Isl1:Ldb1 was proposed. In this mechanism intermediate states 
would involve Ldb1LID binding simultaneously to the Isl1LIM1 and Lhx3LIM2 [18]. However, there 
is no biological evidence to support or refute this hypothetical mechanism.  
Previous Y2H experiments with C. elegans Lhx3/4 orthologue Ceh-14 showed that its 
LIM2 can independently bind the Isl1/2 orthologue Lim7, whereas LIM1 cannot [155]. This 
indicates that the mode of tandem LIM-domain binding could be conserved, at least for some 
proteins. 
The strong conservation of Ldb1LID in metazoans implies that every residue in this 
sequence contributes to complex formation, in terms of making productive protein-protein 
interactions while preventing non-specific interactions. The Ldb1LID domain is mostly disordered 
but the charged DEDER region in the sequence has some helical propensity which is evident in 
the unbound state (pdb code 2LXD) [161]. The LMO2:Ldb1 (pdb code 2XJY) and Lhx3:Ldb1 
complexes (pdb code 2JTN) show that this sequence can retain a degree of helicity in the bound 
state. This is not uncommon for proteins with internal intrinsic disorder where smaller elements 
of secondary structure (e.g., alpha helices) form prior to binding to function as molecular 
recognition elements [348, 349].  
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8.5 Considerations for binding assays 
The yeast two-hybrid data provide some measure of relative binding affinities for similar 
sets of constructs, but are affected by stability of constructs in yeast, background binding events, 
and possible steric effects as detailed in section 3.8. The original ELISA-based homologous 
competition binding experiments appear to have been compromised by invalid assumptions 
about available concentrations of proteins and other experimental considerations as noted in 
sections 1.11 and 7.4.2. Thus, there is still a need for methodologies that can assay binding 
between LIM-HD and LMO family proteins and their peptide binding partners. The 
fluorescence-based binding assays described in chapters 6 and 7 have not yet resulted in high 
confidence binding data, but have provided useful information for design of future experiments.  
Nonspecific adsorption of LIM domain constructs to surfaces in vitro leads to significant 
losses of LIM-domains at low concentrations. This effect can be minimized by including BSA in 
the buffer. Tubes, cuvettes or wells could alternatively be pre-coated with PEG or similar 
polymers, provided that LIM domains do not bind non-specifically to those polymers.  
Future experiments that aim to determine binding affinities of LIM domains by 
competition assays should first determine half-lives of cleaved tethered complexes at very low 
complex concentrations. The incubation times should be long (> 5·t1/2) in order for reactions to 
come sufficiently close to equilibrium as discussed in section 7.4.1. 
Due to the use of tethered complexes, ligand depletion can affect competition assays and, 
depending on the assay, specific equations may need to be derived to adequately fit the data.  
Finally, strong interactions require assays that are sensitive enough to detect very low 
concentrations of the label. Site-specific labelling of proteins with radioactive reagents could 
potentially provide such sensitivity. 
8.6 Concluding remarks 
In conclusion, this thesis has used a series of different experimental approaches to explore 
protein interactions between LIM-HD proteins and between LIM-HD proteins and their key 
binding partner Ldb1. Although many technical challenges were overcome during the course of 
the project, additional experiments will be required to fully characterise the networks of proteins 
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associated with this biologically important class of proteins. This body of work provides a good 
platform for such experiments. 
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Appendix A   LIM-HD proteins: names, isoforms and 
homozygous knockout mice phenotypes  
 
As the discovery of many genes predates the genome sequencing projects and the modern 
gene classification, different names were used for the same proteins in literature, which lead to 
confusion in many cases. In particular, the paralogue of Lhx6 was originally identified and 
named L3 (Matsumoto 1996), but was later renamed to Lhx8 (Kitanaka 1998). It was then 
'rediscovered' as Lhx7 (Grigoriou 1998) and before the controversy was resolved, a newly 
identified paralogue of Lhx2 was named Lhx9 (Retaux 1999, Failli 2000). Identification of 
several alternatively spliced mRNA/protein isoforms of Lhx6 and Lhx8 additionally complicated 
this issue. Since no additional LIM-HD genes were identified, Lhx8 is sometimes referred to as 
Lhx7/8 (Hobert 2000).  
Lhx and Lmx both stand for LIM-homeobox, but because of historical reasons, Lmx1 as 
well as Isl proteins retained their original names. LIM-HD proteins in Drosophila and Nematoda 
have alternative, historical names (Bach 2000). 
Most isoforms of LIM-HD proteins (Table A1) are results of alternatively spliced N-
terminal and/or C-terminal exons. Isl1β isoform is an exception because it is apparently a result 
of an alternative splice acceptor site located within the nearest downstream exon. Consequently, 
the beginning of exon 5 which contains the first half of Isl1LBD is not spliced in this isoform. 
Lhx2b is a validated RefSeq sequence but no data on detected protein is provided in either 
database. NM_027397.2 version of Isl2 was replaced on Jul 28, 2007 by the correct version 
NP_081673.2. 
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Table A.1. Protein-coding, CDS-complete protein isoforms of mouse LIM-HD proteins. Protein names from 
NCBI RefSeq, ENSEMBL and Uniprot databases are shown along with NCBI and EBI protein IDs and the numbers 
of amino acids in parallel. Double EBI IDs for some proteins indicate the same isoform translated from different 
transcripts. Red stars mark isoforms that are not in the NCBI Consensus CDS (CCDS) protein set. P in superscript 
indicates predicted isoforms (NCBI). Lhx3 isoforms from the Uniprot database have opposite names to the RefSeq 
entries (likely database error) and are marked in red. Lmx1b entry in Uniprot has a 23 a.a. extension of the N-
terminal exon due to erroneous translation initiation and is marked with E. Some isoforms have additional 
alternative names in the Uniprot database and they are shown in brackets. 
 
RefSeq 
protein 
NCBI Protein ID 
ENSEMBL 
protein 
EBI Protein ID 
UniProt 
protein 
Number of 
residues 
Lhx1 NP_032524.1 Lhx1-001 ENSMUSP00000018842  Lhx1 406 
Lhx2a NP_034840.1 Lhx2-001 ENSMUSP00000000253  Lhx2 406 
*Lhx2b NP_001277575.1 Lhx2-003 ENSMUSP00000114797  - 365 
Lhx3a NP_001034742.1 Lhx3-001 ENSMUSP00000028302  Lhx3b 402 
*Lhx3b NP_034841.2 Lhx3-002 ENSMUSP00000056822  Lhx3a 400 
Lhx4 NP_034842.2 Lhx4-001 ENSMUSP00000027740  Lhx4 390 
Lhx5 NP_032525.1 Lhx5-001 ENSMUSP00000031591  Lhx5 402 
Lhx6.1 NP_032526.2 Lhx6-003 ENSMUSP00000108584  - 392 
Lhx6.3 NP_001076595.1 
Lhx6-001 
or -201 
ENSMUSP00000108585 
ENSMUSP00000108587 
Lhx6.1a 363 
Lhx6.2 NP_001076594.1 Lhx6-007 ENSMUSP00000108591  - 377 
Lhx6.4 NP_001076596.1 Lhx6-002 ENSMUSP00000108590  Lhx6.1b 348 
Lhx8 NP_034843.2 Lhx8-001 ENSMUSP00000136047  Lhx8 367 
*Lhx8 X1
P
 
or X2
P
 
XP_006501134.1 
XP_006501135.1 
Lhx8-003 ENSMUSP00000134853  - 346 
Lhx9a NP_001020736.1 Lhx9-002 ENSMUSP00000019374  Lhx9.4 330 
Lhx9b NP_034844.1 
Lhx9-004 
or -201 
ENSMUSP00000107661 
ENSMUSP00000091198 
Lhx9.2 
(Lhx9α) 
321 
Lhx9c NP_001036042.1 Lhx9-005 ENSMUSP00000107657  Lhx9.3 397 
*Lhx9 X2
P
 XP_006529234.1 Lhx9-001 ENSMUSP00000036480  
Lhx9.1 
(Lhx9β) 
388 
Lmx1a NP_387501.1 
Lmx1a-001 
or -002 
ENSMUSP00000028003 
ENSMUSP00000107008 
Lmx1a 382 
Lmx1b NP_034855.2 Lmx1b-001 ENSMUSP00000043616  
E
Lmx1b 372 
ISL-1 NP_067434.3 Isl1-001 ENSMUSP00000044879  Isl1α 349 
*ISL-1 X1
P
 XP_006517596.1 Isl1-002 ENSMUSP00000135567  Isl1β 326 
ISL-2 NP_081673.2 Isl2-001 ENSMUSP00000034869  Isl2 359 
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Table A.2. Phenotypes of mice with homozygous knockout mutations of LIM-HD proteins. Each 
column shows closely related paralogue genes. 
lhx3 Perinatal lethal (within 24 hours of 
birth); failure of growth and 
differentiation of Rathke's pouch, lack of 
both anterior and intermediate lobes of 
the pituitary gland. 
lhx4 Neonatal lethal; abnormal lung 
development, pituitary and decreased 
hormone levels. 
lhx1 Embryonic lethal; embryos are small, 
fail to develop head structures anterior to 
rhombomere 3 in the hindbrain, lack 
kidneys and gonads, and show aberrant 
trajectories of limb motor axons; most 
die around embryonic day 10. 
lhx5 Neonatal lethal; defective hippocampal 
development. Postmitotic hippocampal cells 
are unable to differentiate properly and 
migrate to correct positions, resulting in 
structural anomalies of the Ammon's horn 
and the dentate gyrus. 
lmx1a Prenatal to preweaning lethality; fewer 
dopaminergic neurons, neurological and 
skeletal abnormalities, inner ear defects, 
deafness  
lmx1b Neonatal lethal; exhibit various skeletal, 
kidney, and eye defects. Pups also fail to 
suckle.  
lhx2 Embryonic to perinatal lethal; 
abnormal liver, telencephalon, olfactory 
bulb, basal ganglion, and eye 
morphology 
lhx9 Not lethal; failed proliferation of the 
somatic cells of the genital ridge resulting in 
lack of discrete gonad formation, infertility 
in both sexes, and female-like genitalia in 
genetically male mice 
lhx6 Postnatal or preweaning lethal; results 
in impaired migration as well as 
specification of cortical interneurons, 
general weakness 
 
lhx8 Neonatal lethal with incomplete 
penetrance; cleft secondary palate. Those 
without cleft palate survive to adulthood. 
Both have decreased or absent forebrain 
cholinergic neurons. 
isl1 Embryonic lethal; mice fail to develop 
motor neurons and die by embryonic day 
11.5 with abnormal heart and pancreas 
development.  
isl2 Neonatal lethal; motor neuron migration 
defects and impaired visceral motor neuron 
differentiation. 
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Appendix B   Design of bacterial overexpression plasmids 
 
 
pIH1119 (source plasmid) 
 
tcgagctcgaacaacaacaacaataacaataacaacaacctcggg 
 S  S  S  N  N  N  N  N  N  N  N  N  N  L  G 
 
atcgagggaaggatttcagaatttggatccgaattagaattc 
 I  E  G  R  I  S  E  F  G  S  E  L  E  F  
 
Factor Xa cleavage site 
 
 
Derivatives: 
 
 pIH1121 codes for a HRV3C-cleavable fusion linker. 
 
 
      ctcgggccatgggggctcgaagtactctttcaaggacccggatcc 
       L  G  P  W  G  L  E  V  L  F  Q  G  P  G  S  
 
    HRV3C Pro cleavage site 
 
 
 pIH1122nc codes for a non-cleavable short GS linker. 
 
 
      actaattcgagctcgggtggcggcggatccgaattagaattc 
       T  N  S  S  S  G  G  G  G  S  E  L  E  F 
 
 
 
pGEX-2TKE (source plasmid) 
 
ggtggtggcgaccatcctccaaaatcggatctggttccgcgtggatccccgggaattcat 
 G  G  G  D  H  P  P  K  S  D  L  V  P  R  G  S  P  G  I  H 
 
             Thrombin cleavage site 
 
Derivative: 
 
 pGEX-TEVC 
 
  catcctccaaaatcggatgaaaacctgtattttcagtgcggatccccgggaattcat 
    H  P  P  K  S  D  E  N  L  Y  F  Q  C  G  S  P  G  I  H 
 
        TEV cleavage site 
Appendix B 196 
 
 
 
 
pSNAP-tag®(T7) (source plasmid) 
         
gagatatacatatggacaaagattgcgaa... 
            M  D  K  D  C  E  
   SNAP-tag 
 
Derivative: 
 
 pT7-HSNAP codes for a TEV-cleavable His-tag, N-terminal to SNAP-tag 
 
   ...catatgcatcaccatcaccatcacgaaaacctgtattttcagggcatggacaaagattgcgaa 
       H  M  H  H  H  H  H  H  E  N  L  Y  F  Q  G  M  D  K  D  C  E  
  His-tag          SNAP-tag 
               TEV cleavage site 
                                                                    
 
pET15b (source vector) 
 
AACTTTAAGAAGGAGATATACCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCA
GCCATATGCTCGAGGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAA
CTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGATATCC
CGCAAGAGGCCCGGCAGTACCGGCATAACCAAGCCTATGCCTACAGCATCCAGGGTGACGGTGCCGAGGATGACGAT
GAGCGCATTGTTAGATTTCATACACGGTGCCTGACTGCGTTAGCAATTTAACTGTGATAAACTACCGCATTAAAGCT
TATCGATGATAAGCTGTCAAACATGAGAATTCTTGAAGACGAAAGGGCCTCGTGATACGCCTATTTTTATAGGTTAA
TGTCATGATAATAATGGTTTCTTAGACGTCAGGTGGCACTTTTCGGGGAAATGT... 
 
Derivatives: 
 
 pET1bBE  has a BamHI-EcoRI cloning site and lacks the downstream EcoRI site 
 
AACTTTAAGAAGGAGATATACCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGC
GCGGCAGCCATATGGGATCCGCGAATTCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCC
ACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGG
AGGAACTATATCCGGATATCCCGCAAGAGGCCCGGCAGTACCGGCATAACCAAGCCTATGCCTACAGCATC
CAGGGTGACGGTGCCGAGGATGACGATGAGCGCATTGTTAGATTTCATACACGGTGCCTGACTGCGTTAGC
AATTTAACTGTGATAAACTACCGCATTAAAGCTTATCGATGATAAGCTGTCAAACAGACGTCAGGTGGCAC
... 
 
 pET1bBE-GFPsol has a BglII-GFPsol-BamHI-2×STOP-EcoRI sequence inserted between BamHI and 
EcoRI sites. 
...CATATGGGATCTGCATCTAAGGGCGAAGAACTGTTTACGGGTGTTGTTCCAATCCTGGTAGAGCTGGA
CGGCGACGTTAACGGTCACAAGTTCTCCGTTTCCGGCGAAGGTGAAGGCGACGCAACCTACGGCAAACTGA
CCCTGAAGTTCATCTGCACTACTGGCAAACTGCCGGTACCTTGGCCGACTCTGGTAACCACTCTGACGTAC
GGTGTTCAGTGCTTCGCACGCTATCCGGATCACATGAAACAACATGATTTCTTCAAATCCGCTATGCCGGA
AGGTTATGTTCAGGAACGCACTATCAGCTTCAAAGATGACGGTAACTACAAAACCCGTGCGGAAGTGAAAT
TCGAAGGTGATACCCTGGTTAACCGTATCGAGCTGAAAGGTATTGACTTCAAAGAAGACGGTAACATCCTG
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GGCCACAAACTGGAGTACAACTATAATTCTCACAATGTGTACATTACTGCGGATAAACAAAAAAACGGCAT
TAAAGCGAACTTCAAAATCCGTCATAACATTGAGGATGGCGGTGTACAGCTGGCGGATCACTACCAGCAGA
ATACGCCGATTGGCGATGGCCCTGTGCTGCTGCCGGATAACCACTACCTGTCCACCCAGTCTAAACTGTCC
AAAGACCCTAACGAAAAACGCGACCACATGGTGCTGCTGGAATTTGTTACTGCGGCGGGTATTACTCACGG
TATGGATGAGCTGTACAAGGGATCCTAATGAGAATTCGGCTGCTAA... 
 
 
pGEX-6P (source vector) 
 
caaaatcggatctggaagttctgttccaggggcccctgggatccccggaattc 
   K  S  D  L  E  V  L  F  Q  G  P  L  G  S  P  E  F 
 
    HRV3C Pro cleavage site 
 
Derivative: 
 
 pGEX-6P-GFPsol has a BglII-GFPsol-BamHI-2×STOP-EcoRI sequence inserted between BamHI and 
EcoRI sites. 
...GACCATCCTCCAAAATCGGATCTGGAAGTTCTGTTCCAGGGGCCCCTGGGATCTGCATCTAAGGGCGAA
GAACTGTTTACGGGTGTTGTTCCAATCCTGGTAGAGCTGGACGGCGACGTTAACGGTCACAAGTTCTCCGTT
TCCGGCGAAGGTGAAGGCGACGCAACCTACGGCAAACTGACCCTGAAGTTCATCTGCACTACTGGCAAACTG
CCGGTACCTTGGCCGACTCTGGTAACCACTTTCAGCTACGGTGTTCAGTGCTTCGCACGCTATCCGGATCAC
ATGAAACAACATGATTTCTTCAAATCCGCTATGCCGGAAGGTTATGTTCAGGAACGCACTATCAGCTTCAAA
GATGACGGTAACTACAAAACCCGTGCGGAAGTGAAATTCGAAGGTGATACCCTGGTTAACCGTATCGAGCTG
AAAGGTATTGACTTCAAAGAAGACGGTAACATCCTGGGCCACAAACTGGAGTACAACTATAATTCTCACAAT
GTGTACATTACTGCGGATAAACAAAAAAACGGCATTAAAGCGAACTTCAAAATCCGTCATAACATTGAGGAT
GGCGGTGTACAGCTGGCGGATCACTACCAGCAGAATACGCCGATTGGCGATGGCCCTGTGCTGCTGCCGGAT
AACCACTACCTGTCCACCCAGTCTAAACTGTCCAAAGACCCTAACGAAAAACGCGACCACATGGTGCTGCTG
GAATTTGTTACTGCGGCGGGTATTACTCACGGTATGGATGAGCTGTACAAGGGATCCTAATGAGAATTC... 
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Appendix C   Tethered LIMs-LID constructs with Factor Xa-
cleavable linkers 
C.1 Protein constructs expressed from pGEX-TEVC and  pGEX-6P-GFPsol 
plasmids 
LMO4LIMs-Ldb1LID 
LSWKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMILCRNDYIRLFGNSGACSACGQSI
PASELVMRAQGNVYHLKCFTCSTCRNRLVPGDRFHYINGSLFCEHDRPTALINGHLNSGGSIEGRGSGGDVMVVGEP
TLMGGEFGDEDERLITRLENTQFDAANGIDDE- 
Lhx3LIMs-Ldb1LID 
TPEIPMCAGCDQHILDRFILKALDRHWHSKCLKCSDCHVPLAERCFSRGESVYCKDDFFKRFGTKCAACQLGIPPTQ
VVRRAQDFVYHLHCFACVVCKRQLATGDEFYLMEDSRLVCKADYETAKQGGSIEGRGSGGDVMVVGEPTLMGGEFGD
EDERLITRLENTQFDAANGIDDE- 
Isl1LIMs-Ldb1LID 
KRLISLCVGCGNQIHDQYILRVSPDLEWHAACLKCAECNQYLDESCTCFVRDGKTYCKRDYIRLYGIKCAKCSIGFS
KNDFVMRARSKVYHIECFRCVACSRQLIPGDEFALREDGLFCRADHDVVERGGSIEGRGSGGDVMVVGEPTLMGGEF
GDEDERLITRLENTQFDAANGIDDE- 
C.2 Protein constructs expressed from pGEX-TEVC plasmids only 
Lhx1LIMs-Ldb1LID 
MVHCAGCKRPILDRFLLNVLDRAWHVKCVQCCECKCNLTEKCFSREGKLYCKNDFFRCFGTKCAGCAQGISPSDLVR
RARSKVFHLNCFTCMMCNKQLSTGEELYIIDENKFVCKEDYLSNSSGGSIEGRGSGGDVMVVGEPTLMGGEFGDEDE
RLITRLENTQFDAANGIDDE- 
 
Lhx2LIMs-Ldb1LID 
SDRAALCAGCGGKISDRYYLLAVDKQWHMRCLKCCECKLNLESELTCFSKDGSIYCKEDYYRRFSVQRCARCHLGIS
ASEMVMRARDLVYHLNCFTCTTCNKMLTTGDHFGMKDSLVYCRLHFEALLQGGSIEGRGSGGDVMVVGEPTLMGGEF
GDEDERLITRLENTQFDAANGIDDE- 
 
Lhx4LIMs-Ldb1LID 
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MQQIPQCAGCNQHILDKFILKVLDRHWHSSCLKCADCQMQLADRCFSRAGSVYCKEDFFKRFGTKCTACQQGIPPTQ
VVRKAQDFVYHLHCFACIICNRQLATGDEFYLMEDGRLVCKEDYETAKQGGSIEGRGSGGDVMVVGEPTLMGGEFGD
EDERLITRLENTQFDAANGIDDE- 
 
DNA sequences coding for similar constructs containing tandem LIM-domains of Lhx5, 
Lhx6, Lhx8, Lmx1a, Lmx1b and Isl2 were also cloned into pGEX-TVC vectors. LMO4LIMs-
Ldb1LID DNA construct was designed by Dr J. Matthews and other DNA constructs were made 
by Dr M. O'Connell. 
All GST-fusion constructs expressed from pGEX-TEVC plasmids contained a modified 
TEV site in the GST-insert linker. TEV cleavage of these fusion constructs produced tethered 
LIMs-LID fusion constructs with N-terminal CGS sequence. All GST-fusion constructs 
expressed from pGEX-6P-GFPsol plasmids were cleaved with HRV3C protease on the GSH-
resin and the released proteins had a GPLGS-GFPsol-GS-LIMs-LID. 
 
Table C.1. Molecular weights and extinction coefficients of purified constructs.  
Construct Molecular weight (Da) ε280 (M
-1
cm
-1
) 
His6-SNAP-LMO4LIMs-Ldb1LID 42148.9 42400 
Cys-LMO4LIMs-Ldb1LID 20474 19940 
GFPsol-LMO4LIMs-Ldb1LID 47463.3 41830 
Cys-Lhx3LIMs-Ldb1LID 20057.7 11460 
GFPsol-Lhx3LIMs-Ldb1LID 47047.1 33350 
Cys-Isl1LIMs-Ldb1LID 20347 14440 
GFPsol-Isl1LIMs-Ldb1LID 47336.4 36330 
Cys-Lhx1LIMs-Ldb1LID 19691.4 9970 
Cys-Lhx2LIMs-Ldb1LID 20312.1 15930 
Cys-Lhx4LIMs-Ldb1LID 20111.7 11460 
His6-TEV ~27000 see [183, 184] 
MBP-Ldb1LID(331–375) 48275.2 71850  
Cys-DEAF1404-438(T435D) 4436.2 ~0 
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Appendix D   BiFC-related DNA and protein constructs 
D.1 Split-GFP DNA constructs and BiFC plasmids 
Constructs that did not contain F64L and S65T mutations that provide enhanced UV 
properties were named as NGFP, CGFP and NGFP-CGFP (no uv suffix). Only NGFPsol and 
NGFPsol-CGFP construct names contained the sol suffix. 
 
Restriction sites: 
 
GGATCC - BamHI 
GAATTC - EcoRI 
CTGCAG - PstI 
AAGCTT - HindIII 
AGATCT – BglII 
 
CATATG - NdeI 
CCCGGG - SmaI 
CTCGAG - XhoI 
GCATGC  -  SphI 
TGA/TAA/TAG - STOP codons 
 
D.1.1 Removing Gal4 fragments from Y2H vectors 
NpGBT9 (Gal4DBD, yADH1 promoter) 
 
...TGTTTCTTTTTCTGCACAATATTTCAAGCTATACCAAGCATACAATCAACTCCAAGCTTGAAGCAAGCCTCCTG
AAAGATGAAGCTACTGTCTTCTATCGAACAAGCATGCGATATTTGCCGACTTAAAAAGCTCAAGTGCTCCAAAGAAA
AACCGAAGTGCGCCAAGTGTCTGAAGAACAACTGGGAGTGTCGCTACTCTCCCAAAACCAAAAGGTCTCCGCTGACT
AGGGCACATCTGACAGAAGTGGAATCAAGGCTAGAAAGACTGGAACAGCTATTTCTACTGATTTTTCCTCGAGAAGA
CCTTGACATGATTTTGAAAATGGATTCTTTACAGGATATAAAAGCATTGTTAACAGGATTATTTGTACAAGATAATG
TGAATAAAGATGCCGTCACAGATAGATTGGCTTCAGTGGAGACTGATATGCCTCTAACATTGAGACAGCATAGAATA
AGTGCGACATCATCATCGGAAGAGAGTAGTAACAAAGGTCAAAGACAGTTGACTGTATCGCCGGAATTTGGATCCCC
GGGAATTCTGCAGCCAAGCTAATTCCGGGCGAATTTCTTATGATTTATGATTTTTATTATTAA... 
 
 
pW410  
 
...TTCTTTTTCTGCACAATATTTCAAGCTATACCAAGCATACAATCAACTCCAAGCTTGCATATGGGATCCCGGGA
ATTCTGCAGCCAAGCTAATTCCGGGCGAATTTCTTATGATTTATGATTTTTATTATTAA ... 
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pGAD10 (Gal4DBD, yADH1 promoter) 
 
...TGTTTCTTTTTCTGCACAATATTTCAAGCTATACCAAGCATACAATCAACTCCAAGCTTTGCAAAGATGGATAA
AGCGGAATTAATTCCCGAGCCTCCAAAAAAGAAGAGAAAGGTCGAATTGGGTACCGCCGCCAATTTTAATCAAAGTG
GGAATATTGCTGATAGCTCATTGTCCTTCACTTTCACTAACAGTAGCAACGGTCCGAACCTCATAACAACTCAAACA
AATTCTCAAGCGCTTTCACAACCAATTGCCTCCTCTAACGTTCATGATAACTTCATGAATAATGAAATCACGGCTAG
TAAAATTGATGATGGTAATAATTCAAAACCACTGTCACCTGGTTGGACGGACCAAACTGCGTATAACGCGTTTGGAA
TCACTACAGGGATGTTTAATACCACTACAATGGATGATGTATATAACTATCTATTCGATGATGAAGATACCCCACCA
AACCCAAAAAAAGAGATCTCTCGAGGATCCGAATTCCAGATCTATGAATCGTAGATACTGAAAAACCCCGCAAGTTC
ACTTCAACTGTGCATCGTGCACCATCTCAATTTCTTTCATTTATACATCGTTTTGCCTTCTTTTATGTAACTATACT
CCTCTAAGTTTCAATCTTGGCCATGTAACCTCTGATCTATAGAATTTTTTAAATGACTAGAATTAATGCCCATCTTT
TTTTTGGACCTAAATTCTTCATGAAAATATATTACGAGGGCTTATTCAGAAGCTTTGGACTTCTTCGCCAGAGGTTT
GGTCAAGTCTCCAA... 
 
pL410 
 
...TTCTTTTTCTGCACAATATTTCAAGCTATACCAAGCATACAATCAACTCCAAGCTTGCATATGGGATCCGAATT
CCAGATCTATGAATCGTAGATACTGAAAAACCCCGCAAGTTCACTTCAACTGTGCATCGTGCACCATCTCAATTTCT
TTCATTTATACATCGTTTTGCCTTCTTTTATGTAACTATACTCCTCTAAGTTTCAATCTTGGCCATGTAACCTCTGA
TCTATAGAATTTTTTAAATGACTAGAATTAATGCCCATCTTTTTTTTGGACCTAAATTCTTCATGAAAATATATTAC
GAGGGCTTATTCAGAAGCTTTGGACTTCTTCGCCAGAGGTTTGG... 
 
D.1.2 Split-GFP DNA fragments 
NGFP-CGFP (This fragment was inserted in the pW410 plasmid) 
 
CATATGGCATCTAAGGGCGAAGAACTGTTTACGGGTGTTGTTCCAATCCTGGTAGAGCTGGACGGCGACGTTAACGG
TCACAAGTTCTCCGTTTCCGGCGAAGGTGAAGGCGACGCAACCTACGGCAAACTGACCCTGAAGTTCATCTGCACTA
CTGGCAAACTGCCGGTACCTTGGCCGACTCTGGTAACCACTTTCAGCTACGGTGTTCAGTGCTTCGCACGCTATCCG
GATCACATGAAACAACATGATTTCTTCAAATCCGCTATGCCGGAAGGTTATGTTCAGGAACGCACTATCAGCTTCAA
AGATGACGGTAACTACAAAACCCGTGCGGAAGTGAAATTCGAAGGTGATACCCTGGTTAACCGTATCGAGCTGAAAG
GTATTGACTTCAAAGAAGACGGTAACATCCTGGGCCACAAACTGGAGTACAACTATAATTCTCACAATGTGTACATT
ACTGCGGATAAACAAAAAGGTGGCGGCGGTTCTGGCGGTGGTGGATCCCTCGAGGAATTCGGTGGCGGTGGTTCCGG
TGGTGGCGGCAGCAACGGCATTAAAGCGAACTTCAAAATCCGTCATAACATTGAGGATGGCGGTGTACAGCTGGCGG
ATCACTACCAGCAGAATACGCCGATTGGCGATGGCCCTGTGCTGCTGCCGGATAACCACTACCTGTCCACCCAGTCT
AAACTGTCCAAAGACCCTAACGAAAAACGCGACCACATGGTGCTGCTGGAATTTGTTACTGCGGCGGGTATTACTCA
CGGTATGGATGAGCTGTACAAGTAATGACTGCAG 
 
NGFP-CGFP (This fragment was inserted in the pL410 plasmid) 
 
CATATGGCATCTAAGGGCGAAGAACTGTTTACGGGTGTTGTTCCAATCCTGGTAGAGCTGGACGGCGACGTTAACGG
TCACAAGTTCTCCGTTTCCGGCGAAGGTGAAGGCGACGCAACCTACGGCAAACTGACCCTGAAGTTCATCTGCACTA
CTGGCAAACTGCCGGTACCTTGGCCGACTCTGGTAACCACTTTCAGCTACGGTGTTCAGTGCTTCGCACGCTATCCG
GATCACATGAAACAACATGATTTCTTCAAATCCGCTATGCCGGAAGGTTATGTTCAGGAACGCACTATCAGCTTCAA
AGATGACGGTAACTACAAAACCCGTGCGGAAGTGAAATTCGAAGGTGATACCCTGGTTAACCGTATCGAGCTGAAAG
GTATTGACTTCAAAGAAGACGGTAACATCCTGGGCCACAAACTGGAGTACAACTATAATTCTCACAATGTGTACATT
ACTGCGGATAAACAAAAAGGTGGCGGCGGTTCTGGCGGTGGTGGATCCCTCGAGGAATTCGGTGGCGGTGGTTCCGG
TGGTGGCGGCAGCAACGGCATTAAAGCGAACTTCAAAATCCGTCATAACATTGAGGATGGCGGTGTACAGCTGGCGG
ATCACTACCAGCAGAATACGCCGATTGGCGATGGCCCTGTGCTGCTGCCGGATAACCACTACCTGTCCACCCAGTCT
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AAACTGTCCAAAGACCCTAACGAAAAACGCGACCACATGGTGCTGCTGGAATTTGTTACTGCGGCGGGTATTACTCA
CGGTATGGATGAGCTGTACAAGTAATGAAGATCT 
 
NGFPN 
 
CATATGGCATCTAAGGGCGAAGAACTGTTTACGGGTGTTGTTCCAATCCTGGTAGAGCTGGACGGCGACGTTAACGG
TCACAAGTTCTCCGTTTCCGGCGAAGGTGAAGGCGACGCAACCTACGGCAAACTGACCCTGAAGTTCATCTGCACTA
CTGGCAAACTGCCGGTACCTTGGCCGACTCTGGTAACCACTTTCAGCTACGGTGTTCAGTGCTTCGCACGCTATCCG
GATCACATGAAACAACATGATTTCTTCAAATCCGCTATGCCGGAAGGTTATGTTCAGGAACGCACTATCAGCTTCAA
AGATGACGGTAACTACAAAACCCGTGCGGAAGTGAAATTCGAAGGTGATACCCTGGTTAACCGTATCGAGCTGAAAG
GTATTGACTTCAAAGAAGACGGTAACATCCTGGGCCACAAACTGGAGTACAACTATAATTCTCACAATGTGTACATT
ACTGCGGATAAACAAAAAGGTGGCGGCGGTTCTGGCGGTGGTGGATCC 
 
CGFPN 
 
CATATGAACGGCATTAAAGCGAACTTCAAAATCCGTCATAACATTGAGGATGGCGGTGTACAGCTGGCGGATCACTA
CCAGCAGAATACGCCGATTGGCGATGGCCCTGTGCTGCTGCCGGATAACCACTACCTGTCCACCCAGTCTAAACTGT
CCAAAGACCCTAACGAAAAACGCGACCACATGGTGCTGCTGGAATTTGTTACTGCGGCGGGTATTACTCACGGTATG
GATGAGCTGTACAAGGGCGGTGGCGGTTCCGGTGGCGGTGGCTCTGGATCC 
 
NGFPC (This fragment was inserted in the pW410 plasmid) 
 
GAATTCGGCGGTGGCGGTTCCGGTGGCGGTGGCTCTATGGCATCTAAGGGCGAAGAACTGTTTACGGGTGTTGTTCC
AATCCTGGTAGAGCTGGACGGCGACGTTAACGGTCACAAGTTCTCCGTTTCCGGCGAAGGTGAAGGCGACGCAACCT
ACGGCAAACTGACCCTGAAGTTCATCTGCACTACTGGCAAACTGCCGGTACCTTGGCCGACTCTGGTAACCACTTTC
AGCTACGGTGTTCAGTGCTTCGCACGCTATCCGGATCACATGAAACAACATGATTTCTTCAAATCCGCTATGCCGGA
AGGTTATGTTCAGGAACGCACTATCAGCTTCAAAGATGACGGTAACTACAAAACCCGTGCGGAAGTGAAATTCGAAG
GTGATACCCTGGTTAACCGTATCGAGCTGAAAGGTATTGACTTCAAAGAAGACGGTAACATCCTGGGCCACAAACTG
GAGTACAACTATAATTCTCACAATGTGTACATTACTGCGGATAAACAAAAATGATAACTGCAG 
 
CGFPC (This fragment was inserted in the pL410 plasmid) 
 
GAATTCGGTGGCGGTGGTTCCGGTGGTGGCGGCAGCAACGGCATTAAAGCGAACTTCAAAATCCGTCATAACATTGA
GGATGGCGGTGTACAGCTGGCGGATCACTACCAGCAGAATACGCCGATTGGCGATGGCCCTGTGCTGCTGCCGGATA
ACCACTACCTGTCCACCCAGTCTAAACTGTCCAAAGACCCTAACGAAAAACGCGACCACATGGTGCTGCTGGAATTT
GTTACTGCGGCGGGTATTACTCACGGTATGGATGAGCTGTACAAGTAATGAAGATCT 
 
D.1.3 BiFC plasmids 
pW410-NGFP-CGFP 
 
...CATATGGCATCTAAGGGCGAAGAACTGTTTACGGGTGTTGTTCCAATCCTGGTAGAGCTGGACGGCGACGTTAA
CGGTCACAAGTTCTCCGTTTCCGGCGAAGGTGAAGGCGACGCAACCTACGGCAAACTGACCCTGAAGTTCATCTGCA
CTACTGGCAAACTGCCGGTACCTTGGCCGACTCTGGTAACCACTTTCAGCTACGGTGTTCAGTGCTTCGCACGCTAT
CCGGATCACATGAAACAACATGATTTCTTCAAATCCGCTATGCCGGAAGGTTATGTTCAGGAACGCACTATCAGCTT
CAAAGATGACGGTAACTACAAAACCCGTGCGGAAGTGAAATTCGAAGGTGATACCCTGGTTAACCGTATCGAGCTGA
AAGGTATTGACTTCAAAGAAGACGGTAACATCCTGGGCCACAAACTGGAGTACAACTATAATTCTCACAATGTGTAC
ATTACTGCGGATAAACAAAAAGGTGGCGGCGGTTCTGGCGGTGGTGGATCCCTCGAGGAATTCGGTGGCGGTGGTTC
CGGTGGTGGCGGCAGCAACGGCATTAAAGCGAACTTCAAAATCCGTCATAACATTGAGGATGGCGGTGTACAGCTGG
CGGATCACTACCAGCAGAATACGCCGATTGGCGATGGCCCTGTGCTGCTGCCGGATAACCACTACCTGTCCACCCAG
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TCTAAACTGTCCAAAGACCCTAACGAAAAACGCGACCACATGGTGCTGCTGGAATTTGTTACTGCGGCGGGTATTAC
TCACGGTATGGATGAGCTGTACAAGTAATGACTGCAG... 
 
pW410-NGFPN
*
 
 
*
 Initial construct w/o STOPs before EcoRI site. 
 
...CATATGGCATCTAAGGGCGAAGAACTGTTTACGGGTGTTGTTCCAATCCTGGTAGAGCTGGACGGCGACGTTAA
CGGTCACAAGTTCTCCGTTTCCGGCGAAGGTGAAGGCGACGCAACCTACGGCAAACTGACCCTGAAGTTCATCTGCA
CTACTGGCAAACTGCCGGTACCTTGGCCGACTCTGGTAACCACTTTCAGCTACGGTGTTCAGTGCTTCGCACGCTAT
CCGGATCACATGAAACAACATGATTTCTTCAAATCCGCTATGCCGGAAGGTTATGTTCAGGAACGCACTATCAGCTT
CAAAGATGACGGTAACTACAAAACCCGTGCGGAAGTGAAATTCGAAGGTGATACCCTGGTTAACCGTATCGAGCTGA
AAGGTATTGACTTCAAAGAAGACGGTAACATCCTGGGCCACAAACTGGAGTACAACTATAATTCTCACAATGTGTAC
ATTACTGCGGATAAACAAAAAGGTGGCGGCGGTTCTGGCGGTGGTGGATCCCGGGAATTCTGCAGCCAAGCTAATTC
CGGGCGAATTTCTTATGATTTATGA... 
 
pW410-NGFPN 
 
New construct with STOP codons between BamHI and EcoRI sites. 
 
...CATATGGCATCTAAGGGCGAAGAACTGTTTACGGGTGTTGTTCCAATCCTGGTAGAGCTGGACGGCGACGTTAA
CGGTCACAAGTTCTCCGTTTCCGGCGAAGGTGAAGGCGACGCAACCTACGGCAAACTGACCCTGAAGTTCATCTGCA
CTACTGGCAAACTGCCGGTACCTTGGCCGACTCTGGTAACCACTTTCAGCTACGGTGTTCAGTGCTTCGCACGCTAT
CCGGATCACATGAAACAACATGATTTCTTCAAATCCGCTATGCCGGAAGGTTATGTTCAGGAACGCACTATCAGCTT
CAAAGATGACGGTAACTACAAAACCCGTGCGGAAGTGAAATTCGAAGGTGATACCCTGGTTAACCGTATCGAGCTGA
AAGGTATTGACTTCAAAGAAGACGGTAACATCCTGGGCCACAAACTGGAGTACAACTATAATTCTCACAATGTGTAC
ATTACTGCGGATAAACAAAAAGGTGGCGGCGGTTCTGGCGGTGGTGGATCCTGATAATAGGAATTCTGCAG... 
 
pW410-NGFPC 
 
...CATATGGGATCCCGGGAATTCGGCGGTGGCGGTTCCGGTGGCGGTGGCTCTATGGCATCTAAGGGCGAAGAACT
GTTTACGGGTGTTGTTCCAATCCTGGTAGAGCTGGACGGCGACGTTAACGGTCACAAGTTCTCCGTTTCCGGCGAAG
GTGAAGGCGACGCAACCTACGGCAAACTGACCCTGAAGTTCATCTGCACTACTGGCAAACTGCCGGTACCTTGGCCG
ACTCTGGTAACCACTTTCAGCTACGGTGTTCAGTGCTTCGCACGCTATCCGGATCACATGAAACAACATGATTTCTT
CAAATCCGCTATGCCGGAAGGTTATGTTCAGGAACGCACTATCAGCTTCAAAGATGACGGTAACTACAAAACCCGTG
CGGAAGTGAAATTCGAAGGTGATACCCTGGTTAACCGTATCGAGCTGAAAGGTATTGACTTCAAAGAAGACGGTAAC
ATCCTGGGCCACAAACTGGAGTACAACTATAATTCTCACAATGTGTACATTACTGCGGATAAACAAAAATGATAACT
GCAG... 
 
pW410-NLS-NGFPN 
 
...CATATGGCGGAATTAATTCCCGAGCCTCCAAAAAAGAAGAGAAAGGTCGAATTGGGTACCGCCCATATGGCATC
TAAGGGCGAAGAACTGTTTACGGGTGTTGTTCCAATCCTGGTAGAGCTGGACGGCGACGTTAACGGTCACAAGTTCT
CCGTTTCCGGCGAAGGTGAAGGCGACGCAACCTACGGCAAACTGACCCTGAAGTTCATCTGCACTACTGGCAAACTG
CCGGTACCTTGGCCGACTCTGGTAACCACTTTCAGCTACGGTGTTCAGTGCTTCGCACGCTATCCGGATCACATGAA
ACAACATGATTTCTTCAAATCCGCTATGCCGGAAGGTTATGTTCAGGAACGCACTATCAGCTTCAAAGATGACGGTA
ACTACAAAACCCGTGCGGAAGTGAAATTCGAAGGTGATACCCTGGTTAACCGTATCGAGCTGAAAGGTATTGACTTC
AAAGAAGACGGTAACATCCTGGGCCACAAACTGGAGTACAACTATAATTCTCACAATGTGTACATTACTGCGGATAA
ACAAAAAGGTGGCGGCGGTTCTGGCGGTGGTGGATCCTGATAATAGGAATTCTGCAG... 
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pW410-NLS-NGFPC 
 
...CATATGGCGGAATTAATTCCCGAGCCTCCAAAAAAGAAGAGAAAGGTCGAATTGGGTACCGCCCATATGGGATC
CCGGGAATTCGGCGGTGGCGGTTCCGGTGGCGGTGGCTCTATGGCATCTAAGGGCGAAGAACTGTTTACGGGTGTTG
TTCCAATCCTGGTAGAGCTGGACGGCGACGTTAACGGTCACAAGTTCTCCGTTTCCGGCGAAGGTGAAGGCGACGCA
ACCTACGGCAAACTGACCCTGAAGTTCATCTGCACTACTGGCAAACTGCCGGTACCTTGGCCGACTCTGGTAACCAC
TTTCAGCTACGGTGTTCAGTGCTTCGCACGCTATCCGGATCACATGAAACAACATGATTTCTTCAAATCCGCTATGC
CGGAAGGTTATGTTCAGGAACGCACTATCAGCTTCAAAGATGACGGTAACTACAAAACCCGTGCGGAAGTGAAATTC
GAAGGTGATACCCTGGTTAACCGTATCGAGCTGAAAGGTATTGACTTCAAAGAAGACGGTAACATCCTGGGCCACAA
ACTGGAGTACAACTATAATTCTCACAATGTGTACATTACTGCGGATAAACAAAAATGATAACTGCAG... 
 
pWAFL-NGFPN plasmids are pW410-NGFPN plasmids with the full-length yADH1 promoter 
(Appendix E). 
 
pL410-NGFP-CGFP 
 
...CATATGGCATCTAAGGGCGAAGAACTGTTTACGGGTGTTGTTCCAATCCTGGTAGAGCTGGACGGCGACGTTAA
CGGTCACAAGTTCTCCGTTTCCGGCGAAGGTGAAGGCGACGCAACCTACGGCAAACTGACCCTGAAGTTCATCTGCA
CTACTGGCAAACTGCCGGTACCTTGGCCGACTCTGGTAACCACTTTCAGCTACGGTGTTCAGTGCTTCGCACGCTAT
CCGGATCACATGAAACAACATGATTTCTTCAAATCCGCTATGCCGGAAGGTTATGTTCAGGAACGCACTATCAGCTT
CAAAGATGACGGTAACTACAAAACCCGTGCGGAAGTGAAATTCGAAGGTGATACCCTGGTTAACCGTATCGAGCTGA
AAGGTATTGACTTCAAAGAAGACGGTAACATCCTGGGCCACAAACTGGAGTACAACTATAATTCTCACAATGTGTAC
ATTACTGCGGATAAACAAAAAGGTGGCGGCGGTTCTGGCGGTGGTGGATCCGAATTCGGTGGCGGTGGTTCCGGTGG
TGGCGGCAGCAACGGCATTAAAGCGAACTTCAAAATCCGTCATAACATTGAGGATGGCGGTGTACAGCTGGCGGATC
ACTACCAGCAGAATACGCCGATTGGCGATGGCCCTGTGCTGCTGCCGGATAACCACTACCTGTCCACCCAGTCTAAA
CTGTCCAAAGACCCTAACGAAAAACGCGACCACATGGTGCTGCTGGAATTTGTTACTGCGGCGGGTATTACTCACGG
TATGGATGAGCTGTACAAGTAATGAAGATCT... 
 
pL410-CGFPN 
 
...CATATGAACGGCATTAAAGCGAACTTCAAAATCCGTCATAACATTGAGGATGGCGGTGTACAGCTGGCGGATCA
CTACCAGCAGAATACGCCGATTGGCGATGGCCCTGTGCTGCTGCCGGATAACCACTACCTGTCCACCCAGTCTAAAC
TGTCCAAAGACCCTAACGAAAAACGCGACCACATGGTGCTGCTGGAATTTGTTACTGCGGCGGGTATTACTCACGGT
ATGGATGAGCTGTACAAGGGCGGTGGCGGTTCCGGTGGCGGTGGCTCTGGATCCGAATTCCAGATCTATGAATCGTA
G... 
 
pL410-CGFPC 
 
...CATATGGGATCCGAATTCGGTGGCGGTGGTTCCGGTGGTGGCGGCAGCAACGGCATTAAAGCGAACTTCAAAAT
CCGTCATAACATTGAGGATGGCGGTGTACAGCTGGCGGATCACTACCAGCAGAATACGCCGATTGGCGATGGCCCTG
TGCTGCTGCCGGATAACCACTACCTGTCCACCCAGTCTAAACTGTCCAAAGACCCTAACGAAAAACGCGACCACATG
GTGCTGCTGGAATTTGTTACTGCGGCGGGTATTACTCACGGTATGGATGAGCTGTACAAGTAATGAAGATCT... 
 
 
pL410-NLS-CGFPN 
 
...CATATGGCGGAATTAATTCCCGAGCCTCCAAAAAAGAAGAGAAAGGTCGAATTGGGTACCGCCCATATGAACGG
CATTAAAGCGAACTTCAAAATCCGTCATAACATTGAGGATGGCGGTGTACAGCTGGCGGATCACTACCAGCAGAATA
CGCCGATTGGCGATGGCCCTGTGCTGCTGCCGGATAACCACTACCTGTCCACCCAGTCTAAACTGTCCAAAGACCCT
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AACGAAAAACGCGACCACATGGTGCTGCTGGAATTTGTTACTGCGGCGGGTATTACTCACGGTATGGATGAGCTGTA
CAAGGGCGGTGGCGGTTCCGGTGGCGGTGGCTCTGGATCCGAATTCCAGATCTATGAATCGTAG... 
 
D.1.4 Inserting constructs into BiFC plasmids 
Inserts with STOP codons             
e.g., GGATCCconstructSTOPsGAATTC   
were inserted in pW410-NGFPN and pL410-CGFPN plasmids.  
Inserts without  STOP codons  
e.g., GGATCCconstructGAATTC        
were inserted in pW410-NGFPC and pL410-CGFPC plasmids. 
 
pW410-NGFPN-construct 
 
...CATATGGCATCTAAGGGCGAAGAACTGTTTACGGGTGTTGTTCCAATCCTGGTAGAGCTGGACGGCGACGTTAA
CGGTCACAAGTTCTCCGTTTCCGGCGAAGGTGAAGGCGACGCAACCTACGGCAAACTGACCCTGAAGTTCATCTGCA
CTACTGGCAAACTGCCGGTACCTTGGCCGACTCTGGTAACCACTTTCAGCTACGGTGTTCAGTGCTTCGCACGCTAT
CCGGATCACATGAAACAACATGATTTCTTCAAATCCGCTATGCCGGAAGGTTATGTTCAGGAACGCACTATCAGCTT
CAAAGATGACGGTAACTACAAAACCCGTGCGGAAGTGAAATTCGAAGGTGATACCCTGGTTAACCGTATCGAGCTGA
AAGGTATTGACTTCAAAGAAGACGGTAACATCCTGGGCCACAAACTGGAGTACAACTATAATTCTCACAATGTGTAC
ATTACTGCGGATAAACAAAAAGGTGGCGGCGGTTCTGGCGGTGGTGGATCCconstructSTOPsGAATTCTGCAG.
.. 
 
pW410-NGFPC-construct 
 
...CATATGGGATCCconstructGAATTCGGCGGTGGCGGTTCCGGTGGCGGTGGCTCTATGGCATCTAAGGGCGA
AGAACTGTTTACGGGTGTTGTTCCAATCCTGGTAGAGCTGGACGGCGACGTTAACGGTCACAAGTTCTCCGTTTCCG
GCGAAGGTGAAGGCGACGCAACCTACGGCAAACTGACCCTGAAGTTCATCTGCACTACTGGCAAACTGCCGGTACCT
TGGCCGACTCTGGTAACCACTTTCAGCTACGGTGTTCAGTGCTTCGCACGCTATCCGGATCACATGAAACAACATGA
TTTCTTCAAATCCGCTATGCCGGAAGGTTATGTTCAGGAACGCACTATCAGCTTCAAAGATGACGGTAACTACAAAA
CCCGTGCGGAAGTGAAATTCGAAGGTGATACCCTGGTTAACCGTATCGAGCTGAAAGGTATTGACTTCAAAGAAGAC
GGTAACATCCTGGGCCACAAACTGGAGTACAACTATAATTCTCACAATGTGTACATTACTGCGGATAAACAAAAATG
ATAACTGCAG... 
 
pW410-NLS-NGFPN-construct 
 
...CATATGGCGGAATTAATTCCCGAGCCTCCAAAAAAGAAGAGAAAGGTCGAATTGGGTACCGCCCATATGGCATC
TAAGGGCGAAGAACTGTTTACGGGTGTTGTTCCAATCCTGGTAGAGCTGGACGGCGACGTTAACGGTCACAAGTTCT
CCGTTTCCGGCGAAGGTGAAGGCGACGCAACCTACGGCAAACTGACCCTGAAGTTCATCTGCACTACTGGCAAACTG
CCGGTACCTTGGCCGACTCTGGTAACCACTTTCAGCTACGGTGTTCAGTGCTTCGCACGCTATCCGGATCACATGAA
ACAACATGATTTCTTCAAATCCGCTATGCCGGAAGGTTATGTTCAGGAACGCACTATCAGCTTCAAAGATGACGGTA
ACTACAAAACCCGTGCGGAAGTGAAATTCGAAGGTGATACCCTGGTTAACCGTATCGAGCTGAAAGGTATTGACTTC
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AAAGAAGACGGTAACATCCTGGGCCACAAACTGGAGTACAACTATAATTCTCACAATGTGTACATTACTGCGGATAA
ACAAAAAGGTGGCGGCGGTTCTGGCGGTGGTGGATCCconstructSTOPsGAATTCTGCAG... 
 
 
pL410-CGFPN-construct 
 
...CATATGAACGGCATTAAAGCGAACTTCAAAATCCGTCATAACATTGAGGATGGCGGTGTACAGCTGGCGGATCA
CTACCAGCAGAATACGCCGATTGGCGATGGCCCTGTGCTGCTGCCGGATAACCACTACCTGTCCACCCAGTCTAAAC
TGTCCAAAGACCCTAACGAAAAACGCGACCACATGGTGCTGCTGGAATTTGTTACTGCGGCGGGTATTACTCACGGT
ATGGATGAGCTGTACAAGGGCGGTGGCGGTTCCGGTGGCGGTGGCTCTGGATCCconstructSTOPsGAATTCCAG
ATCT... 
 
pL410-CGFPC-construct 
 
...CATATGGGATCCconstructGAATTCGGTGGCGGTGGTTCCGGTGGTGGCGGCAGCAACGGCATTAAAGCGAA
CTTCAAAATCCGTCATAACATTGAGGATGGCGGTGTACAGCTGGCGGATCACTACCAGCAGAATACGCCGATTGGCG
ATGGCCCTGTGCTGCTGCCGGATAACCACTACCTGTCCACCCAGTCTAAACTGTCCAAAGACCCTAACGAAAAACGC
GACCACATGGTGCTGCTGGAATTTGTTACTGCGGCGGGTATTACTCACGGTATGGATGAGCTGTACAAGTAATGAAG
ATCT... 
 
 
pL410-NLS-CGFPN-construct 
 
...CATATGGCGGAATTAATTCCCGAGCCTCCAAAAAAGAAGAGAAAGGTCGAATTGGGTACCGCCCATATGAACGG
CATTAAAGCGAACTTCAAAATCCGTCATAACATTGAGGATGGCGGTGTACAGCTGGCGGATCACTACCAGCAGAATA
CGCCGATTGGCGATGGCCCTGTGCTGCTGCCGGATAACCACTACCTGTCCACCCAGTCTAAACTGTCCAAAGACCCT
AACGAAAAACGCGACCACATGGTGCTGCTGGAATTTGTTACTGCGGCGGGTATTACTCACGGTATGGATGAGCTGTA
CAAGGGCGGTGGCGGTTCCGGTGGCGGTGGCTCTGGATCCconstructSTOPsGAATTCCAGATCT... 
 
 
pW410-HGFPsol-construct and pL410-HGFPsol-construct plasmids were created by 
inserting a PCR copy of the NdeI-BamHI insert from pGEX-6P-GFPsol into NdeI/BamHI cut 
pW410-NGFPN-construct and pL410-CGFPN-construct plasmids. 
 
D.2 BiFC protein constructs 
NGFP-CGFP (expressed from either plasmid) 
 
MASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFARYPD
HMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIT
ADKQKGGGGSGGGGSLEEFGGGGSGGGGSNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSTQSK
LSKDPNEKRDHMVLLEFVTAAGITHGMDELYK- 
 
Molecular weight: 28629.9 Da 
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NGFPN
*
 
 
MASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFARYPD
HMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIT
ADKQKGGGGSGGGGSREFCSQANSGRISYDL- 
 
Molecular weight: 20370.7 Da 
 
NGFPN 
 
MASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFARYPD
HMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIT
ADKQKGGGGSGGGGS- 
 
NGFPC 
 
MGSREFGGGGSGGGGSMASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL
VTTFSYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNIL
GHKLEYNYNSHNVYITADKQK- 
 
NGFPN-LMO4LIMs 
 
MASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFARYPD
HMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIT
ADKQKGGGGSGGGGSLSWKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMILCRNDYIR
LFGNSGACSACGQSIPASELVMRAQGNVYHLKCFTCSTCRNRLVPGDRFHYINGSLFCEHDRPTALINGHL- 
 
Molecular weight: 33253.6 Da 
 
LMO4LIMs-NGFPC 
 
MGSLSWKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMILCRNDYIRLFGNSGACSACG
QSIPASELVMRAQGNVYHLKCFTCSTCRNRLVPGDRFHYINGSLFCEHDRPTALINGHLNEFGGGGSGGGGSMASKG
EELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFARYPDHMKQH
DFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQK
- 
 
Ldb1LID-NGFPC 
 
MGSDVMVVGEPTLMGGEFGDEDERLITRLENTQFDAANGIDDEEFGGGGSGGGGSMASKGEELFTGVVPILVELDGD
VNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTI
SFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQK- 
 
NGFPN-Ldb1LID 
 
MASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFARYPD
HMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIT
ADKQKGGGGSGGGGSDVMVVGEPTLMGGEFGDEDERLITRLENTQF- 
 
NGFPN-Lhx3a 
 
MASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFARYPD
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HMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIT
ADKQKGGGGSGGGGSMLLEAELDCHRERPGAPGASALCTFSRTPEIPMCAGCDQHILDRFILKALDRHWHSKCLKCS
DCHVPLAERCFSRGESVYCKDDFFKRFGTKCAACQLGIPPTQVVRRAQDFVYHLHCFACVVCKRQLATGDEFYLMED
SRLVCKADYETAKQREAEATAKRPRTTITAKQLETLKSAYNTSPKPARHVREQLSSETGLDMRVVQVWFQNRRAKEK
RLKKDAGRQRWGQYFRNMKRSRGSSKSDKDSIQEGQDSDAEVSFTDEPSMADMGPANGLYSSLGEPAPALGRPVGGL
GSFTLDHGGLTGPEQYRELRPGSPYGIPPSPAAPQSLPGPQPLLSSLVYPDTNLSLVPSGPPGGPPPMRVLAGNGPS
SDLSTESSSGYPDFPASPASWLDEVDHAQF- 
 
Molecular weight: 62534.4 Da 
 
NGFPN-Lhx3LIMs 
 
MASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFARYPD
HMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIT
ADKQKGGGGSGGGGSTPEIPMCAGCDQHILDRFILKALDRHWHSKCLKCSDCHVPLAERCFSRGESVYCKDDFFKRF
GTKCAACQLGIPPTQVVRRAQDFVYHLHCFACVVCKRQLATGDEFYLMEDSRLVCKADYETAKQ- 
 
Lhx3a-NGFPC 
 
MGSMLLEAELDCHRERPGAPGASALCTFSRTPEIPMCAGCDQHILDRFILKALDRHWHSKCLKCSDCHVPLAERCFS
RGESVYCKDDFFKRFGTKCAACQLGIPPTQVVRRAQDFVYHLHCFACVVCKRQLATGDEFYLMEDSRLVCKADYETA
KQREAEATAKRPRTTITAKQLETLKSAYNTSPKPARHVREQLSSETGLDMRVVQVWFQNRRAKEKRLKKDAGRQRWG
QYFRNMKRSRGSSKSDKDSIQEGQDSDAEVSFTDEPSMADMGPANGLYSSLGEPAPALGRPVGGLGSFTLDHGGLTG
PEQYRELRPGSPYGIPPSPAAPQSLPGPQPLLSSLVYPDTNLSLVPSGPPGGPPPMRVLAGNGPSSDLSTESSSGYP
DFPASPASWLDEVDHAQFEFGGGGSGGGGSMASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKF
ICTTGKLPVPWPTLVTTFSYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRI
ELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQK- 
 
NGFPN-Isl1 
 
MASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFARYPD
HMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIT
ADKQKGGGGSGGGGSMGDMGDPPKKKRLISLCVGCGNQIHDQYILRVSPDLEWHAACLKCAECNQYLDESCTCFVRD
GKTYCKRDYIRLYGIKCAKCSIGFSKNDFVMRARSKVYHIECFRCVACSRQLIPGDEFALREDGLFCRADHDVVERA
SLGAGDPLSPLHPARPLQMAAEPISARQPALRPHVHKQPEKTTRVRTVLNEKQLHTLRTCYAANPRPDALMKEQLVE
MTGLSPRVIRVWFQNKRCKDKKRSIMMKQLQQQQPNDKTNIQGMTGTPMVAASPERHDGGLQANPVEVQSYQPPWKV
LSDFALQSDIDQPAFQQLVNFSEGGPGSNSTGSEVASMSSQLPDTPNSMVASPIEA- 
 
Isl1-NGFPC 
 
MGSMGDMGDPPKKKRLISLCVGCGNQIHDQYILRVSPDLEWHAACLKCAECNQYLDESCTCFVRDGKTYCKRDYIRL
YGIKCAKCSIGFSKNDFVMRARSKVYHIECFRCVACSRQLIPGDEFALREDGLFCRADHDVVERASLGAGDPLSPLH
PARPLQMAAEPISARQPALRPHVHKQPEKTTRVRTVLNEKQLHTLRTCYAANPRPDALMKEQLVEMTGLSPRVIRVW
FQNKRCKDKKRSIMMKQLQQQQPNDKTNIQGMTGTPMVAASPERHDGGLQANPVEVQSYQPPWKVLSDFALQSDIDQ
PAFQQLVNFSEGGPGSNSTGSEVASMSSQLPDTPNSMVASPIEAEFGGGGSGGGGSMASKGEELFTGVVPILVELDG
DVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFARYPDHMKQHDFFKSAMPEGYVQERT
ISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQK- 
 
NLS-NGFPN 
 
MAELIPEPPKKKRKVELGTAHMASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPV
PWPTLVTTFSYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKE
DGNILGHKLEYNYNSHNVYITADKQKGGGGSGGGGS- 
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NLS-NGFPN-LMO4LIMs 
 
MAELIPEPPKKKRKVELGTAHMASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPV
PWPTLVTTFSYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKE
DGNILGHKLEYNYNSHNVYITADKQKGGGGSGGGGSLSWKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLG
DIGTSSYTKSGMILCRNDYIRLFGNSGACSACGQSIPASELVMRAQGNVYHLKCFTCSTCRNRLVPGDRFHYINGSL
FCEHDRPTALINGHL- 
 
NLS-NGFPC 
 
MAELIPEPPKKKRKVELGTAHMGSREFGGGGSGGGGSMASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATY
GKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEG
DTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQK- 
 
NGFPsolN 
 
MASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFARYPD
HMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIT
ADKQKGGGGSGGGGS- 
 
NGFPsolC 
 
MGSREFGGGGSGGGGSMASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL
VTTLTYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNIL
GHKLEYNYNSHNVYITADKQK- 
 
NGFPsol-CGFP (expressed from either plasmid) 
 
MASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFARYPD
HMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIT
ADKQKGGGGSGGGGSLEEFGGGGSGGGGSNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSTQSK
LSKDPNEKRDHMVLLEFVTAAGITHGMDELYK- 
 
NGFPsolN-LMO4LIMs 
 
MASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFARYPD
HMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIT
ADKQKGGGGSGGGGSLSWKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMILCRNDYIR
LFGNSGACSACGQSIPASELVMRAQGNVYHLKCFTCSTCRNRLVPGDRFHYINGSLFCEHDRPTALINGHL- 
 
NGFPN-LMO2LIMs 
 
MASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFARYPD
HMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIT
ADKQKGGGGSGGGGSLLTCGGCQQNIGDRYFLKAIDQYWHEDCLSCDLCGCRLGEVGRRLYYKLGRKLCRRDYLRLF
GQDGLCASCDKRIRAYEMTMRVKDKVYHLECFKCAACQKHFCVGDRYLLINSDIVCEQDIYEWTKINGII- 
 
NGFPN-USHF1 
 
MASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFARYPD
HMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIT
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ADKQKGGGGSGGGGSPDTQAQPEVAEPLLKPARFMCLPCGIAFSSPSTLEAHQAYYCSHRIKDTDEAGSDKSGAGGS
GATAGDAAGLTGGSTEPPA- 
 
NGFPN-USHF9 
 
MASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFARYPD
HMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIT
ADKQKGGGGSGGGGSGNSSSVAAAAAAAAEVMKKYCSTCDISFNYVKTYLAHKQFYCKNKPIRPEASDSPSPNHLGG
GVAVGLGIGGLVGGHGQQKN- 
 
CGFPN 
 
MNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITHGMD
ELYKGGGGSGGGGSGSEFQIYES- 
 
Molecular weight: 10758.8 Da 
 
CGFPC 
 
MGSEFGGGGSGGGGSNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVL
LEFVTAAGITHGMDELYK- 
 
CGFPN-Ldb1LID 
 
MNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITHGMD
ELYKGGGGSGGGGSGSDVMVVGEPTLMGGEFGDEDERLITRLENTQF- 
 
Molecular weight: 13342.8 Da 
 
Ldb1LID-CGFPC 
 
MGSDVMVVGEPTLMGGEFGDEDERLITRLENTQFDAANGIDDEEFGGGGSGGGGSNGIKANFKIRHNIEDGGVQLAD
HYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITHGMDELYK- 
 
CGFPN-LMO4LIMs 
 
MNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITHGMD
ELYKGGGGSGGGGSGSLSWKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMILCRNDYI
RLFGNSGACSACGQSIPASELVMRAQGNVYHLKCFTCSTCRNRLVPGDRFHYINGSLFCEHDRPTALINGHL- 
 
LMO4LIMs-CGFPC 
 
MGSLSWKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMILCRNDYIRLFGNSGACSACG
QSIPASELVMRAQGNVYHLKCFTCSTCRNRLVPGDRFHYINGSLFCEHDRPTALINGHLNEFGGGGSGGGGSNGIKA
NFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITHGMDELYK- 
 
CGFPN-Isl1 
 
MNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITHGMD
ELYKGGGGSGGGGSGSMGDMGDPPKKKRLISLCVGCGNQIHDQYILRVSPDLEWHAACLKCAECNQYLDESCTCFVR
DGKTYCKRDYIRLYGIKCAKCSIGFSKNDFVMRARSKVYHIECFRCVACSRQLIPGDEFALREDGLFCRADHDVVER
ASLGAGDPLSPLHPARPLQMAAEPISARQPALRPHVHKQPEKTTRVRTVLNEKQLHTLRTCYAANPRPDALMKEQLV
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EMTGLSPRVIRVWFQNKRCKDKKRSIMMKQLQQQQPNDKTNIQGMTGTPMVAASPERHDGGLQANPVEVQSYQPPWK
VLSDFALQSDIDQPAFQQLVNFSEGGPGSNSTGSEVASMSSQLPDTPNSMVASPIEA- 
 
Molecular weight:  48879.6 Da 
 
CGFPN-Isl1LBD 
 
MNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITHGMD
ELYKGGGGSGGGGSGSGTPMVAASPERHDGGLQANPVEVQSYQPPW- 
 
Isl1-CGFPC 
 
MGSMGDMGDPPKKKRLISLCVGCGNQIHDQYILRVSPDLEWHAACLKCAECNQYLDESCTCFVRDGKTYCKRDYIRL
YGIKCAKCSIGFSKNDFVMRARSKVYHIECFRCVACSRQLIPGDEFALREDGLFCRADHDVVERASLGAGDPLSPLH
PARPLQMAAEPISARQPALRPHVHKQPEKTTRVRTVLNEKQLHTLRTCYAANPRPDALMKEQLVEMTGLSPRVIRVW
FQNKRCKDKKRSIMMKQLQQQQPNDKTNIQGMTGTPMVAASPERHDGGLQANPVEVQSYQPPWKVLSDFALQSDIDQ
PAFQQLVNFSEGGPGSNSTGSEVASMSSQLPDTPNSMVASPIEAEFGGGGSGGGGSNGIKANFKIRHNIEDGGVQLA
DHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITHGMDELYK- 
 
CGFPN-Lhx3 
 
MNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITHGMD
ELYKGGGGSGGGGSGSMLLEAELDCHRERPGAPGASALCTFSRTPEIPMCAGCDQHILDRFILKALDRHWHSKCLKC
SDCHVPLAERCFSRGESVYCKDDFFKRFGTKCAACQLGIPPTQVVRRAQDFVYHLHCFACVVCKRQLATGDEFYLME
DSRLVCKADYETAKQREAEATAKRPRTTITAKQLETLKSAYNTSPKPARHVREQLSSETGLDMRVVQVWFQNRRAKE
KRLKKDAGRQRWGQYFRNMKRSRGSSKSDKDSIQEGQDSDAEVSFTDEPSMADMGPANGLYSSLGEPAPALGRPVGG
LGSFTLDHGGLTGPEQYRELRPGSPYGIPPSPAAPQSLPGPQPLLSSLVYPDTNLSLVPSGPPGGPPPMRVLAGNGP
SSDLSTESSSGYPDFPASPASWLDEVDHAQF- 
 
Lhx3-CGFPC 
 
MGSMLLEAELDCHRERPGAPGASALCTFSRTPEIPMCAGCDQHILDRFILKALDRHWHSKCLKCSDCHVPLAERCFS
RGESVYCKDDFFKRFGTKCAACQLGIPPTQVVRRAQDFVYHLHCFACVVCKRQLATGDEFYLMEDSRLVCKADYETA
KQREAEATAKRPRTTITAKQLETLKSAYNTSPKPARHVREQLSSETGLDMRVVQVWFQNRRAKEKRLKKDAGRQRWG
QYFRNMKRSRGSSKSDKDSIQEGQDSDAEVSFTDEPSMADMGPANGLYSSLGEPAPALGRPVGGLGSFTLDHGGLTG
PEQYRELRPGSPYGIPPSPAAPQSLPGPQPLLSSLVYPDTNLSLVPSGPPGGPPPMRVLAGNGPSSDLSTESSSGYP
DFPASPASWLDEVDHAQFEFGGGGSGGGGSNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSTQS
KLSKDPNEKRDHMVLLEFVTAAGITHGMDELYK- 
 
NLS-CGFPN 
 
MAELIPEPPKKKRKVELGTAHMNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNE
KRDHMVLLEFVTAAGITHGMDELYKGGGGSGGGGSGSEFQIYES- 
 
NLS-CGFPN-Ldb1LID 
 
MAELIPEPPKKKRKVELGTAHMNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNE
KRDHMVLLEFVTAAGITHGMDELYKGGGGSGGGGSGSDVMVVGEPTLMGGEFGDEDERLITRLENTQF- 
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CGFPN-PNRNF 
 
MNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITHGMD
ELYKGGGGSGGGGSGSEGRECVNCGAISTPLWRRDGTGHYLCNACGLYHKMNGMNRPLIKPSKRL- 
 
His6-GFPsol-Lhx3a  
 
MRGSHHHHHHGLVPRGSASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL
VTTFSYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNIL
GHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEK
RDHMVLLEFVTAAGITHGMDELYKGSMLLEAELDCHRERPGAPGASALCTFSRTPEIPMCAGCDQHILDRFILKALD
RHWHSKCLKCSDCHVPLAERCFSRGESVYCKDDFFKRFGTKCAACQLGIPPTQVVRRAQDFVYHLHCFACVVCKRQL
ATGDEFYLMEDSRLVCKADYETAKQREAEATAKRPRTTITAKQLETLKSAYNTSPKPARHVREQLSSETGLDMRVVQ
VWFQNRRAKEKRLKKDAGRQRWGQYFRNMKRSRGSSKSDKDSIQEGQDSDAEVSFTDEPSMADMGPANGLYSSLGEP
APALGRPVGGLGSFTLDHGGLTGPEQYRELRPGSPYGIPPSPAAPQSLPGPQPLLSSLVYPDTNLSLVPSGPPGGPP
PMRVLAGNGPSSDLSTESSSGYPDFPASPASWLDEVDHAQF- 
 
Molecular weight: 72776.0 Da 
 
Theoretical pI: 6.82 
 
His6-GFPsol-Isl1 
 
MRGSHHHHHHGLVPRGSASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL
VTTFSYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNIL
GHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEK
RDHMVLLEFVTAAGITHGMDELYKGSMGDMGDPPKKKRLISLCVGCGNQIHDQYILRVSPDLEWHAACLKCAECNQY
LDESCTCFVRDGKTYCKRDYIRLYGIKCAKCSIGFSKNDFVMRARSKVYHIECFRCVACSRQLIPGDEFALREDGLF
CRADHDVVERASLGAGDPLSPLHPARPLQMAAEPISARQPALRPHVHKQPEKTTRVRTVLNEKQLHTLRTCYAANPR
PDALMKEQLVEMTGLSPRVIRVWFQNKRCKDKKRSIMMKQLQQQQPNDKTNIQGMTGTPMVAASPERHDGGLQANPV
EVQSYQPPWKVLSDFALQSDIDQPAFQQLVNFSEGGPGSNSTGSEVASMSSQLPDTPNSMVASPIEA- 
 
Molecular weight: 67802.0 Da 
 
Theoretical pI: 7.82 
 
 
Linkers are in italic font and molecular weight was shown only for proteins that were 
subjected to Western blot. 
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Appendix E   ADH1 promoters in BiFC plasmids 
 
pW410 (with the short yADH1 promoter, 411 bp) 
GCATGCAACTTCTTTTCTTTTTTTTTCTTTTCTCTCTCCCCCGTTGTTGTCTCACCATATCCGCAATGACAAAAAAA
ATGATGGAAGACACTAAAGGAAAAAATTAACGACAAAGACAGCACCAACAGATGTCGTTGTTCCAGAGCTGATGAGG
GGTATCTTCGAACACACGAAACTTTTTCCTTCCTTCATTCACGCACACTACTCTCTAATGAGCAACGGTATACGGCC
TTCCTTCCAGTTACTTGAATTTGAAATAAAAAAAGTTTGCCGCTTTGCTATCAAGTATAAATAGACCTGCAATTATT
AATCTTTTGTTTCCTCGTCATTGTTCTCGTTCCCTTTCTTCCTTGTTTCTTTTTCTGCACAATATTTCAAGCTATAC
CAAGCATACAATCAACTCCAAGCTTGCATATGGGATCCCGGGAATTCTGCAGCCAAGCTAATTCCGGGCGAATTTCT
TATGATTTATGATTTTTATTATTAAATAAGTTATAAAAAAAATAAGTGTATACAAATTTTAAAGTGACTCTTAGGTT
TTAAAACGAAAATTCTTGTTCTTGAGTAACTCTTTCCTGTAGGTCAGGTTGCTTTCTCAGGTATAGCATGAGGTCGC
TCTTATTGACCACACCTCTACCGGCATGC 
 
pWAFL (with full-length yADH1 promoter, 1482 bp) 
GCATGCCTGCAGGTCGAGATCCGGGATCGAAGAAATGATGGTAAATGAAATAGGAAATCAAGGAGCATGAAGGCAAA
AGACAAATATAAGGGTCGAACGAAAAATAAAGTGAAAAGTGTTGATATGATGTATTTGGCTTTGCGGCGCCGAAAAA
ACGAGTTTACGCAATTGCACAATCATGCTGACTCTGTGGCGGACCCGCGCTCTTGCCGGCCCGGCGATAACGCTGGG
CGTGAGGCTGTGCCCGGCGGAGTTTTTTGCGCCTGCATTTTCCAAGGTTTACCCTGCGCTAAGGGGCGAGATTGGAG
AAGCAATAAGAATGCCGGTTGGGGTTGCGATGATGACGACCACGACAACTGGTGTCATTATTTAAGTTGCCGAAAGA
ACCTGAGTGCATTTGCAACATGAGTATACTAGAAGAATGAGCCAAGACTTGCGAGACGCGAGTTTGCCGGTGGTGCG
AACAATAGAGCGACCATGACCTTGAAGGTGAGACGCGCATAACCGCTAGAGTACTTTGAAGAGGAAACAGCAATAGG
GTTGCTACCAGTATAAATAGACAGGTACATACAACACTGGAAATGGTTGTCTGTTTGAGTACGCTTTCAATTCATTT
GGGTGTGCACTTTATTATGTTACAATATGGAAGGGAACTTTACACTTCTCCTATGCACATATATTAATTAAAGTCCA
ATGCTAGTAGAGAAGGGGGGTAACACCCCTCCGCGCTCTTTTCCGATTTTTTTCTAAACCGTGGAATATTTCGGATA
TCCTTTTGTTGTTTCCGGGTGTACAATATGGACTTCCTCTTTTCTGGCAACCAAACCCATACATCGGGATTCCTATA
ATACCTTCGTTGGTCTCCCTAACATGTAGGTGGCGGAGGGGAGATATACAATAGAACAGATACCAGACAAGACATAA
TGGGCTAAACAAGACTACACCAATTACACTGCCTCATTGATGGTGGTACATAACGAACTAATACTGTAGCCCTAGAC
TTGATAGCCATCATCATATCGAAGTTTCACTACCCTTTTTCCATTTGCCATCTATTGAAGTAATAATAGGCGCATGC
AACTTCTTTTCTTTTTTTTTCTTTTCTCTCTCCCCCGTTGTTGTCTCACCATATCCGCAATGACAAAAAAAATGATG
GAAGACACTAAAGGAAAAAATTAACGACAAAGACAGCACCAACAGATGTCGTTGTTCCAGAGCTGATGAGGGGTATC
TTCGAACACACGAAACTTTTTCCTTCCTTCATTCACGCACACTACTCTCTAATGAGCAACGGTATACGGCCTTCCTT
CCAGTTACTTGAATTTGAAATAAAAAAAGTTTGCCGCTTTGCTATCAAGTATAAATAGACCTGCAATTATTAATCTT
TTGTTTCCTCGTCATTGTTCTCGTTCCCTTTCTTCCTTGTTTCTTTTTCTGCACAATATTTCAAGCTATACCAAGCA
TACAATCAACTCAAGCTTGCATATGGGATCCCGGGAATTCTGCAGCCAAGCTAATTCCGGGCGAATTTCTTATGATT 
 
pL410 (with the short yADH1 promoter, 411 b) 
GCATGCAACTTCTTTTCTTTTTTTTTCTTTTCTCTCTCCCCCGTTGTTGTCTCACCATATCCGCAATGACAAAAAAA
ATGATGGAAGACACTAAAGGAAAAAATTAACGACAAAGACAGCACCAACAGATGTCGTTGTTCCAGAGCTGATGAGG
GGTATCTTCGAACACACGAAACTTTTTCCTTCCTTCATTCACGCACACTACTCTCTAATGAGCAACGGTATACGGCC
TTCCTTCCAGTTACTTGAATTTGAAATAAAAAAAGTTTGCCGCTTTGCTATCAAGTATAAATAGACCTGCAATTATT
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AATCTTTTGTTTCCTCGTCATTGTTCTCGTTCCCTTTCTTCCTTGTTTCTTTTTCTGCACAATATTTCAAGCTATAC
CAAGCATACAATCAACTCCAAGCTTGCATATGGGATCCGAATTCCAGATCTATGAATCGTAGATACTGAAAAACCCC
GCAAGTT 
 
pLAFL (with full-length yADH1 promoter, 1482 bp) 
GCATGCCTGCAGGTCGAGATCCGGGATCGAAGAAATGATGGTAAATGAAATAGGAAATCAAGGAGCATGAAGGCAAA
AGACAAATATAAGGGTCGAACGAAAAATAAAGTGAAAAGTGTTGATATGATGTATTTGGCTTTGCGGCGCCGAAAAA
ACGAGTTTACGCAATTGCACAATCATGCTGACTCTGTGGCGGACCCGCGCTCTTGCCGGCCCGGCGATAACGCTGGG
CGTGAGGCTGTGCCCGGCGGAGTTTTTTGCGCCTGCATTTTCCAAGGTTTACCCTGCGCTAAGGGGCGAGATTGGAG
AAGCAATAAGAATGCCGGTTGGGGTTGCGATGATGACGACCACGACAACTGGTGTCATTATTTAAGTTGCCGAAAGA
ACCTGAGTGCATTTGCAACATGAGTATACTAGAAGAATGAGCCAAGACTTGCGAGACGCGAGTTTGCCGGTGGTGCG
AACAATAGAGCGACCATGACCTTGAAGGTGAGACGCGCATAACCGCTAGAGTACTTTGAAGAGGAAACAGCAATAGG
GTTGCTACCAGTATAAATAGACAGGTACATACAACACTGGAAATGGTTGTCTGTTTGAGTACGCTTTCAATTCATTT
GGGTGTGCACTTTATTATGTTACAATATGGAAGGGAACTTTACACTTCTCCTATGCACATATATTAATTAAAGTCCA
ATGCTAGTAGAGAAGGGGGGTAACACCCCTCCGCGCTCTTTTCCGATTTTTTTCTAAACCGTGGAATATTTCGGATA
TCCTTTTGTTGTTTCCGGGTGTACAATATGGACTTCCTCTTTTCTGGCAACCAAACCCATACATCGGGATTCCTATA
ATACCTTCGTTGGTCTCCCTAACATGTAGGTGGCGGAGGGGAGATATACAATAGAACAGATACCAGACAAGACATAA
TGGGCTAAACAAGACTACACCAATTACACTGCCTCATTGATGGTGGTACATAACGAACTAATACTGTAGCCCTAGAC
TTGATAGCCATCATCATATCGAAGTTTCACTACCCTTTTTCCATTTGCCATCTATTGAAGTAATAATAGGCGCATGC
AACTTCTTTTCTTTTTTTTTCTTTTCTCTCTCCCCCGTTGTTGTCTCACCATATCCGCAATGACAAAAAAAATGATG
GAAGACACTAAAGGAAAAAATTAACGACAAAGACAGCACCAACAGATGTCGTTGTTCCAGAGCTGATGAGGGGTATC
TTCGAACACACGAAACTTTTTCCTTCCTTCATTCACGCACACTACTCTCTAATGAGCAACGGTATACGGCCTTCCTT
CCAGTTACTTGAATTTGAAATAAAAAAAGTTTGCCGCTTTGCTATCAAGTATAAATAGACCTGCAATTATTAATCTT
TTGTTTCCTCGTCATTGTTCTCGTTCCCTTTCTTCCTTGTTTCTTTTTCTGCACAATATTTCAAGCTATACCAAGCA
TACAATCAACTCAAGCTTGCATATGGGATCCGAATTCCAGATCTATGAATCGTAGATACTGAAAAACCCCGCAAGTT 
 
GGATCC - BamHI 
GAATTC - EcoRI 
CTGCAG - PstI 
AAGCTT - HindIII 
AGATCT – BglII 
CATATG - NdeI 
CCCGGG - SmaI 
CTCGAG - XhoI 
GCATGC  -  SphI 
TGA/TAA/TAG - STOP codons
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Appendix F   Calculations and curve fitting of data from binding 
affinity assays  
 
In the competition binding assays described in this thesis, the cleaved Ldb1LID peptide 
(4.7 kDa) should be displaced by the larger MBP-Ldb1LID construct (48.3 kDa) with an assumed 
identical binding affinity. In this case there is a fluorescent 'receptor' (A= Fl-Cys-LMO4LIMs, 
Table F.1) and two homologous non-fluorescent 'ligands' (B=Ldb1LID and B'=MBP-Ldb1LID) as 
opposed to standard FA competition formats where a smaller fluorescent ligand is displaced 
from the larger receptor protein resulting in reduced anisotropy. Therefore, instead of two 
fluorescent species, this assay contains three (free A and two complexes AB and AB'), which 
makes calculations of binding affinity complex. Note that the total concentrations of A and B are 
also equal ([A]T=[B]T).  
 
Table F.1. Definition of terms. 
 
Term Definition 
A Fluorescently labelled LIMs construct 
B Ldb1LID 
B' MBP-Ldb1LID 
AB Fluorescent-LIMs : Ldb1LID complex 
AB' Fluorescent-LIMs : MBP-Ldb1LID complex 
[A], [B] and [B'] Concentrations of relevant unbound (free) species 
[AB] and [AB'] Concentrations of relevant complexes 
[A]T, [B]T and [B']T 
Total concentrations. Sums of concentrations of a free species and 
relevant complex(es) it takes part in. [A]T=[A]+[AB]+[AB'], 
[B]T=[B]+[AB] and [B']T=[B']+[AB'] 
robs Observed (measured) anisotropy 
rA, rAB and rAB' 
Anisotropy values of theoretical samples with 100% A, AB or AB' 
respectively 
rmax and rmin 
Maximal and minimal observed anisotropy for any specific titration 
(binding assay). 
Ishift Intensity of a shifted complex band in protein gel shift assays 
Ins Intensity of a non-shifted band(s) in protein gel shift assays 
IT Total fluorescence intensity in a gel lane. IT = Ishift + Ins 
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In this analysis it is assumed that the Ldb1LID peptide binds along the labelled LIMs 
construct without significantly changing shape and size of the labelled construct upon 
dissociation. Therefore, it can be assumed that the relevant anisotropy value of a sample with 
100% of labelled-LIMs monomer (rA) or with a 100% labelled-LIMs:LID complex (rAB) are 
approximately the same.  
  rA ≈ rAB         Equation F.1 
The observed anisotropy (robs) is a sum of anisotropies from the relevant labelled species, 
  robs = rA·ƒ(A) + rAB'·ƒ(AB') + rAB·ƒ(AB)     Equation F.2 
By replacing the rA with rAB and some rearranging the following is obtained, 
  robs = rAB· (ƒ(A) + ƒ(AB)) + rAB'·ƒ(AB')    Equation F.3 
and since ƒ(A) +ƒ(AB) +ƒ(AB') = 1      Equation F.4 
ƒ(A) + ƒ(AB) can be substituted to obtain 
  robs = rAB· (1 - ƒ(AB')) + rAB'·ƒ(AB')     Equation F.5 
which can be further rearranged to 
  robs = rAB + ƒ(AB') · (rAB' - rAB)     Equation F.6 
and knowing that rAB' = rmax and rAB = rmin , a normalized response rn can be calculated  
  rn = (robs - rmin) / (rmax - rmin)       Equation F.7 
Since   rn = ƒ(AB') = [AB']/AT       Equation F.8 
rn values can be used to plot the data. 
In gel shift experiments, each lane contains bands with the free labelled monomer and/or 
the complex(es) containing it, whereas the band intensities are proportional to amounts of 
labelled monomer in each band. Even though the reaction is not at equilibrium during 
electrophoresis, it is assumed that for strong interactions (with low off rates) and at a low 
temperature (4° C in this case), the ratio of band intensities in each lane is a good approximation 
to a ratio of labelled species in the relevant sample. If the bands in a gradient gel do not have a 
significant smear, this assumption is likely to be true. 
A ratio of the shifted band intensity (Ishift) vs. the sum of shifted and non-shifted (Ins) band 
intensities equals the fraction of labelled protein that is in the complex: 
  Ishift/(Ishift+Ins) = [AB']/[A]T      Equation F.9 
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and if the following is defined  
  Itotal = Ishift + Ins        Equation F.10 
  Ishift/IT = [AB']/[A]T         Equation F.11 
Since IT calculations were not always reliable, and knowing that multiplying a function 
by a constant would not affect the IC50 estimate from the non-linear regression analysis [176], 
Ishift instead of Ishift/IT values could be easily entered when the function is fitted, provided that the 
slope (k) parameter is not fixed.  
F.1 Fitting the data for homologous competition binding with  ligand 
depletion 
A solution to the ligand depletion problem can be obtained [323, 350]. When two 
different constructs B = Ldb1LID and B' = MBP-Ldb1LID with the same binding affinity Kd for a 
fluorescently labelled protein (A) are in competition and total concentrations of A and B are the 
same and constant, assuming an equilibrium and no non-specific binding, the following 
equations can be worked out: 
  [AB'] = [A]T·[B']/([B] + [B'] + Kd)      Equation F.12 
and the experimentally obtained responses (Y) to a titration of [B']T can be normalized, 
  (Y - Ymin)/(Ymax - Ymin) = YN     Equation F.13 
As  YN = [AB']/[A]T       Equation F.14 
using the F.12, the following can be obtained  
  YN = [B']/([B] + [B'] + Kd)      Equation F.15 
At equilibrium, the fractions of free vs. total protein are the same for B and B', therefore  
  [B] = [B']·[B]T/[B']T       Equation F.16 
and  [B'] = [B']T - [AB']       Equation F.17  
so the following can be derived: 
  YN = ([B']T - [AB'])/(([B']T - [AB'])·([A]T/[B']T + 1) + Kd)  Equation F.18 
and after exchanging [AB'] = [A]T·YN the following is obtained 
  ([A]T
2
/[B']T + [A]T)·YN
2
 - (Kd + 2·[A]T + [B']T)·YN + [B']T = 0 Equation F.19 
Consequently, the solution to this quadratic equation gives   
Appendix F 218 
 
 
 
  YN = ( - b - ((b)
2
 - 4·a·c)
1/2
)/(2·a)     Equation F.20 
where 
  a = [A]T
2
/[B']T + [A]T       Equation F.21 
  b = - (Kd + 2· [A]T + [B']T)      Equation F.22 
  c = [B']T        Equation F.23 
By entering values for [A]T and fitting this formula to experimental data for [B']T and Y 
(YN) in the Origin9.1 program, Kd values were determined.  
 
 
